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Zusammenfassung 
 
Die Myc Proto-Onkogene sind Transkriptionsfaktoren, die eine wichtige Rolle in unterschiedlichen 
zellulären Prozessen spielen. Mutationen in Myc-Genen, oder deren Fehlregulierung, können zur 
Entstehung verschiedenster Krebsarten beitragen. Besonders wichtig sind die Myc-Proteine für die 
Kontrolle des Wachstums auf zellulärer und organismischer Ebene. Im Gegensatz zu Säugetieren 
besitzt Drosophila nur ein Myc-Ortholog. Die Funktionen, welche die Myc-Proteine in der Zelle 
übernehmen, sind zumindest teilweise konserviert. Drosophila Myc ist in Säugerzellen teilweise 
funktionell, und umgekehrt kann menschliches c-Myc letale Myc-Mutationen in der Fruchtfliege retten. 
Das Verständnis über die molekularen Mechanismen, durch welche Myc die Expression seiner 
Zielgene kontrolliert ist in den letzen Jahren stark angewachsen, und etliche neue Myc-Cofaktoren 
sind entdeckt worden. Überraschenderweise ist jedoch wenig über die physiologische Relevanz von 
Myc-Cofaktoren bekannt. 
In dieser Arbeit wird die Entwicklung und die Durchführung eines Myc-abhängigen RNA-Interferenz-
Screens beschrieben. Mithilfe dieses Systems konnten wir mehrere bis anhin unbekannte Myc-
Cofaktoren identifizieren. Zudem beschreiben wir die genauere Analyse zweier Gruppen dieser 
identifizierten Myc-Interaktoren. Dabei handelt sich einerseits um den PAF-Komplex und andererseits 
um das Protein HCF. Der RNA Polymerase II-associated factor1 (PAF) Komplex wurde in Hefe als 
Transkriptions-Elongationsfaktor identifiziert. Im hier beschriebenen RNA-Interferenz-Screen erwiesen 
sich drei Komponenten des PAF-Komplexes als Repressoren des Myc-abhängigen Reportersystems. 
In vivo Experimente haben hingegen gezeigt, dass einige PAF-Komplexkomponenten auch 
aktivierende Funktionen im Zusammenhang mit Myc haben. Zwischen den PAF-
Komplexkomponenten Atms, Atu und Rtf1 und Myc besteht eine genetische Interaktion, und eine 
Reduktion der Proteinmenge dieser Komponenten führt zu verringertem Wachstumspotential in 
verschiedenen Geweben. Wir stellten auch fest, dass der PAF-Komplex für die korrekte Expression 
von Myc-Zielgenen benötigt wird und dass er mittels seiner Untereinheit Atu direkt an Myc bindet. 
Im Gegensatz zum PAF-Komplex, wurde im Screen das Protein Host cell factor (HCF) als Aktivator 
identifiziert. Wir konnten zeigen, dass HCF zusammen mit Myc im Drosophila-Auge 
wachstumsfördernd wirkt. Myc-Überexpression in Flügeln führt zu erhöhtem Wachstum und 
verursacht verschiedenste Defekte. Eine Reduktion der HCF-Menge in Flügeln hemmt die Entstehung 
solcher Myc-Überexpressionsdefekte, was dafür spricht, dass Myc HCF benötigt, um seine volle 
Aktivität zu erreichen. Ein weiteres Indiz für diese Annahme lieferten qRTPCR-Messungen, die 
zeigten, dass HCF die Expression von Myc-Zielgenen beeinflusst. Schliesslich stellten wir mittels 
Coimmunopräzipitationen aus Embryolysaten eine direkte Bindung zwischen Myc und HCF fest. Diese 
Daten zeigen schlüssig auf, dass es sich bei HCF um einen essentiellen Cofaktoren von Myc handelt, 
der zu dessen vollen Aktivität beiträgt. Bis anhin ist es jedoch unbekannt, wie diese Interaktion auf 
molekularer Basis abläuft. Mit dieser Arbeit konnten wir zeigen, dass sowohl der PAF-Komplex als 
auch HCF genetisch mit Myc interagieren und dass beide Faktoren direkt an Myc binden. Diese 
Resultate weisen sehr stark darauf hin, dass es sich bei beiden Faktoren um physiologisch wichtige 
Cofaktoren von Myc handelt. 
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Summary 
 
The myc proto-oncogenes, which encode transcription factors of the bHLHzip superfamily, play an 
important role in a wide variety of cellular processes. Most prominent is their involvement in the control 
of cellular and organismal growth. In contrast to the situation in vertebrates, where several members of 
the Myc protein family are present, there is one sole Drosophila orthologue. Drosophila Myc and its 
human homologue c-Myc can partially substitute for each other in several assays. This suggests that 
the Myc functions between Drosophila and humans are conserved. In recent years, the knowledge of 
the molecular mechanisms how Myc regulates the expression of its many targets has been 
significantly expanded and a considerable number of putative cofactors involved in these processes 
have been identified; still the physiological relevance of these proteins is far less well understood. 
In this study, we describe the setup and performance of a Myc-dependent RNA interference (RNAi) 
screen and we report the characterisation of novel Myc cofactors identified in the screen.  
The generation of a reporter system that reliably monitors Myc activity made it possible to perform a 
screen for novel cofactors of Myc involved in transcription control. Using Myc-dependent luciferase 
reporters, we have identified the multisubunit PAF complex and HCF as potential Myc cofactors and 
have analysed them further. The RNA Polymerase II-associated factor1 (PAF) complex, which is 
required for several steps during transcription elongation, was identified as a repressor of the Myc-
dependent reporter system. However, in vivo experiments have revealed that several PAF complex 
components exert coactivating functions. We could show that the PAF complex interacts genetically 
with Myc, since depletion of Atms, Atu and Rtf1 reduces the growth potential in a variety of tissues in 
vivo, especially in the presence of elevated Myc levels. Interestingly, we also found evidence that the 
PAF complex component Hyx acts as a repressor of Myc in some contexts. Furthermore, the PAF 
complex subunits Atu, Atms, Hyx and Rtf1 are required for the proper expression of RNA polymerase 
II-transcribed target genes of Myc. We also revealed a physical interaction between Myc and the PAF 
complex mediated by the direct binding of Myc to the Atu subunit of PAF.  
The Host cell factor (HCF) was identified as an activator of the Myc-dependent reporter system. In vivo 
HCF synergises with Myc to promote growth in the eye. Conversely, depletion of HCF by RNAi 
potently reverts Myc overexpression phenotypes in the wing, and to a lesser extent also in the eye. 
Moreover, expression of Myc target genes in S2 cells is influenced by HCF. We could also show that 
the endogenous HCF and Myc proteins physically interact in Drosophila embryos. These data 
coherently indicate that Myc requires HCF to attain its full transcriptional activity. The molecular 
mechanism behind the Myc:HCF interaction remains to be elucidated. However, there is preliminary 
evidence for a possible involvement of Ash2-containing HMT complexes. Taken together, we present 
evidence that both the PAF complex and HCF genetically and physically interact with Myc, which 
identifies them as physiologically relevant cofactors of Myc. 
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Introduction 
 
1. The proto-oncogene myc 
myc is one of the most widely studied and medically relevant human proto-oncogenes. myc gene 
expression is estimated to be deregulated in 20% of all human cancers, resulting in elevated levels of 
Myc protein (Nesbit et al., 1999). Three decades ago, variants of the viral oncogene v-myc were 
isolated from four separate avian retroviruses (Sheiness et al., 1978). Several years later, it became 
clear that the v-myc variants were virally captured forms of the cellular homologue (c-myc) and were 
shown to confer the oncogenic potential to the myelocytomatosis virus (Vennstrom et al., 1982). The 
observation that retroviruses lacking oncogenes become tumorigenic when they integrate adjacent to 
the cellular myc locus (c-myc), and the discovery that Burkitt’s lymphoma is caused by a chromosomal 
translocation of c-myc in B cells (Hollis et al., 1984) have further established myc’s role as a potent 
oncogene. In humans myc is a multigene family including c-myc and two distinct paralogues that are 
frequently mutated in neuroblastomas and retinoblastomas (N-myc) (Kohl et al., 1983) and small cell 
lung carcinomas (L-myc) (Nau et al., 1985). In addition, there are two paralogues S-myc and B-myc, 
which so far have only been characterised in rodents. Both variants do not possess neoplastic 
potential (Henriksson and Luscher, 1996). 
The myc genes encode transcription regulators of the basic region/helix-loop-helix/leucine zipper 
(bHLHzip) superfamily, which play an important role in the control of a variety of cell behaviours, 
including cellular growth, cell-cycle progression, metabolism, differentiation and apoptosis (reviewed in 
Dang et al., 2006). The importance of the myc genes in controlling cell growth and proliferation 
(amongst others), and their involvement in diverse cellular disorders, is demonstrated by the 
essentiality of c-myc and N-myc during development. A null mutation in c-myc leads to lethality of 
mouse zygotes after 10.5 days of gestation (Davis et al., 1993), N-myc null mutants die after 11.5 days 
(Sawai et al., 1991; Sawai et al., 1993), while L-myc mutants are fully viable (Hatton et al., 1996). 
 
1.1. Biological functions of Myc 
The expression of Myc is tightly controlled by the availability of growth factors, cytokines and mitogens 
(Kelly et al., 1983; Shibuya et al., 1992; Armelin et al., 1984). Consistent with its role as one of the 
classical “immediate early genes” Myc activity is required for cell cycle entry (Johnston et al., 1999; 
Amati, 1998). Ectopic expression of c-myc from a retroviral vector can drive quiescent cells into the 
cell cycle and has been shown to promote S phase entry and shorten G1 phase in cycling cells (Karn 
et al., 1989). Furthermore, the requirements for growth factors are reduced upon Myc overexpression 
and cell cycle exit is prevented (Sorrentino et al., 1986; Stern et al., 1986). Conversely, reduced Myc 
levels prevent quiescent cells from entering the cell cycle in the presence of mitogenic signals 
(Roussel et al., 1991; Barone and Courtneidge, 1995). Several cell cycle regulators, including cyclins 
D1, D2 and cdk4, were found to be direct targets of myc (Bouchard et al., 2001; Menssen and 
Hermeking, 2002). Moreover, Myc has been shown to collaborate with Ras in the accumulation of 
active cyclin E/cdk2 and E2F, therefore inducing cell-cycle entry (Leone et al., 1997). Not only the 
induction of cell cycle promoting genes, but also suppression of inhibitory factors, contribute to Myc’s 
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activating role of the cell cycle. Both CDK inhibitors p21CIP and p15INK4B are repressed by Myc 
(Staller et al., 2001; Wu et al., 2003).  
Overexpression of c-Myc in the absence of survival factors does not only promote proliferation, but 
also leads to both ARF-Mdm2-p53-pathway-dependent and p53-independent apoptosis (reviewed in 
Meyer et al., 2006; Askew et al., 1991; Evan et al., 1992; Zindy et al., 1998). This observation initially 
stood in marked contrast to the view of myc’s role as an oncogene. However, other oncogenes such 
as E1A and E2F1 were identified to induce apoptosis in a similar manner. The recent view states that 
in addition to mutations in oncogenes, pro-apoptotic pathways must be disabled in order to promote 
transformation (Nilsson and Cleveland, 2003). In addition to inducing apoptosis, Myc overexpression 
was shown to prevent terminal differentiation. Consistently, endogenous myc expression decreases 
rapidly during the terminal differentiation of many cell types (Freytag, 1988; Henriksson and Luscher, 
1996). 
Myc not only regulates proliferation but also heavily impacts on cell growth (accumulation of cell 
mass). It has been shown, both in murine and human cell lines, that overexpressed Myc induces cell 
growth independently of the cell cycle phase and that this increased growth correlates with higher 
protein synthesis rates (Schuhmacher et al., 1999; Iritani and Eisenman, 1999). Also in Drosophila 
Myc plays a crucial role in the regulation of cell growth, since growth is accelerated and cell size is 
inreased upon overexpression of Myc (Johnston et al., 1999). Conversely, partial loss of Myc function 
(as in the hypomorphic myc mutation dmP0) results in a prolongation of G1 phase and a substantial 
reduction of cellular size, irrespective of the cell cycle phase (Johnston et al., 1999). In accordance 
with the observation that Myc drives protein synthesis, transcriptome profiling techniques (such as 
SAGE and microarrays) identified a considerable number of genes involved in ribosome biosynthesis 
and protein biosynthesis as direct target genes of Myc (Boon et al., 2001; Hulf et al., 2005; Zeller et 
al., 2003). Myc’s role as an important integrator of cell growth became even more apparent when it 
was found not only to regulate RNA polymerase II-transcribed protein-coding genes. In mammals and 
Drosophila Myc controls both the transcription of RNA polymerase III-dependent small RNA genes 
(Steiger et al., 2008; Gomez-Roman et al., 2003) and of polymerase I-dependent ribosomal RNA 
(Grandori et al., 2005; Grewal et al., 2005). Additionally to the broad influence on transcription, Myc is 
proposed to play a direct non-transcriptional role in the initiation of DNA replication. It has recently 
been shown that c-Myc interacts with the pre-replicative complex and localises to early sites of DNA 
synthesis (Dominguez-Sola et al., 2007). Moreover, Myc also influences DNA replication in 
Drosophila, as it was shown to drive endoreplication (Maines et al., 2004). 
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1.2. Molecular functions of Myc 
Myc proteins belong to the basic region/helix-loop-helix/leucine zipper (bHLHzip) superfamily of 
transcription regulators. Analysis of the primary sequence and structure-function analysis of the c-Myc 
protein identified an N-terminal transactivation domain (TAD) (Kato et al., 1990), containing the two 
highly conserved motifs termed Myc Box 1 (MB1) and Myc Box 2 (MB2), and a C-terminally located 
bHLHzip domain. The bHLHzip mediates interaction with Myc’s heterodimerisation partner, the small 
bHLHzip protein Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) and is required for 
DNA binding. Upon interaction with Max, Myc/Max heterodimers are able to bind to hexameric DNA 
sequences with the canonical sequence CACGTG, called E-Boxes (Blackwood and Eisenman, 1991). 
Additionally, non-canonical E-Box variants of the general sequence CANNTG are bound (Blackwell et 
al., 1993; Grandori et al., 1996). Binding of the Myc/Max heterodimers to E-Box sequences is required 
for the transactivation effects of Myc (Amati et al., 1992) and Max was thought to be an essential 
cofactor for all biological activities of Myc, including cell cycle progression, apoptotic and oncogenic 
effects (Amati et al., 1993a; Amati et al., 1993b). However, observations made in rat PC12 cells 
presented evidence for Max-independent functions of Myc, since overexpression of Myc induced 
apoptosis in the complete absence of Max (Wert et al., 2001). Such Max-independent functions of Myc 
were indeed demonstrated by Steiger et al., who could show that control of endoreplication and cell 
competition in Drosophila does not, or only partly, require the association with Max (Steiger et al., 
2008). 
The Myc N-terminus was found to function as a transcription regulation domain. More recent studies 
have provided insight how transactivation by Myc is mediated (reviewed in Cowling and Cole, 2006). 
Association of the transactivation domain with chromatin remodelling (nucleosome 
movement/displacement) and chromatin modifying (histone modification) factors was shown to be 
crucial for biological Myc activity. One factor that was found to bind to the Myc-Box 2 (MB2) sequence 
in the Myc N-terminus is TRRAP (Transformation/tRanscription Domain Associated Protein), whose 
function is required for Myc-mediated transformation (McMahon et al., 1998). TRRAP, homologous to 
the Saccharomyces cerevisiae protein Tra1p, is a component of several histone acetyltransferase 
complexes, including the SAGA (SPT/ADA/GCN5/Acetyltransferase) (Grant et al., 1998) and Tip60 
complexes (Frank et al., 2003). At least part of the transcription activation function of Myc is mediated 
by the recruitment of the HAT GCN5 through TRRAP (McMahon et al., 2000; Liu et al., 2003). 
Furthermore, Myc has been shown to associate with two distinct subunits of the Tip60 complex (Shen 
et al., 2000) independently of TRRAP, the two DNA-helicase/ATPases Tip48 and Tip49 (Wood et al., 
2000). Homologues of Tip48 and Tip49 (Reptin and Pontin) have been shown to interact genetically 
with Myc both in Drosophila (Bellosta et al., 2005) and Xenopus (Etard et al., 2005). In addition to their 
role in HAT complexes, both RVBL1p and RVBL2p (the yeast homologues of Tip49 and Tip48) are 
subunits of the chromatin remodelling complex Ino80 (Shen et al., 2000), while TRRAP is a member of 
the SWI/SNF-related p400 chromatin remodelling complex (Fuchs et al., 2001). This involvement for 
TRRAP, Tip49 and Tip48 in both HAT as well as chromatin remodelling complexes suggests that 
either of these complexes (or both) could have a role in Myc-dependent transcription. Additionally, the 
SWI/SNF subunit INI1/hSNF5 was found to physically interact with c-Myc (Cheng et al., 1999). 
Moreover, overexpression of dominant-negative forms of BRG1, a SWI/SNF complex component, and 
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RUVBL1 (Tip49) block c-Myc-mediated transactivation (Cheng et al., 1999) and transformation, 
respectively (Dugan et al., 2002). Another mechanism of transactivation exerted by Myc works 
independently of chromatin modification or nucleosome displacement, as it was shown in the cases of 
the cad and TERT promoters. At these promoters Myc binding regulates promoter clearance by RNA 
polymerase II directly. Myc was found to directly bind both subunits of the RNA polymerase-associated 
factor P-TEFb (positive transcription elongation factor b), cyclin T1 and CDK9 (Eberhardy and 
Farnham, 2002, 2001; Bouchard et al., 2001). 
In addition, Myc also has the potential to repress certain target genes without binding to E-Boxes. 
Many of the repressed targets encode proteins involved in cell cycle arrest and contain TATA-less 
promoters, featuring a specific initiator element (Inr) that recruits the basal transcription machinery to 
TATA-lacking promoters. Included in this subset of repressed targets are cyclin-dependent kinase 
inhibitors (e.g., p21CIP1, p15INK4B), differentiation inducers, and proteins linked to growth arrest in 
response to stress (Kleine-Kohlbrecher et al., 2006). In the best characterised examples, Myc causes 
trans-repression by associating with the transcriptional activator Miz-1 and thereby preventing it from 
associating with the coactivator protein p300 (reviewed in Wanzel et al., 2003). 
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2. The Max network 
The fact that Myc is unable to homodimerise, or specifically bind DNA at physiological protein 
concentrations, prompted the search for Myc interacting factors. This led to the identification of the 
small bHLHzip protein Max (Grandori et al., 2000). Max has no transactivation domain on its own and 
is transcriptionally inert in reporter assays (Kato et al., 1992). Still, Max is able to form homodimers 
which bind to the same E-Boxes in vitro that are recognised by Myc/Max heterodimers (Blackwood 
and Eisenman, 1991; Prendergast et al., 1991) and repress transcription from E-Box reporters 
(Kretzner et al., 1992). However, the biological relevance of this observation seems to be limited, since 
this repression is only confined to artificial reporter genes as Max homodimers do not repress Myc-
responsive genes in vivo (Yin et al., 1998). Moreover, Max is limiting under normal physiological 
condititons and therefore the Max protein pool in a given cell is bound by other bHLHzip proteins 
(Walker et al., 2005). 
Apart from its role as a cofactor of Myc, Max was shown to dimerise with other bHLHzip proteins that 
function as transcriptional repressors (reviewed in Hurlin and Huang, 2006). Various assays using Max 
protein as a probe, led to the discovery of the four closely related bHLHzip proteins Mad1, Mxi1, Mad3 
and Mad4 (also called MXD1-4) (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995) and of the 
proteins Mnt (also termed Rox) (Hurlin et al., 1997) and Mga (Hurlin et al., 1999). The five proteins 
MXD1-4 and Mnt were shown to interact with Sin3 corepressor complexes via their SID (Sin3-
interaction domains). Sin3, in turn, mediates active repression by recruitment of the class I histone 
deacetylases HDAC1 and HDAC2 which leads to subsequent deacetylation of histone tails, and 
formation of repressive chromatin structure (Hassig et al., 1997). Consistent with their role as 
transcriptional repressors, the Mad and Mnt proteins block Myc-dependent cell transformation in cell 
culture assays (Ayer and Eisenman, 1993; Hurlin et al., 1995; Koskinen et al., 1995; Schreiber-Agus et 
al., 1995; Hurlin et al., 1997; Ayer et al., 1993), as well as the expression of synthetic reporters in an 
E-Box dependent manner (Ayer et al., 1993; Hurlin et al., 1997). Increased expression of the Mad 
proteins is associated with the onset of cellular differentiation and growth arrest (Ayer and Eisenman, 
1993; Chin et al., 1995). Moreover, for both Mxi and Mnt tumour suppressor activity could be shown 
(Hurlin and Huang, 2006).  
Recent studies have provided evidence that Mnt is the crucial antagonist of Myc function. While the 
expression of Mad proteins is highly regulated and generally restricted to terminal differentiation in a 
range of cell types (Hurlin et al., 1995; Queva et al., 1998), mnt is ubiquitously expressed and readily 
detected as Mnt/Max heterodimers along with Myc/Max in proliferating cells (Zhou and Hurlin, 2001). 
In accordance with this expression pattern mnt knockout mice display the severest phenotype. They 
die shortly after birth, whereas mad1, mxi1 and mad3 single-mutant mice are viable and display rather 
subtle phenotypes. In addition, cells that are mutant for mnt show many characteristics of Myc 
overexpression (Hurlin et al., 2003; Nilsson et al., 2004; Dezfouli et al., 2006; Toyo-oka et al., 2006). 
Furthermore, Myc and Mnt have been shown to control similar sets of target genes (Toyo-oka et al., 
2006). Taken together, these data show that Mnt directly antagonises Myc function in vivo. 
The biological functions of Mga are less well understood (Hurlin et al., 1999). Mga is a large protein 
with two DNA binding domains: the bHLHzip domain and a T-Box, a domain involved in the control of 
a wide range of developmental processes (Papaioannou and Silver, 1998). Mga might function as a 
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dual-specificity transcription factor that regulates the expression of both Max-network and T-box family 
target genes in a Max-dependent manner. Interestingly, Mga and Max are also found in an E2F6 
repression complex. This complex occupies E2F- and Brachyury- (i.e. T-box-) binding sites as well as 
E-Boxes in G0 phase, which suggests that these chromatin modifiers contribute to silencing of E2F- 
and Myc-responsive genes in quiescent cells (Ogawa et al., 2002). 
 
3. The Max network in Drosophila 
Drosophila contains single orthologs of the mammalian myc, max and mad/mnt genes (Gallant et al., 
1996; Loo et al., 2005), called dmyc, dmax and dmnt (hereafter the terms myc, max and mnt will refer 
to the Drosophila orthologues). In addition to the advantages of Drosophila as a genetically well 
characterised animal model, the lack of redundancy made it possible to overcome many problems 
associated with studying Myc genes in mammalian model organisms. Moreover, there is conservation 
of many of the important Myc interactors and cofactors that were characterised in mammalian 
systems, including TRRAP, Tip48, Tip49 and other components of histone modifying and chromatin 
remodelling complexes. 
 
3.1. myc 
The Drosophila Myc protein is encoded by the gene diminutive (dm), a gene that was described based 
on the mutation dm1 in the 1930s (Bridges, 1935). The official gene designation is dm but the synonym 
myc (or dmyc) is widely used in the literature. As in vertebrates, heterodimers between Drosophila 
Myc and Max bind to canonical E-Box sequences, thereby activating target genes (Gallant et al., 
1996). While the overall conservation of Myc compared to its vertebrate orthologues is rather limited, 
the bHLHzip domain is highly conserved, as is the MB2 domain in the N-terminus, and the central 
acidic region (Gallant, 2006). Importantly, Myc and c-Myc can functionally substitute for each other. 
Myc can transform rat embryo fibroblasts when coexpressed with oncongenic RasV12 (Schreiber-
Agus et al., 1997). Myc also functionally substitutes for c-Myc in transactivation assays (Gallant et al., 
1996), and rescues proliferation defects of mouse embryonic fibroblasts from c-myc conditional 
knockouts (Trumpp et al., 2001). Conversely, the lethality of a strong hypomorphic myc mutant can be 
rescued by expressing an isoform of c-Myc (Benassayag et al., 2005). The interchangeability of the 
Drosophila and vertebrate Myc proteins demonstrates a high degree of functional conservation 
between the Myc homologues. 
In general, loss of Myc function is associated with growth defects. Hypomorphic myc mutants can 
reach adulthood, are normally patterned, but they are reduced in body size and weight. Additionally, 
they also display a thin bristle phenotype and prolonged development. The small body size of myc 
mutants is caused by a reduction in cell size and not a reduced number of cells (Johnston et al., 
1999), as opposed to mice with hypomorphic or null mutations in c-myc, where both cell number and 
cell size are reduced. Strong hypomorphic or null mutations cause larval lethality (Maines et al., 2004; 
Pierce et al., 2004). Clonal analyses revealed growth defects of myc mutant clones both in diploid and 
polyploid tissues (Pierce et al., 2004; Maines et al., 2004; Johnston et al., 1999). Conversely, Myc- 
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overexpression leads to size increases in diploid cells and, to an even larger extent, in polyploid 
endoreplicating cells. 
Myc impacts both on cellular growth and the cell cycle. Hypomorphic mutant imaginal wing disc cells 
remain small and show a slight prolongation in G1 phase, whereas overexpression of Myc leads to a 
size increase and a strong acceleration of the G1-S transition. However, the cycling rates of the cells 
are not accelerated, since the shorter G1 phases are compensated with a prolonged duration of the S 
and G2 phases. Therefore, only cell size but not cell number is increased (Johnston et al., 1999). 
Several of the hallmark characteristics of myc mutants, like developmental delay, or slender bristles 
are reminiscent of the phenotypes seen with Minute mutants. Minute genes encode ribosomal 
proteins; therefore Minute mutants are partially impaired in biosynthesis. These similarities, the 
increase of nucleolar size in Myc-overexpressing animals (Grewal et al., 2005), and the fact that a 
large number of direct Myc target genes is involved in rRNA processing and ribosome biosynthesis 
(Orian et al., 2003; Hulf et al., 2005) suggest an important role for Myc in the regulation of these 
processes. Moreover, Myc has been shown to regulate RNA polymerase I-dependent transcription 
(Grandori et al., 2005; Grewal et al., 2005).  
Another striking resemblance between Minute and myc mutations comes from the observation of 
clonal growth in wing imaginal discs. In both myc and Minute mutant situations cells with lower 
biosynthesis rates are eliminated and replaced by their fitter neighbouring cells, a phenomenon that 
was discovered for Minute mutations in the 1980s and which was termed cell competition (Simpson 
and Morata, 1981). Similarly, clones mutant for the weak hypomorphic allele dmP0 are eliminated by 
the heterozygous dmP0/+ tissue (Johnston et al., 1999). More recently, it has been demonstrated that 
upon juxtaposition of cells with differing myc levels, apoptosis is induced in the cell with lower myc 
levels (De La Cova et al., 2004; Moreno and Basler, 2004). This competition also holds true in a 
situation where cells with physiological myc levels are outcompeted by neighbours containing (even 
moderately) enhanced myc levels. So far, cell competition has not been described for mammalian 
systems. However, if it existed, the process of field cancerogenesis might play an important role in the 
formation of tumours (Braakhuis et al., 2005). 
 
3.2. max 
Like its mammalian orthologues, Max is an essential cofactor for the regulation of E-Box dependent 
transcription. It forms transcription-activating Myc/Max heterodimers as well as the repressive Max/Mnt 
counterparts that regulate the expression of target genes upon binding to E-Box sequences (Gallant et 
al., 1996; Loo et al., 2005). The observation that phenotypes of max null mutations are less severe 
than lesions in myc, led to the identification of Max-independent functions of Myc (Steiger et al., 2008). 
In contradiction to the present notion, several biological functions of Myc, like cell competition, 
endoreplication and the regulation of RNA polymerase III-transcribed small RNA genes do not, or at 
least not fully, depend on Max. 
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3.3. mnt 
The sole Drosophila ortholog of the mad/mxi/mnt family has been termed mnt, as it is most similar to 
the vertebrate mnt gene regarding its size and structure (Loo et al., 2005). Together with Max, Mnt 
binds to canonical E-Box sequences and acts as a transcriptional repressor by recruiting Sin3 
corepressors, which subsequently cause deacetylation of surrounding chromatin by HDACs. Unlike 
the mnt mutant knockout mice, which die at birth, mnt mutant flies are fully viable. Compared to wild 
type animals, mnt mutants have larger individual cells and a higher body weight (Loo et al., 2005).   
 
4. Identification of Myc target genes 
The development of large scale screening technologies like microarry expression profiling, ChIP on 
chip assays, or serial analysis of gene expression (SAGE) has greatly facilitated the identification of 
potential Myc targets (reviewed in Dang et al., 2006). Recent estimates suggest that Myc could 
regulate as many as 15% of genes in genomes from flies to humans (Orian et al., 2003; Fernandez et 
al., 2003; O'Connell et al., 2003). Despite the fact that a large number of target genes have been 
identified in recent years, the data from various studies only show a limited overlap, which can be 
attributed to several factors: First of all, data compilation is dependent on the technique and biological 
system of choice. Furthermore, Myc is a short-lived protein, whose transcriptional regulatory effects 
only ranges from 2 to 5 fold. Thus, targets can be difficult to identify against the background of the 
strong global effects on cell behaviour. 
Recently, a long list of putative Myc target genes has been compiled by using methods such as 
microarrays, ChIP-on-chip, or in silico bioinformatic searches. Most studies have relied on responses 
to changes in Myc protein levels as their primary screening approach. Methods like the inducible 
MycER system (Eilers et al., 1989) have been extensively used. The MycER method relies on a 
chimeric Myc-estrogen receptor fusion protein that is being sequestered in the cytoplasm by 
chaperones and upon induction with estrogenic compounds travels to the nucleus to induce target 
gene expression. In order to identify primary targets, the MycER method is preferably applied in the 
presence of cycloheximide to block translation. However, the MycER system does not fully reflect the 
physiological conditions in the cell. Therefore, it is crucial to identify endogenous target genes of Myc 
in the presence of physiological Myc levels. Chromatin immunoprecipitation (ChIP) experiments are 
suitable to detect Myc binding in vivo at cognate genomic sites (Eberhardy and Farnham, 2001). ChIP 
experiments in human cell lines overexpressing Myc showed that an extremely large number of loci 
were bound by Myc. These loci can be roughly divided into two classes of genes that are bound in a 
Myc titre dependent manner (Fernandez et al., 2003): A “high-affinity” group of targets that is being 
bound independently of the Myc-expression level and invariably at the E-Box sequence(s), and a set 
of “low-affnity” target genes that are bound by Myc with increased frequency upon Myc overexpression 
and, at extreme Myc levels, also at sequences other than E-Boxes. This finding might be interpreted to 
indicate that overexpression of Myc leads to widespread unspecific association with sites that are not 
bound in cells with lower Myc expression, which definitely holds true for unphysiologically high Myc 
concentrations upon strong overexpression. But how does Myc recognise the subset of targets 
amongst the huge number of potential Myc binding sites present throughout the genome? Recent data 
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from Guccione and coworkers (Guccione et al., 2006) prove that binding-site recognition by Myc is 
determined by the chromatin context. Myc was shown to cluster with euchromatin sites that are 
characterised by elevated levels of histone H3 trimethylated on residue K4 or histone H3 trimethylated 
on K79 (abbreviated as H3K4me3 or H3K79me3) and acetylated H3, whereby H3K4me3 showed the 
strongest correlation with Myc binding. Moreover, these euchromatin marks are present independently 
of Myc binding, and they are not affected by changes in Myc levels. This suggests that Myc binding to 
specific sites is a consequence of the chromatin structure and that sequence recognition by Myc is 
important, but comes second to chromatin recognition. Thus, E-Boxes outside euchromatic islands are 
not normally bound in a physiological context, but might possibly be bound in the presence of 
supraphysiological Myc levels, which might account for the large number of loci that were only 
identified in Myc overexpression studies. The correlation between distinctive histone marks and 
preferential recruitment of Myc to these sites may well constitute a mechanism of target selection. In 
such cases, Myc would be associated with cofactors that recognise – perhaps redundantly - acetylated 
or methylated histone residues with their chromo- or bromo-domains and therefore are able to 
selectively “read” the histone code. Such a tethering of Myc to restricted chromatin domains would 
greatly reduce the portion of the genome accessible to physiological Myc binding. Once bound to 
DNA, Myc locally enhances histone acetylation, but not methylation (Guccione et al., 2006). Other 
adaptor proteins, such as β-catenin, induce trimethylation of histone H3 on K4 (Sierra et al., 2006) and 
may regulate the access of Myc to a subset of promoters. 
With Myc target genes approaching a total of about 3000-4000 in humans, it is critical to further 
decode regulatory modules (i.e. the protein complexes that are required for Myc-dependent 
expression of certain subsets or all target genes) that associate with Myc and to determine the 
contribution of individual Myc binding sites to the regulation of target genes.  
 
4.1. Myc target genes 
Even though overexpression studies suggest that c-Myc might control up to 15% of all loci in a 
genome, this is likely to be an overestimate, and Myc is probably influences less than 5% of all genes 
under physiological conditions (Hulf et al., 2005). Within this group of c-Myc targets, certain classes of 
genes are greatly overrepresented. These targets are involved in protein biosynthesis, metabolism, 
cell cycle regulation, cell adhesion and the cytoskeleton. The deregulated expression of c-Myc also 
induces genes that contribute to apoptosis under nutrient or growth factor deprivation. In addition to 
protein coding genes, microRNAs were identified to be regulated by Myc proteins in vertebrates 
(O'Donnell et al., 2005; reviewed in Dang et al., 2006; Chang et al., 2008). microRNAs are small 
regulatory molecules that regulate the stability or translational efficiency of target mRNAs. They are 
transcribed as long transcripts, which subsequently undergo processing and maturation to form 
microRNA duplexes. One of the mature miRNA strands is incorporated into the RNA-induced silencing 
complex (RISC) and guides target mRNA silencing. Recently, c-Myc and Myc were also discovered to 
control RNA polymerase I and III-transcribed targets (Grewal et al., 2005; Grandori et al., 2005; 
Gomez-Roman et al., 2003; Steiger et al., 2008). By regulating transcriptional activity of all three RNA 
polymerases, Myc even has greater influence on ribosome biogenesis and protein synthesis. Despite 
significant advances in the knowledge of Myc target genes, it is to date unknown whether Myc 
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promotes tumorigenesis by altering the expression levels of physiological Myc targets, by controlling 
non-physiological targets, or by a combination of both mechanisms. 
 
5. RNA interference 
The discovery of the RNA interference (RNAi) phenomenon has radically changed the field of 
experimental genetics in recent years. Not surprisingly, Andrew Fire and Craig Mello, the researchers 
who discovered RNAi gene silencing, were awarded the Nobel Prize for Physiology or Medicine in 
2006. Because of RNAi reverse genetic approaches to globally or selectively dissect genetic pathways 
by specific knockdown of gene expression became feasible in many model organisms. Moreover, the 
reduction of expression without fully abrogating gene function makes it possible to assess 
hypomorphic phenotypes of essential genes.  
The phenomenon RNAi, also known as post-transcriptional gene silencing (PTGS), was discovered by 
chance in the late 1980s. Attempts to increase the colouration of petunia flowers by inserting extra 
copies of the pigmentation gene surprisingly led to variegating petal colouration or even complete 
absence of colour, due to degradation of pigmentation mRNAs from both the endogenous locus and 
the transgene (Napoli et al., 1990). The injection of antisense RNA complementary to the gene par-1 
in Caenorhabditis elegans resulted in the expected embryonic lethality, but surprisingly also control 
sense RNA gave a similar phenotype (Guo and Kemphues, 1995). Experiments performed in following 
years revealed, that a mixture of sense and antisense RNA resultet in 10-fold greater reduction of 
endogenous transcript levels than either strand alone (Fire et al., 1998). In retrospective, the initial par-
1 single-strand RNAs were most probably contaminated with complementary strands. 
RNA interference plays an important part in regulating the expression of cellular RNAs. On one hand, 
RNAi is involved in the innate immune surveillance system. Double stranded RNAs, which can be 
produced by invasive genetic elements but is not supposed to arise from tightly regulated cellular 
genes, are detected and the corresponding target genes are post-transcriptionally silenced. On the 
other hand the same mechanism is important in production of microRNAs (miRNAs). These small 
RNAs, which are cellularly expressed, regulate the translation efficiency of partially complementary 
target mRNAs, many of which code for crucial developmental genes that are often also involved in the 
genesis of neoplastic diseases. The RNAi mechanism is activated when dsRNA recruits an RNase III 
type enzyme called Dicer, which cleaves the dsRNA – either long transcripts of invasive elements or 
pre-miRNA – into 21- and 22-nucleotide double stranded fragments (Bernstein et al., 2001; 
Sontheimer, 2005). The 21 and 22 nt fragments, termed short interfering RNAs (siRNAs), are 
subsequently loaded into the large multiprotein nuclease RNA-induced silencing complex (RISC). The 
antisense strand of the siRNAs is used as a template to find homologous mRNA molecules, which are 
then degraded by the complex (siRNAs, miRNAs) or translationally silenced (miRNAs). 
Since the the discovery of the RNAi phenomenon and the unravelling of its mechanism, the technique 
has successfully been used in a variety of model systems. In conjuction with the still expanding 
genomic sequence data, it has become an immensely powerful genetic tool to study biological 
processes. 
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6. Project overview 
Even though the knowledge about the molecular mechanism how Myc regulates the expression of its 
targets has been significantly expanded, and many proteins that interact physically with Myc have 
been identified in vertebrate tissue culture systems in recent years, the physiological relevance of only 
a handful of these putative cofactors has fully been demonstrated. Many studies have relied on Myc 
overexpression to elucidate its transactivation properties or they have examined - the potentially 
indirect - effects of putative cofactors on the transformation potential of Myc in immortalised cell lines. 
A great deal less is known about the physiological effects of putative cofactors in vivo, e.g. on the 
expression of endogenous Myc target genes or their localisation to target promoters in a Myc-
dependent fashion. Furthermore, the association of putative cofactors with Myc is not exclusively 
influencing initial transcription activation but also other Myc-dependent processes, such as re-initiation 
of transcription or repression of certain targets. Moreover, candidate cofactors might impact on Myc’s 
involvement in DNA replication. This lack of data concerning the physiological regulation of Myc 
targets prompted us to carry out an RNA interference screen in Drosophila Schneider 2 cells in order 
to identify physiologically relevant novel cofactors involved in Myc-dependent transcription regulation. 
The fact that the Max network and many essential cofactors are functionally conserved but present in 
a simpler form in Drosophila - with only single orthologues of myc and mnt families present - makes it 
an ideal model to study Myc function. 
In the course of the RNAi screen, gene products of roughly 750 transcription-associated factors were 
downregulated, and the effect on a Myc-dependent luciferase reporter was assayed. About four 
percent of the candidates tested showed a specific influence on the reporter construct driven by the 
promoter of the Myc target gene CG5033. These were considered to be specific Myc-dependent 
transcription regulators. Subsequently, we focussed on two groups of candidates to further 
characterise their molecular and genetic interaction with Myc. The Drosophila Host cell factor protein 
(HCF) and the components of the RNA polymerase-associated factor 1 complex (PAF complex) were 
confirmed as specific Myc cofactors, which are required for the correct expression of Myc target 
genes. Both HCF and the Drosophila orthologue of Leo1, which is termed Atu, directly interact with 
Myc. While HCF clearly acts as a coactivator of Myc function in vivo, experiments with PAF complex 
mutants provided evidence for converse activities of individual subunits. Originally identified as 
repressors of Myc activity in the RNAi screen, in vivo experiments suggest that several PAF complex 
components exert coactivating functions. We could show that the PAF complex subunits Atu, Atms 
and Rtf1 are required for the proper expression of RNA polymerase II-transcribed target genes of Myc. 
Moreover depletion of Atms, Atu and Rtf1 reduces the growth potential in a variety of tissues in vivo, 
especially in the presence of ectopic Myc levels. In contrast the PAF complex component Hyrax (Hyx) 
can also act as a repressor of Myc in a context dependent manner.  
As mentioned above HCF was identified as a positive cofactor of Myc-dependent transcription control. 
In addition to the interaction of overexpressed proteins, we have shown a direct physical interaction 
between endogenous HCF and Myc. Furthermore, HCF impacts on the expression of Myc target 
genes in S2 cells. In vivo HCF synergises with Myc in the promotion of growth in the eye and of 
imaginal wing disc clones. HCF depletion by RNAi has the potential to revert Myc overexpression 
phenotypes in the wing and, to a lesser extent, also in the eye. These data show that Myc requires 
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HCF to reach its full transcriptional activity during proliferation and differentiation. In order to activate 
Myc-dependent transcription, HCF has to recruit additional complexes with enzymatic activity. The 
molecular nature of such a mechanism has to be elucidated, but it might depend on Ash2-containing 
HMT complexes. 
Taken together, we present clear evidence that both the PAF complex and HCF are physiologically 
relevant cofactors of Myc in transcription control.  
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7. Introduction of RNAi screen candidates 
7.1. Proteasome components 
The 26S proteasome is the major non-lysosomal proteolytic manchinery in eukaryotes, by which 
polyubiquitylated proteins are degraded in an ATP-dependent manner (Ciechanover, 1998). 
Polyubiquitylation is known to be responsible for the degradation of many short lived growth-regulating 
proteins, and more than 80% of the proteins in mammalian cells are degraded in the proteasome. 
More recently it became evident that the ubiquitin-proteasome system is implicated in transcriptional 
control, and is used in controlling the distribution, abundance and activity of components of the 
transcriptional machinery (Muratani and Tansey, 2003). It was shown that the activity of many 
transcriptional activators, including Myc, is enhanced by ubiquitylation (Kim et al., 2003; von der Lehr 
et al., 2003). For example the E3 ubiquitin ligase Skp2 not only regulates the stability of Myc in vivo 
but is also required for full activity of Myc (Muratani and Tansey, 2003). Both the “timer” and “black 
widow” mechanism (Kodadek et al., 2006) propose that transcriptional activators have to be 
designated for subsequent destruction in order to obtain their full activation potential. While the timer 
model focusses on a window of activity, during which the activator drives target gene expression, the 
“black widow” model states that activator polyubiquitination and subsequent destruction are a 
necessary consequence of physical interaction with the RNA polymerase holoenzyme. Both models 
stipulate that full activation of transcription factors depends on their ubiquitination. However, it is not 
clear how depletion of proteasome components in the RNAi screen should lead to reduced 
transactivation potential of Myc and hence decreased Myc activity reporter expression. 
The 26S proteasome is assembled from two large macromolecular complexes. The 20S proteolytic 
particle and the 19S regulatory complex (RC). The 20S proteasome is composed of four seven-
membered rings that form a barrel-like structure. Within this chamber, which can be accessed through 
axial pores, the six protease catalytic sites are contained. The 900kDa 19S RC caps one or both ends 
of the 20S particle, and can be functionally subdivided into base and lid components. The base 
complex consists of six homologous AAA ATPases (Rpt1-6: regulatory particle ATPases) and three 
non-ATPase components, whereas the lid of the RC is made of an additional eight non-ATPase 
subunits (Rpns: regulatory particle non-ATPases). The 19S ATPases regulate the assembly of the 
26S proteasome, they unfold substrate proteins targeted for degradation, and they gate protein 
translocation into the central chamber of the 20S proteasome (Ciechanover, 1998; Pickart and Cohen, 
2004). A proteasome complex that consists of the 20S particle and the RC base still performs ATP-
dependent degradation of unfolded proteins, but it can no longer degrade ubiquitin-tagged substrates. 
Therefore the lid subcomplex of the RC recognises polyubiquitin signals. Six components of the 19S 
RC were found in the Myc-dependent RNAi screen as modulators of the luciferase reporter system. 
Five non-ATPase subunits of the lid subcomplex (Rpn5, Rpn6, Rpn7, Rpn11, Rpn12) and Rpn2, which 
forms part of the base subcomplex, were identified. Rpn11, a de-ubiquitylase of whole ubiquitin-
chains, is the only protein of the lid complex with a known enzymatic activity (Verma et al., 2002).  
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7.2. Host cell factor (HCF) 
7.2.1. Vertebrate HCF-1 
The Host cell factor 1, a highly conserved and abundant chromatin-associated protein, was initially 
identified as a component of the VP16-induced transcriptional regulatory complex (Kristie and Sharp, 
1990). HCF-1, one of the two human paralogues, is a broadly expressed nuclear protein, which is 
involved in the regulation of cellular and viral gene expression (Wilson et al., 1993). Upon infection 
with Herpes simplex virus (HSV) the virion transactivator protein VP16 is a key player in the decision 
whether the virus enters the lytic or latent life cycle. To initiate the lytic state, VP16 induces the 
expression of the first set of viral proteins by associating with HCF-1, and subsequently with another 
cellular protein, Oct-1, on regulatory elements in each immediate early gene promoter (Wysocka and 
Herr, 2003).  
HCF-1 is synthesised as a large 2035 amino acid long precursor protein that is subsequently cleaved 
at six central HCF-1PRO repeats (Figure 2). However, the two resulting subunits (HCF-1N and HCF-1C) 
remain non-covalently associated through their self-association sequences SAS1 and SAS2. The 
interaction between HCF-1 and transactivator proteins, including VP16, is mediated by the N-terminal 
Kelch domain, named because of its similarity to the Drosophila protein Kelch. Additionally, HCF-1 
contains centrally located basic and acidic regions, two Fibronectin type 3 (Fn3) repeats that make up 
the SAS2 element, and a C-terminal nuclear localisation signal (NLS). Sequence analyses of the HCF-
1 interacting proteins VP16 and LZIP (cellular leucine zipper protein) identified a conserved four amino 
acid sequence D/EHxY, termed HCF-binding motif (HBM). This particular sequence was shown to be 
indispensable for their binding to HCF (Freiman and Herr, 1997). 
In addition to its role as a cotransactivator in viral infection, HCF-1 emerged as an important regulator 
of the cell cycle. It controls exit from mitosis, where it ensures proper cytokinesis, as well as passage 
through G1 phase (Julien and Herr, 2003). In keeping with these two functions, depletion of HCF-1 
causes cell cycle arrest in G1 phase with a population of multinucleated cells. Interestingly, expression 
of the N-terminal subunit HCF-1N is sufficient to promote G1 phase progression and S phase entry. 
This activating effect of HCF-1 on cell cycle progression is, at least partially, due to inactivation of the 
Myc-interacting protein Miz-1. Miz-1 stimulates the expression of the CDK inhibitor p15INK4b, and is 
thereby inhibiting retinablastoma protein (pRb) inactivation (Piluso et al., 2002). HCF-1 binds to Miz-1 
and interferes with p300 recruitment and the activation of cell cycle repressors. However, recent 
studies have revealed a much broader impact of HCF-1 on cell growth and division. HCF-1 proteins 
exert the cell-cycle control through temporally regulated association with various effector proteins. For 
example, HCF-1 was found to interact with a trithorax-related Set1/Ash2 H3K4 methyltransferase 
complex (Wysocka et al., 2003), and concomitant association with E2F transcription factors and the 
MLL family of histone H3K4 methyltransferases is crucial for HCF-1 dependent activation of S phase 
promoters (Tyagi et al., 2007). MLL (mixed lineage leukemia) was identified as the human homologue 
of the Drosophila Trx protein, and was characterised as a proto-oncogene. It is found in complex with 
hAsh2, the tumour suppressor Menin, and both human host cell factor orthologues HCF-1 and HCF-2 
(Yokoyama et al., 2004). The same mechanism seems to be applied by HCF-1 in the activation of 
HSV immediate early genes, since both Set1 and MLL1 H3K4 methyltransferases are found in 
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complex with HCF-1 at IE enhancers (Narayanan et al., 2007). Moreover, HCF-1 was found to interact 
with several core components of the Sin3 histone deacetylase complex (Wysocka et al., 2003). Taken 
together HCF-1 interacts with several histone modifying complexes and tethers the Sin3 HDAC 
complex to the Set1/Ash2 HMT complex. Since these two complexes exert opposite transcriptional 
activities – repression in the case of Sin3 and activation for Set1/Ash2 – HCF-1 might constitute a 
switch between both positive and negative chromatin modifications. Intriguingly, the tethering of 
different complexes via HCF-1 is context-dependent. The transcriptional coactivator VP16 was only 
found in complex with Ash2 HMT-bound HCF-1 but not with repressive Sin3 HDAC–HCF-1 complexes 
(Wysocka and Herr, 2003). As mentioned above, HCF-1 was shown to interact with activator E2F1 
proteins to drive G1-to-S phase progression by recruiting H3K4 HMT complexes to E2F-responsive 
promoters (Tyagi et al., 2007). In a cell cycle-dependent manner HCF-1 also binds repressive E2F4 
proteins to switch off S phase genes in a mechanism dependent on Sin3A HDAC complexes. This 
selective interaction with both activating and repressive E2Fs is conserved in insect cells and 
constitutes another example for context dependent interaction of HCF-1 with transcription modulators.  
 
7.2.2. Drosophila HCF 
The sole Drosophila HCF orthologue (HCF) is expressed from the hcf gene located on the 4th 
chromosome at the cytological location 102B5. The whole gene spans 15 kb and comprises 13 exons. 
HCF displays high sequence conservation with vertebrate HCF proteins within the Kelch and Fn3 
domains but not in the intervening stretches. Despite the lack of sequence identity in the central 
portion of the protein, HCF contains corresponding basic- and acidic-residue enriched regions but the 
HCF-1PRO repeats are absent. Nevertheless, the HCF protein undergoes proteolytic processing. Like 
the vertebrate counterparts the mature HCF protein consists of two cleavage products that remain 
associated with each other (Figure 2) (Mahajan et al., 2003). 
Figure 2 
 
Schematic depiction of human HCF-1 and 
Drosophila HCF.  
Structural elements are labelled above HCF-1 
and related elements are shown similarly for 
HCF. HCF-1PRO, HCF-1 proteolytic processing 
repeats; HCF-1Fn3, fibronectin type 3 repeats;  
NLS, nucelar localisation signal  
 
(Adapted from Tyagi et al 2007). 
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Although HSV infection is restricted to mammalian cells, a VP16-induced HCF-complex can be formed 
in invertebrate cell extracts, including Drosophila cells (Mahajan et al., 2003). This led to the 
assumption that the Drosophila homologue HCF applies the same or similar molecular mechanisms as 
HCF-1. Indeed, coimmunoprecipitation studies and immunolocalisation on polytene chromosomes 
demonstrated that HCF interacts with the Drosophila homologue of human Sin3A, dSin3A, which is 
also a subunit of a class 1 HDAC complex (Beltran et al., 2007; Cho et al., 2005), as well as with Ash2 
(Beltran et al., 2007). These data suggest that HCF tethers both HDAC and HMT activities as it was 
reported in mammals. Experiments on the histone acetyltransferase (HAT) dGcn5 and its associated 
complexes led to the identification of another HCF-associated complex. dGcn5 is a conserved HAT 
found in a number of multisubunit complexes in yeast, mammals, and flies. In the Drosophila version 
of the SAGA complex (dSAGA), dGcn5 is associated with dAda3, dAda2B, dSpt3 and dTra1, the 
homologue of TRRAP. The analysis of proteins interacting with the novel Ada2 orthologue dAda2A, 
led to the identfication of the previously unknown HAT complex ATAC (Guelman et al., 2006). In 
addition to the subunits common with dSAGA (dGcn5 and dAda3), ATAC contains dAda2A, Atac1 and 
HCF. Taken together, HCF is found in association with the Sin3a HDAC complex, the Ash2-containing 
HMT complex, and the novel HAT complex ATAC. However, reports of a linkage between specific 
transcription factors and the chromatin modifying machinery via HCF are still missing in Drosophila. 
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7.3. RNA Polymerase II-associated factor complex (PAF complex) 
7.3.1. Yeast PAF complex 
The PAF complex was first identified in yeast (yPAF) as an RNA polymerase II-associated factor that 
interacts with TATA Binding Protein (TBP), the elongation factors Spt4–Spt5, and FACT during 
transcription elongation (reviewed in Shilatifard, 2006). The yPAF complex comprises the five 
components Paf1, Cdc73, Leo1, Ctr9, and Rtf1 (Krogan et al., 2002). During RNAP II-mediated 
transcription the PAF complex is associated with both the promoter and coding regions of 
transcriptionally active genes. Furthermore, it was found to interact with the non-phosphorylated and 
both the Ser2- and Ser5-phosphorylated forms of the RNAP II large subunit (Rozenblatt-Rosen et al., 
2005). The C-terminal domain (CTD) of the RNA polymerase II large subunit contains two important 
serine residues, Ser2 and Ser5, which are phosphorylated during transcription. Phosphorylation of 
Ser5 is required during transcription initiation and the early phase of elongation, while phosphorylation 
of Ser2 is linked to elongation (Komarnitsky et al., 2000). The association with all three forms of RNAP 
II and the distribution throughout the coding regions of transcribed genes indicate an involvement for 
the PAF complex in both transcription initiation and elongation. Indeed, the PAF complex mediates the 
successive recruitment of various stage-specific factors required for the formation of the mature 
elongation complex. It was shown that the PAF complex stimulates the Rad6-mediated 
monoubiquitination of the core histone H2B (Wood et al., 2003, 2005), the Set1-mediated histone H3-
K4 methylation (Dover et al., 2002; Krogan et al., 2003b; Ng et al., 2003), and the Dot1-mediated 
histone H3-K79 methylation (Krogan et al., 2003b; Krogan et al., 2003a). Also, the recruitment of the 
elongation factor FACT is dependent on the presence of the PAF complex. FACT is a dimeric protein 
that plays a major role in displacing the H2A/H2B dimer from the core nucleosome and thus allowing 
elongation to proceed over chromatin (Belotserkovskaya et al., 2003). Surprisingly, considering their 
broad function in transcription, components of the PAF complex are nonessential in yeast. Losses of 
individual components display differences in phenotypic severity. While paf1Δ and ctr9Δ strains show 
severe and nearly identical growth defects, Cdc73 and Rtf1 mutants are less strongly affected - 
nevertheless they cause disruption of the PAF complex chromatin association -, and the Leo1Δ strains 
exhibited few detectable deficiencies (Betz et al., 2002). However, mutations of all the components 
show defects in transcription elongation. While the overall chromatin distribution of RNAP II is not 
affected upon loss of PAF components, RNAP II Ser2 phosphorylation is strongly reduced and poly(A) 
tails are shortenend. This indicates an essential additional role of the PAF complex in the linkage of 
transcriptional and posttranscriptional events (Mueller et al., 2004; Penheiter et al., 2005). Most likely 
the influence of the PAF complex on pre-mRNA processing and maturation is exerted by recruiting 
factors involved in 3’ end formation. Sheldon and colleagues revealed a functional interaction between 
the PAF complex and the Nab3 and Nrd1 proteins in the 3’ end formation of nonpolyadenylated RNAP 
II transcripts like snoRNAs (Sheldon et al., 2005).  
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7.3.2. The PAF complex in humans (hPAF) 
Like the yPAF complex, the human counterpart hPAF contains five subunits. However it differs from 
yPAF in having an additional eukaryote specific component hSki8, which is involved in mRNA quality 
control (Zhu et al., 2005), and lacking the human homologue of yRtf1. The hPAF complex interacts 
with the non-phosphorylated and Ser2- and Ser5-phosphorylated forms of the RNAP II large subunit 
(Rozenblatt-Rosen et al., 2005), which indicates an involvement in both transcription initiation and -
elongation. Also the regulation of transcription-associated histone monoubiquitination of H2B, a 
prerequisite for transcription elongation, as well as trimethylation of histone H3-K4 and dimethylation 
of histone H3-K79 are conserved functions between yeast and human PAF complexes (Pavri et al., 
2006; Zhu et al., 2005). This suggests that the PAF complex in humans affects gene expression 
through a mechanism similar to that in yeast. 
Various studies to identify genes which may play a role in progression of cancer found several hPAF 
complex subunits to be dysregulated in tumours. Like its yeast homologue Cdc73, the human PAF 
complex component Parafibromin induces cell-cycle arrest in the G1 phase by blocking expression of 
cyclin D1 (Zhang et al., 2006). Parafibromin is encoded by the HRPT2 gene and indeed was 
characterised as a tumour suppressor associated with the suppression of the hyperparathyroidism-jaw 
tumour (HPT-JT) syndrome (reviewed in Wang et al., 2005). Interestingly, HRPT2 is amplified in liver 
carcinomas (Parada et al., 1998) and breast cancers (Stange et al., 2006), which points to opposing 
functions of Parafibromin in different tissues. hPaf1/PD2, the human homologue of yPaf1, in contrast, 
was identified as a potential oncogene, since it is overexpressed in pancreatic cancer cell lines 
(Chaudhary et al., 2007), and it was shown to synergise with AKT2 in the development of cancers 
(Cheng et al., 1996; Moniaux et al., 2006). Also, a third hPAF complex component hLeo1 was 
implicated in the etiology of cancers. In Drosophila the hLeo1 homologue Atu interacts with β-catenin 
in the Wnt/Wg-signalling cascade (Mosimann et al., 2006) and is amplified in human colorectal 
cancers – which often display dysregulation of Wnt-signalling - (Camps et al., 2006) and malignant 
bone tumours (Tarkkanen et al., 2006). Taken together, various human PAF complex components 
play a role in the development of cancers. Strikingly, the hPaf1 and hLeo1 subunits were 
characterised as oncogenes, whereas Parafibromin is a potential tumour suppressor. 
 
7.3.3. Drosophila PAF complex 
A comparison between yPAF and its metazoan homologue in Drosophila has revealed extensive 
functional conservation but also striking differences. Like yPAF, the Drosophila PAF complex globally 
associates with actively elongating RNAP II and is required for the activation of target genes (Adelman 
et al., 2006). However, the nature of the Polymerase II association and the composition of the complex 
are markedly different between the two species.  
In contrast to the situation in yeast, loss of PAF complex in Drosophila does not cause changes in the 
levels of Ser2 phosphorylated RNAP II, however, the level of the chromatin associated elongation 
factors Spt6 and the FACT component SSRP1 are strongly reduced (Adelman et al., 2006). Moreover, 
depletion of Paf1 results in a loss of histone H3-K4 trimethylation within actively transcribed regions, 
while the levels of histone H3-K79 trimethylation remain unaffected (Adelman et al., 2006; Tenney et 
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al., 2006). Despite these considerable differences between yPAF and its homologue in Drosophila, 
there is evidence that the molecular mechanisms used by the PAF complex are conserved between 
the two species. Induction of histone H3-K4 methylation at the Hsp70 promoter through PAF complex 
action was shown to involve Trithorax, the Drosophila homolog of the yeast Set1 histone 
methyltrasferase of the COMPASS (Complex Proteins Associated with Set1) complex (Smith et al., 
2004). In turn, Histone H2B ubiquitination activity by the Rad6 and Bre1 proteins is a prerequisite for 
Histone H3 methylation at lysine 4 in yeast (Krogan et al., 2003a; Wood et al., 2003). As discussed 
previously, the PAF complex is required to activate Rad6 and Bre1 histone ubiquitination activity in 
yeast. Tenney et al. (2006) determined that the Drosophila Rtf1 subunit of the PAF complex facilitates 
Notch signalling, providing a link between histone ubiquitination and methylation to gene activation by 
the Notch pathway, since Bre1 is also required for Notch target gene expression in Drosophila (Bray et 
al., 2005). Therefore, the important functional links between the PAF complex, Rad6/Bre1 and histone 
methylation seen in yeast seem to be conserved in Drosophila. 
While Rtf1 is an integral part of the yPAF complex, the Drosophila and human homologues do not 
appear to be a stable part of the PAF complex. The Drosophila Rtf1 protein neither stably associates 
with Paf1 nor Hyrax, the homologue of Cdc73. However, Rtf1 colocalises broadly with actively 
transcribing RNAP II and with Paf1 in the context of active transcription (Adelman et al., 2006). Rtf1 
also plays an important role in histone methylation (Tenney et al., 2006). Thus, the function of this 
protein is conserved in yeast and Drosophila, suggesting that Rtf1 functions in association with the 
PAF complex in vivo.  
In contrast to the situation in yeast, where PAF components are nonessential, mutations of the 
Drosophila PAF subunits Hyx, Paf1, which is also called Antimeros, or RNAi-mediated depletion of 
Rtf1 are lethal (Adelman et al., 2006; Tenney et al., 2006). Presumably the metazoan PAF 
components have acquired additional functions as compared to their yeast homologues. Indeed, 
Adelman et al. (2006) provide evidence for a nucleolar function for both Paf1 and Rtf1 in Drosophila. 
Moreover several PAF components in Drosophila have been implicated in complex signalling 
cascades. As discussed above, Rtf1 is involved in Notch signalling, while the Cdc73 homologue Hyrax 
plays an important role in the activation of Wg signalling targets (Mosimann et al., 2006). While the 
yPAF complex plays a broad, almost genome-wide role in transcription (i.e. it is found in association 
with RNAP II at most gene loci) without needing sequence-specific transcription factors, there is 
evidence for PAF complex recruitment by specific signalling pathways in Drosophila (Mosimann et al., 
2006; Bray et al., 2005).. 
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Results 
 
1. RNAi screen for Myc cofactors 
One strategy to characterise the function and specificity of a transcription factor is through the 
identification of its target genes. A long and still growing list of putative targets of Myc has been 
compiled during recent years in humans and Drosophila (Dang et al., 2006; Hulf et al., 2005; 
Fernandez et al., 2003; Orian et al., 2003; Oster et al., 2002). This process was greatly assisted by the 
availability of technologies suitable for large-scale assays such as genome-wide location of Myc/Max 
binding sites, or transcriptome profiling techniques (SAGE, microarrays). A subset of these potential 
targets was further characterised and the dependence on Myc binding for their transactivation was 
verified (McMahon et al., 1998; Nikiforov et al., 2002a). 
To add another level of complexity, transcription factors depend on a number of cofactors to elicit their 
full activation potential. Even though several cofactors that are involved in Myc-dependent 
transcription control have been identified, (e.g. McMahon et al., 1998; Cheng et al., 1999; Wood et al., 
2000; Bellosta et al., 2005), both in vertebrates and Drosophila, still comparatively little is known about 
the mechanistic aspects of transcription modulation by Myc. 
In order to identify novel physiologically relevant cofactors of Myc, we performed an RNA interference 
(RNAi) screen in embryonic hematopoietic Schneider 2 (S2) cells. The screen was based on a directly 
Myc-dependent Dual luciferase reporter system and 752 in silico preselected transcription-associated 
genes were tested for their influence on Myc-dependent regulation of reporter expression. 
 
1.1. Myc-dependent luciferase reporter system 
In order to identify physiological Myc targets and to further characterise Myc-responsive regulatory 
sequences, T. Hulf significantly down-regulated Myc in exponentially proliferating S2 cells by RNA 
interference during the course of his PhD thesis (Hulf, 2004). Based on this microarray analysis, a set 
of direct Myc targets was established. The majority of the 30 genes that were significantly 
downregulated at all the timepoints tested (6, 12, and 48 hours after addition of myc dsRNA) play a 
role in in ribosome biogenesis, protein synthesis, and metabolism. Screening for common nucleotide 
sequences within 1000 bp of the predicted transcription start site of all these genes displaying 
expression differences, revealed the E-box to be significantly enriched (27 of 30 genes contained at 
least one E-box, 13 of them two). A clear positional bias of E-boxes to the first 100 bp following the 
predicted transcription start was also discovered. The genes containing such a downstream E-box 
potentially constitute a distinct subset of Myc targets (Hulf et al., 2005). 
To demonstrate the importance of the sequence and position of the E-box for the regulation of Myc 
target genes, the promoter of the Myc responsive gene nnp-1 (a sequence homolog of the nucleolar 
protein Nnp1/Nop52 (in vertebrates) and Rrp1 (in Saccharomyces cerevisae)) was chosen to control 
the expression of the firefly luciferase open reading frame (Hulf et al., 2005). The nnp-1 gene is 
significantly downregulated at all time-points after myc RNAi in S2 cells and upregulated after Myc 
overexpression in wing discs. Its regulatory region also contains one E-box at position +29 relative to 
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the transcription start site. This E-box conforms to the consensus of the general sequence 
CANN(N)TG (Blackwell et al., 1993), and furthermore, it is bound by Myc in S2 cells as demonstrated 
by ChIP experiments. To analyse the function of the E-Box a 386 bp fragment of the nnp-1 promoter, 
including 108 bp downstream of the transcription start site, was fused to the luciferase ORF, with 
translation of the luciferase starting at the ATG of Nnp-1. Additionally to the wild type nnp-1 promoter a 
mutated form lacking the E-box (ΔE-Box) was created. The reporter constructs were transiently 
transfected into S2 cells, together with myc dsRNA and a control plasmid expressing the Renilla 
luciferase gene under the control of the constitutive α-tubulin promoter. The ability of myc-RNAi to 
inhibit wild type nnp-1 driven luciferase expression to a similar extent as nnp-1 mRNA confirmed nnp-1 
to be a direct target of Myc.  
Based on these nnp-1 model reporters for Myc activity we proceeded to create additional constructs. 
Analogous to the nnp-1 reporters, a 390 bp promoter sequence of the directly Myc activated target 
CG5033 (a sequence homolog of the vertebrate protein Bop-1, which is involved in rRNA processing 
and ribosome biogenesis) was fused to the Renilla luciferase ORF. This reporter showed a 
qualitatively similar, but quantitatively stronger response to myc-RNAi than the nnp-1 reporter (Figure 
3b). In contrast to the original reporter system, in which we used an α-tubulin driven luciferase as 
control plasmid, a ΔE-Box firefly reporter served as an internal control to monitor basal expression 
level of the promoter. Since the regulatory sequences driving the reporter genes are identical, except 
for the presence or absence of the single E-Box sequence at position +21 relative to the transcription 
start, the readout of the system directly reflects Myc’s activation potential (Figure 4b). Hereafter, we 
refer to the wild type/ΔE-Box luciferase reporter pairs as Myc activity reporter. 
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In addition to the two Myc activity reporters mentioned above (nnp-1 and CG5033), which both contain 
a single E-Box in their promoter region downstream of the transcription start site, we also tested 
another Myc activity reporter with a different E-Box pattern. CG4364, whose vertebrate homologue 
pescadillo is also involved in rRNA processing, does not possess a downstream E-Box in its regulatory 
region but a putative Myc binding site at position -421 relative to the transcription start. After site-
directed mutagenesis of the E-Box the reporter was still responsive to changes in Myc levels, possibly 
due to redundantly acting variant Myc binding sites at position -261 (of the sequence CATGCG) and at 
position +15 (CACGCG) which both retained their function. It was shown for c-Myc that not only the 
core E-Box sequence CACGTG but also variants thereof (CANNTG) are bound by Myc/Max dimers 
(Luscher and Larsson, 1999). We refrained from mutating these E-Boxes, as the wildtype CG4364 
reporter could only be repressed about two-fold by myc-RNAi; a readout we deemed not sensitive 
enough for our purposes (Figure 5a). In contrast to the functional luciferase reporters containing the 
regulatory region of either one of the positive Myc target genes nnp-1, CG5033 or CG4364, a 
construct carrying regulatory sequences of mfas (midline fasciclin; a gene involved in axonogenesis 
that is repressed by Myc (Bellosta et al., 2005; Orian et al., 2003)) was unresponsive to changing Myc 
levels (Figure 5b). 
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1.2. Screening of a preselected candidate pool using a Myc-dependent 
reporter system 
Based on the previous experiments with the constructed Myc activity reporters, in which we compared 
the expression levels of wildtype promoter containing vs. ΔE-Box luciferase constructs (at various 
timepoints 24, 48 and 72 hours after addition of dsRNA), we chose to use the CG5033 reporter pair 
over the nnp-1 constructs for the initial screen of the selection of double-stranded RNAs. While the 
CG4364 ΔE-Box reporter still responded to changing myc levels and therefore was not suitable for our 
purposes, both the CG5033 ΔE-Box and nnp-1 ΔE-Box constructs are unresponsive to myc-RNAi. 
However, the CG5033 Myc activity reporter constituted a more sensitive system as the wild type 
variant could be downregulated 3 to 4 fold upon RNA interference (RNAi) against myc as compared to 
1.5 to 2.5 fold in the case of nnp-1 (Figures 6a & 6b). 
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 As we were interested in identifying physiological cofactors of Myc involved in transcription control and 
to minimise the scale of the screen, we chose not to carry out a genome-wide RNAi screen but rather 
focused on a subset of 752 preselected candidates. The selection was compiled of proteins that are 
known to be associated with transcription because of earlier reports, or because their gene ontology 
(GO) annotation placed them into transcription-related processes. Furthermore, the list contained a 
number of factors that were known to be involved in Myc-dependent processes in various model 
organisms and/or to interact with Myc genetically or physically. Examples of factors in this subset are 
Gcn5 (Grant et al., 1997; McMahon et al., 2000; Patel et al., 2004) a histone acetyltransferase known 
to be the catalytic subunit of both the SAGA and ATAC1 histone acetyltransferase (HAT) complexes 
(Grant et al., 1997; Guelman et al., 2006), and TRRAP (TRansactivation/ tRansformation Associated 
Protein), a component of several histone acetyltransferase (HAT) complexes (McMahon et al., 1998; 
McMahon et al., 2000; Bouchard et al., 2001). Both proteins were identified to interact with the 
transactivation domain of the Myc protein. Additionally, the Tip60 DNA-helicase/ATPases Tip48/Reptin 
and Tip49/Pontin, which had been identified as c-Myc interacting proteins in vertebrate tissue culture 
cells (Wood et al., 2000), and were later shown to interact genetically with Myc in Drosophila (Bellosta 
et al., 2005) and Xenopus (Etard et al., 2005), the elongation factor p-TEFb (Eberhardy and Farnham, 
2001; Kanazawa et al., 2003), or components of the BRM chromatin-remodellling complex (Cheng et 
al., 1999) were included. In addition to this group of “characterised” putative cofactors, a second tier of 
candidates containing known components of “transcription-associated” complexes like transcription 
initiation or elongation factors, histone-modifiers like acetyltransferases or methylases, chromatin 
remodellers or enzymes of the ubiquitination-machinery was included in the list (e.g. trx, Iswi, or Taf2). 
A third subset of poorly characterised or uncharacterised proteins was added based on their gene 
ontology (GO) annotation. Within this group fall a large number of the computed genes (CGs), which 
have not been fully characterised and were predicted to be involved in transcription. Finally a number 
of handpicked candidates were also included in the list. One example for a handpicked candidate is 
the sequence-specific transcription factor E2F. It was included in the list because it was shown that 
activating E2F proteins and Myc share common target genes (Grandori et al., 2000), which might 
indicate a concerted control of certain targets. However, in general we omitted sequence-specific 
transcription factors from the screen, since the use of the E-Box/ΔE-Box system ensured a strictly 
Myc-dependent readout. Furthermore, an inclusion would have significantly increased the number of 
candidate factors. Since there is no significant sequence conservation among Myc target gene 
promoters (except for E-Boxes) we would expect sequence-specific transcription factors to affect only 
the expression of a limited number of targets, whereas the screen was designed to identify general 
cofactors of Myc. 
For all of the 752 selected candidates sequence specific primer pairs, which allow for the amplification 
of gene-specific amplicons of an average length of 400 base pairs, were ordered from Eurogentec. 
The design of the oligonucleotides was based on the BDGP annotation of the Drosophila 
melanogaster genomic sequence v2.0 and excluded predicted homology regions between individual 
Drosophila proteins (e.g. of a related protein family). Primary PCR products were amplified using 
genomic Drosophila DNA as template. Furthermore, universal sequences were added to the primers 
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that permitted re-amplification of the primary products. All 3’-primers contained the same tag 
sequence, while 5’-primers contained 9 different sequences. Therefore, the whole set of sequence-
specific amplicons could be re-amplified using only 9 primer pairs. The secondary primers used for re-
amplification also contained a 5’ 23bp T7 promoter sequence, resulting in PCR products with T7 
promoter sequences added to both ends of the amplicons. These were subsequently used as 
templates for the generation of dsRNA by phage T7 RNA polymerase. The whole amplification 
procedure was carried out by P. Zipperlen (Group of Prof. K. Basler) and was done in an automated 
fashion in 96-well plates using a pipetting robot.  
 
1.3. Screening procedure and candidate selection 
dsRNA against all the 752 candidates was transferred to 96-well plates and transiently transfected into 
Drosophila S2 cells together with the two CG5033-Myc activity reporters. After an incubation period of 
60 hours, individual luciferase values were measured. This screen procedure was carried out twice for 
the whole set of candidate genes. Individual plates were selected for a second repetition, since they 
showed a slight but systematic regional bias across the plate. Within every single sample plate myc 
dsRNA was plated into 8 sample wells as a positive control for the functionality of the transfection 
procedure. Furthermore, this also provided an estimate of the variation of transfection efficiency 
between the individual plates. Subseqently, the ratio between the firefly and Renilla luciferase 
expression levels for each transfected dsRNA sample was calculated. For the initial screen runs we 
determined the ratios by dividing ΔE-Box by wild type reporter values. Later on, the reporter ratios 
were determined reciprocally since they then directly reflect Myc activity, rather than being inversely 
proportional to Myc activity. To determine the RNAi samples that lead to a significant change in 
luciferase expression ratio, we first calculated the difference between the ratio of each experimental 
well and the average ratio of all the samples within the same sample plate. Next, we assessed the z-
score for each sample by dividing the resulting values by the standard deviation of all experimental 
values of a single plate; this revealed 80 genes to have an influence on the Myc activity reporter 
system. Forty-five of the 80 dsRNAs included in this second candidate list lead to an upregulation of 
the wildtype reporter, while the ΔE-Box reporter remained unaffected, (this results in a decrease of 
luciferase ratio), and 35 lead to a repression of the wild type reporter gene (increase of the luciferase 
ratio). In the list we included candidate dsRNAs that either had a considerable effect in both screen 
runs (for some samples all the 3 runs) or that showed a large change in expression ratios in one single 
screen run. 
For the secondary screen, all the 80 dsRNA species were freshly replated, and 8 myc dsRNA samples 
(positive control) and 8 gfp dsRNA samples (negative control) were included per 96 well plate. After 
screening the subset, the difference between each experimental luciferase ratio and the average gfp 
ratio per plate was determined. Out of these 80 dsRNAs 33 changed the reporter activity by at least 
1.5 fold as compared to gfp-RNAi: 19 dsRNAs had a Myc-like effect, 14 lead to an activation of the 
reporter (Table 1). 
A number of 33 significant modulators of the Myc activity reporter out of a total number of 752 
candidates tested corresponds to 4.5 % specific "hits", which suggests high specificity of the screen, 
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even more so as a biased preselection of candidates was used. Further evidence that the screen 
allowed us to find specific Myc-interactors came from the rescreen of the last 33 candidates with nnp-1 
luciferase reporters which gave a considerable overlap of the upregulating factors with the screen. 
Most prominently three components of the Polymerase-associated factor 1 complex (PAF), the PAF-
associated factor Spt6, and the deacetylase Sin3A were positively identified with both reporter 
variants. The Myc-activating factors (i.e. the downregulators of the Myc activity reporter), however, 
were not picked up with the significance criteria used in the screen, which is due probably to the 
reduced sensitivity of the nnp-1 reporter compared to CG5033. However the strongest downregulators 
of the screen (i.e. several components of the 19S proteasome regulatory complex) reduced the 
reporter activity to about the same extent as Myc itself.  
Finally, 7 candidates influence both the wildtype and ΔE-Box luciferase expression levels and 
therefore they might affect transcription in a manner that is not strictly Myc-dependent. 
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2. Candidate overview 
Of the 752 dsRNAs against transcription-associated factors tested, we identified 33 as significant 
modulators of the Myc activity reporter system. RNAi against 14 of these factors lead to an increase in 
the ratio between the expressions of the two experimental reporter genes. In five cases (histone 4, 
histone 3, Su(z)2, sima, Med21) this shift of the ratio was mostly due to their influence on the Myc-
unresponsive ΔE-Box reporter. These five factors might therefore act, at least partially, in a Myc-
independent manner. This leaves nine candidates which act as specific repressors of the reporter 
system (Table 1). Within this group of nine significant repressors of the Myc activity reporter are three 
homologues of PAF complex subunits in yeast and vertebrates and one PAF-complex associated 
factor. This suggests that the Drosophila version of the PAF complex as a whole plays a role in 
controlling the Myc activity reporter. This finding prompted us to focus on the characterisation of the 
PAF complex. The three PAF complex components identified in the RNAi screen are the following: 
Hyrax (Hyx) (which corresponds to CG11990; homologous to the yeast protein Cdc73), Ctr9 (also 
termed CG2469), and Antimeros (Atms) (also called dPaf1 or CG2503). Furthermore, another Paf 
complex associated factor Spt6 was identified in the screen.  
In addition to the 14 repressing factors we also identified 19 positive regulators of the system. RNAi 
against these factors leads to a downregulation of the reporter expression. Two of the positive factors 
(cdk8 and CG2097, which is also termed Symplekin) have a considerable influence on the ΔE-Box 
reporter, suggesting that they (partly) influence the reporter expression independently of Myc, 
analogous to the situation observed with histone 3 and 4. Of the remaining 17 factors, 6 of the most 
potent regulators are components of the 19S regulatory subunit of the 26S proteasome. Another factor 
within the list of downregulators we concentrated on, is HCF (Host cell factor), an abundant chromatin-
associated protein, whose mammalian homologue was originally identified for its role in the 
propagation of Herpes simplex virus upon infection. The characterisation of HCF was largely carried 
by Mirjam Balbi during her master thesis. 
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3. Proteasome components 
Of the 10 known eukaryotic non-ATPase subunits that are comprised in the 19S regulatory complex of 
the proteasome (Pickart and Cohen, 2004; Holzl et al., 2000) eight were included in the original RNAi 
screen candidate list (Rpn1, Rpn2, Rpn5-7, Rpn9, Rpn11 & Rpn12; regulatory particle non-ATPase). 
Six of these eight (75%; all except Rpn1 and Rpn9, which is also known as Rpn4) were found to 
belong to the strongest modulators of the CG5033-Myc activity reporter. Downregulation of the Rpns 
led to significant repression of the reporter activity to 28-42% of the average reporter activity upon gfp 
control RNAi (see final candidate list Table 1 and Figure 8). This finding was unexpected as 
downregulation of proteasome components decreases protein turnover and therefore might increase 
the level of active Myc protein in a cell, as Myc has been shown to be a target of the ubiquitin-
mediated proteolysis machinery (Gregory and Hann, 2000; von der Lehr et al., 2003). On the other 
hand it has been reported that poly-ubiquitination, and thereby priming for later destruction, is one of 
the necessary steps for the full activation of several transcription factors, including Myc (reviewed both 
in Muratani and Tansey, 2003; Weake and Workman, 2008). To determine whether the effect on the 
luciferase expression caused by rpn-RNAi is due to influences on Myc protein levels, we treated 
Schneider 2 (S2) cells with dsRNA against gfp, and the various rpns found to be modulators of the 
reporters and assessed if Myc protein levels were changed. The corresponding Western blot in Figure 
9 was probed with anti-dMyc hybridoma supernatant and anti-α-tubulin as a loading control. No 
obvious changes in the abundance of endogenous Myc protein in response to RNAi against the 
proteasome components are seen as compared to treatment with gfp control dsRNA. Therefore, the 
reduced expression of the luciferase reporter genes is not due to reduced Myc protein levels. 
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3.1. The Drosophila eye is sensitive to downregulation of 19S proteasome 
components 
Since RNAi against the majority of the 19S proteasome components included in the screen (75%) led 
to a significant downregulation of the Myc activity reporter, we tested whether reduction of rpn levels 
also caused specific phenotypes in vivo. For this purpose we examined if reduction of Rpn proteins 
resulted in dominant genetic interactions with the hypomorphic myc allele dmP0. The dmP0 allele is 
caused by a P-element insertion into the myc promoter, which results in reduced myc expression. 
dmP0 had been found to show a strong genetic interaction with the essential Myc cofactor Tip49/Pontin 
(Pont) (Bellosta et al., 2005). The interaction of myc with pont is essential for tissue growth in vivo and 
it is manifested by a prolonged duration of development, reduced survival rates, and decreased size of 
adult animals in flies that are hypomorphic for myc and heterozygous for pont (Bellosta et al., 2005). 
Most strikingly, these animals have small, irregularly shaped, and slightly rough eyes (Bellosta et al., 
2005). Interestingly, the same eye defect occurs in dmP0/Y males at a very low frequency, but its 
prevalence is enhanced upon mutation of one pont allele (Bellosta et al., 2005). Based on these 
observations, we examined the eye phenotype of dmP0 flies with reduced rpn levels, as the eye seems 
to be particularly sensitive to a reduction of Myc activity. To analyse a potential interaction between 
myc and the proteasome components (and also other interactors found in the screen) we used flies of 
the following genotype: w dmP0 tub>myc>GAL4 ey-flp. These animals carry the hypomorphic allele 
dmP0 but the mutant phenotypes are rescued by the ubiquitously expressed myc cDNA under the 
control of the tubulin-promoter. The myc cDNA-transgene is flanked by FRT sites, which allow for 
recombination with each other when FLP-recombinase is expressed. Since the eyeless promoter is 
used to drive the FLP-recombinase expression, the myc cDNA will be eliminated in the whole head 
capsule, including the eyes. Thus, the hypomorphic dmP0 phenotype will only be revealed in these 
tissues. This line will be called ey>dmP0 for simplification. 
Four classical alleles of the Rpn genes identified in the screen were available from the Bloomington 
stock collection. Three alleles of Rpn6/proteasome subunit p44.5 and one allele of Rpn11/p37B, which 
codes for a de-ubiquitinating enzyme (Holzl et al., 2000). Rpn62F (loss of function; recessive lethal 
1901 bp deletion that removes putative upstream regulatory sequences, the complete 5’ UTR and the 
first 145 codons) and Rpn620F (hypomorph; recessive lethal; imprecise excision, leaving P-element 
sequences at the insertion site; Rpn6 coding sequences intact), which are both imprecise excisions of 
the original insertion Rpn6k00103, had no effect on the eye phenotype of ey>dmP0 animals. However, 
Rpn6k00103 itself led to eye defects that resemble the ones observed in dmP0/Y; pont-/+ in 33.3% of the 
males tested (3/9). In contrary, the only available Rpn11 allele Rpn11BG01694 (a recessive lethal P-
element insertion generated by the Gene Disruption project) showed no interaction with dmP0. In 
addition to their ability to interact with ey>dmP0 we also tested whether the Rpn mutants modulated the 
eye phenotype of Myc overexpressing y w; GMR-GAL4 UAS-myc132/+; UAS-myc132 UAS-myc42/+ flies. 
Flies of this genotype highly overexpress Myc in the eye. This leads to an increase of ommatidial size 
by more than 20% and disruption of the regular ommatidial pattern, which results in a rough eye 
phenotype. In only two (out of 30-50 animals examined), the P-element insertions Rpn6k00103 and 
Rpn11BG01694 led to a suppression of the Myc overexpression phenotype, where the eyes resembled 
wild type control eyes, concerning size, texture and pigmentation. 
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We also tested whether RNAi lines against the Rpn proteins, available from the Vienna Drosophila 
RNAi Center (VDRC), interact genetically with myc in a hypomorphic situation. This allows us to 
assess the effect of potentially stronger reduction-of-function mutants than observed with 
heterozygosity for Rpns. Indeed, six of the seven lines tested showed a strong interaction in the 
ey>dmP0 background. RNAi against Rpn5 only had a moderate effect. Taken together, downregulation 
of the proteasome components by RNAi caused severe defects of the eye structure. With a 
penetrance of almost 100% the eyes became smaller, showed an irregular shape due to loss of a 
large number of ommatidia, or were completely missing. As a comparison, RNAi in a myc wildtype 
background caused only mild defects. The eyes were slightly reduced in size (as judged by inspection 
under the dissecting microscope) and had a mild rough eye phenotype. 
While 6 of the 19S regulatory complex subunits belonged to the strongest interactors in the RNAi 
screen (knockdown of the reporter by about 3-4 fold), the classical mutants of Rpn6 and Rpn11 
interacted very moderately in myc hypomorphic and overexpression backgrounds. Conversely, six of 
seven RNAi lines tested, lead to eye defects with almost complete penetrance. The most obvious 
explanation is that even in the case of complete loss of function, still 50% of the gene product are 
present in a heterozyous mutant rpn6 or rpn11 fly, whereas downregulation by RNA interference, 
although it is never complete, probably leads to a larger reduction. Concluding from the few results 
obtained, there seems to be a considerable genetic interaction between these factors and myc. Since 
we focussed our investigations on other Myc interactors found in the screen, we only scratched the 
surface of the potential interaction between the 19S proteasome components and myc. For a thorough 
characterisation more in vivo interaction data and biochemical analyses are necessary.   
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4. Drosophila Host cell factor (HCF) 
4.1. Overview 
The following part of the project concerning the interaction between Myc and HCF was mainly carried 
out by Mirjam Balbi, a Master Student, under my supervision. In her Master thesis (Balbi, 2007), an in 
depth characterisation of the interaction between Myc and Drosophila host cell factor (HCF) has been 
described. This section gives a brief summary of the performed experiments, and some more recent 
results are included at the end. 
Found as a negative regulator in the initial RNAi screen, HCF seems to be required for full 
transcriptional activity of Myc in S2 cells. Experiments with two additional independent dsRNAs 
against HCF ruled out that RNAi off-target effects are responsible for the observed reporter knock-
down to approximately 60% compared to gfp control RNAi, and thereby corroborated HCF’s role as a 
putative cofactor of Myc (Figure 10). It was also shown that RNA interference with all the dsRNA 
variants efficiently induced hcf degradation for HCF protein levels were undetectable on Western blots 
at 48 hours after dsRNA addition (Figure 11). Myc protein levels however, remain unchanged by hcf-
RNAi (see Results section 4.2.). This fact suggests that HCF modulates Myc activity, rather than its 
abundance. Ectopic expression of HCF under the control of an actin-promoter highly activated reporter 
gene expression (Figure 10). This boost of luciferase expression to approximately 300% is well above 
the effect observed upon Myc overexpression, which is indicative of the limiting nature of HCF under 
physiological conditions. Moreover, the influence of HCF overexpression is dependent on Myc as it 
can be suppressed by either myc (or hcf) –RNAi (data not shown). The effect of hcf-RNAi was not 
restricted to the used artificial reporter system since qRTPCR measurements revealed that HCF is 
also required for the correct expression of selected endogenous Myc target genes transcribed by RNA 
Polymerase II (see Results section 4.2.). Taken together Myc requires HCF for proper transcactivation 
of its targets in S2 cells. 
Coimmunoprecipitations between overexpressed HCF and Myc revealed a physical interaction of the 
two proteins (Figure 12). The Drosophila Myc protein was found to contain a conserved four amino 
acid HCF-binding motif (HBM) of the sequence DHSY (consensus sequence D/EHxY). The HBM was 
identified in VP16 and its cellular counterpart LZIP (Freiman and Herr, 1997), and was also shown to 
be of importance in the E2F-family of transcription factors (Tyagi et al., 2007). The HBM motif is 
located in the central part of the Myc protein (aa 387-390). Surprisingly, the HCF binding motif (HBM) 
present in Myc is dispensable for the physical association with HCF, since a mutant form lacking the 
HBM also interacts with HCF (data not shown). This contrasts with several other HCF-associated 
proteins that require the HBM for interaction. In order to map the HCF interaction site(s) within the Myc 
protein, various Myc truncations were generated and examined for their ability to associate with HCF. 
None of the known conserved domains in Myc, neither Myc-Boxes 1-3 (MB1-3), nor the C-terminal 
basic helix-loop-helix zipper region are required for stable association between Myc and HCF. Since 
these experiments revealed a central stretch of Myc (from amino acids 179 to 403) to interact most 
strongly with HCF, it is therefore likely to contain an interaction site. Furthermore, 
coimmunoprecipitations and GST-pulldown experiments suggest that additional regions in Myc can 
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provide contact to HCF. These weaker interaction sites are located between aa 176-295 and in the C-
terminal part of Myc between aa 523-626 respectively (data not shown). 
All experiments described above suggest that HCF is an essential cofactor of Myc. To examine the 
physiological importance of the observed interaction in vivo experiments were carried out. Induction of 
hcf-RNAi in the dorsal compartment of the wing by expressing hcf-dsRNA under the control of 
apterous-Gal4 led to a moderate aberrance of the wing morphology as additional vein tissue was 
present between longitudinal veins L1 and L2. Far more pronounced was the ability of hcf-RNAi to 
revert the wing defects caused by Myc overexpression. Elevated Myc levels in the apterous 
expression domain result in overgrowth of the dorsal wing compartment. This is manifested by a slight 
bent-down phenotype. Additionally, the majority of the animals display severely disturbed wings. The 
two wing blade epithelia do not adhere to each other anymore. As a consequence fluid-filled bubbles 
between the epithelial sheets are formed. In older flies the affected wings become necrotic. Strikingly, 
both the overgrowth phenotype and the severe defects caused by Myc overexpression are strongly 
suppressed by hcf-RNAi (Figure 13). A similar suppression of the Myc overexpression phenotype was 
also observed after RNA-mediated knock-down of Ash2 and Gcn5, which are both published cofactors 
of Myc. In addition to its effect on Myc activity in adult wings, HCF also restricts the size of Myc 
overexpressing clones in imaginal wing discs as well as the nuclear size in polyploid salivary gland 
tissue. In both tissues hcf-RNAi significantly decreases the size of Myc overexpressing clones without 
strongly affecting control clones (data not shown). More evidence that HCF is indeed a physiologically 
relevant cofactor of Myc’s, comes from experiments in which the size of ommatidia in the Drosophila 
eye were measured. As in the other tissues examined, hcf-RNAi led to a significant size reduction in 
ommatidia in which Myc is overexpressed and to a lesser extent in eyes with endogenous Myc levels 
(Figure 14). Consistent with these observations, co-overexpression of HCF and Myc has a synergistic 
effect on ommatidial size, whereas overexpression of HCF alone has no effect on ommatidial size 
(Figure 15)  
Since neither Myc nor HCF possesses intrinsic enzymatic activities, other coactivators have to provide 
the enzymatic function in order to achieve transcriptional modulation. Therefore, we tried to identify the 
enzyme [complexes] responsible for the observed activation. We focussed on complexes that were 
already known to play a role in transcription and that associate with HCF, as these were likely to be 
recruited to Myc. The three complexes examined were the ATAC histone-acetyltransferase complex, 
the Sin3A histone-deacetylase complex, and the Set1/Ash2 histone methyltransferase complex. By 
performing coimmunoprecipitations Mirjam Balbi could confirm interactions between the two ATAC 
components ATAC-1 and dAda2A and HCF but not between those two and Myc – which could be due 
to general technical problems and does not rule out an association between Myc and ATAC. RNAi-
mediated downregulation of both ATAC complex proteins in S2 cells did not alter expression of the 
Myc activity reporter. Furthermore, in vivo interactions with Myc could not be assessed as atac1 
dsRNA fly lines were not available and dada2-RNAi caused lethality at the pupal stage when 
expressed under the control of apterous-GAL4. The only ATAC component that showed interaction in 
the assays tested was the acetyltransferase Gcn5. Like the other ATAC components gcn5-RNAi had 
no impact on the Myc activity reporter in S2 cells, but knockdown of Gcn5 in the dorsal compartment 
of the adult wing almost completely suppressed defects caused by ectopic Myc expression. However, 
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expression of a second Gcn5-RNAi transgene (Gcn5-T2-IR), which targets the same sequence as 
Gcn5-T1-IR, yielded contradictory results as it led to severe wing defects when expressed alone, but 
showed no suppression of the Myc overexpression phenotypes. This discrepancy is presumably due 
to insertion effects of the individual transgenes. Gcn5 is a shared subunit of the ATAC and dSAGA 
HAT complexes which makes it possible that dSAGA, and not ATAC, is the complex involved in 
transcription control by Myc. However, RNAi against the dSAGA protein Spt3 had neither an effect on 
luciferase expression in S2 cells nor on the Myc overexpression phentype in wings. 
Second, knockdown of the histone-deacetylase associated corepressor Sin3A led to a strong 
activation of the Myc activity reporter and to severe defects when expressed in the adult wing. The 
dorsal wing compartment show marked overgrowth phenotypes when sin3A-dsRNA is being 
expressed by apterous-GAL4. The wings are clearly bent downwards and the attachment of the two 
wing epithelia is disrupted. This disruption is manifested by the formation of fluid-filled bubbles 
between the epithelial layers and necrotic patches on the wing. In contrast, myc-RNAi causes a bent-
up wing phenotype when expressed by apterous-GAL4, due to reduced growth in the dorsal wing 
compartment. Since Sin3A-associated histone-deacetylases have been shown to be recruited to 
regulatory regions by the Myc antagonist Mnt, the overgrowth phenotype of the dorsal wing blade and 
the increase in luciferase expression most probably reflect the loss of Mnt-dependent growth gene 
repression upon sin3A-RNAi, which is mediated by Sin3A. 
The third complex tested for its interaction with HCF and Myc looks most promising. Even though ash2 
RNAi only leads to a slight reduction of the Myc activity reporter in S2 cells, ash2-RNAi in the wing led 
to an almost complete suppression of the Myc overexpression phenotype. On the other hand 
overexpression of Ash2 in the wing, which has barely an effect on its own, synergises with co-
overexpressed Myc, i.e. leads to most strongly affected wings.In contrast to the situation in the wing, 
neither effects of Ash2 up- or downregulation nor a genetic interaction with Myc could be observed in 
the eye. Taken together, the experiments performed to identify the cofactors of HCF involved in 
modulating Mc-dependent transcription control have revealed that all tested complexes had some 
influence on Myc-dependent processes with the Ash2/Set1 HMT being the most promising of the 
candidates.  
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4.2. Additional experiments 
4.2.1. Downregulation of HCF influences expression of Pol II transcribed Myc target genes 
The initial screen runs and numerous luciferase assays performed subsequently showed that 
downregulation of hcf consistently and significantly reduced the activity of the Myc-dependent reporter 
system. We wanted to examine whether the levels of endogenous Myc target genes were also 
changed in response to hcf-RNAi, or whether this downregulation was confined to the artificial reporter 
system. For this purpose S2 cells were plated out at a density of 5×106 cells/ml and incubated with 
10μg of dsRNA for 30 minutes in serum-free medium. After addition of full medium, the cells were 
incubated for 48 hours and then harvested. By choosing an incubation time of 48 hours we sought to 
ensure comparable downregulation of putative targets as in the screen runs and luciferase assays, 
which were always performed with the same time frame. After the lysis of the cells, total RNA was 
extracted, the integrity of the extracted total RNA was confirmed on bioanalyzer chips, and cDNA was 
generated. Subsequently, we analysed the expression of the selected genes with qRTPCR assays. 
Based on microarray analysis, a set of direct Myc targets had been established previously (Hulf et al., 
2005). In this study, most of the genes found to be regulated by Myc contained E-boxes, with a strong 
preference for a localisation of the E-box downstream of the promoter (see Results section 1.1.). We 
included both of the Myc-regulated genes whose regulatory regions were used for the cloning of the 
luciferase reporters: nnp-1 and CG5033 (see Results section 1.1.). As mentioned above both of these 
genes contain a downstream E-box, and for both of the genes it had been shown that their expression 
depends on the presence of the E-box (Hulf et al., 2005). The ability of these genes to be reliably 
upregulated by Myc overexpression and downregulated by loss of myc had been confirmed by 
qRTPCR assays and luciferase reporter transgenes. In addition, two other direct targets of myc were 
included: CG12295 (also termed straightjacket (stj); homologous to the human voltage-dependent 
calcium channel subunit α2/δ3), which contains an E-Box 627 bp upstream of the transcription start 
site and fibrillarin (fib), a gene involved in 35S RNA primary transcript processing, which contains an 
E-Box 26 nt downstream of the transcription start.  
The microarrays used in the analysis mentioned above, only included RNA polymerase II-transcribed 
protein-coding genes but not RNA polymerase I and RNA polymerase III-transcribed RNA genes. 
Since Myc was shown to control the transcription of RNA polymerase III-dependent small RNA genes 
in mammals (Gomez-Roman et al., 2003; Grewal et al., 2005) and in Drosophila (Steiger et al., 2008), 
we included the previously characterised Myc target genes 5sRNA, tRNA(Leu) and snoRNA U3 in the 
analysis.  
Figure 16 shows the epxression levels of myc, hcf, nnp-1, CG5033, CG12295, fibrillarin, 5sRNA, 
snoRNA U3 and tRNA(Leu) in S2 cells in which HCF or Myc levels were reduced by RNAi. For every 
dsRNA species two independent RNA extractions were performed. For the assays myc, CG5033 and 
CG12295 data from two independent experiments are depicted. The levels were normalised against 
the average of the reference genes actin5C and sec24 and charted relative to their expression levels 
in samples treated with gfp control RNAi. The downregulation of hcf was efficient since mRNA levels 
were reduced to 18 ± 5%. On the other hand myc levels fluctuate in response to hcf-RNAi. While they 
remained unchanged in one experiment, they are reduced by almost 30% in a second measurement. 
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The efficiency of myc-RNAi also varied between the two individual experiments. Whereas it did not 
work as efficiently in one case, as about 60% myc mRNA compared to the gfp control sample still 
persisted after 48 hours, downregulation to roughly 30% was achieved in the second experiment. 
Despite rather high persistence of myc mRNA the levels of the four direct RNA polymerase II-
transcribed targets (nnp-1, CG5033, CG12295, and fibrillarin) consistently dropped to under 40%. This 
downregulation of the direct targets is even more pronounced in other experiments where myc 
reduction is stronger (data not shown). The levels of the two Pol III-transcribed targets snoRNA U3 
and tRNA(Leu) were also reduced by myc-RNAi, however to a lesser extent than the Pol II-transcribed 
targets. Similarly, hcf-RNAi has a clear but moderate effect on the levels of the direct Pol II targets of 
Myc, even though myc mRNA levels remain high. In contrast, the levels of the small RNAs do not 
decrease in response to hcf-RNAi. Possible reasons might be that the Pol III targets are less sensitive 
to reduction of Myc activity or that HCF is not involved in the transcactivation of RNA polymerase III-
transcribed targets of Myc. Taken together, these data consistently show that HCF is involved in the 
transcriptional regulation of physiological and direct Myc targets. Moreover the observed repression of 
the Myc target genes to about 60-70% by hcf-RNAi is not indirectly caused by fluctuations of myc 
levels, since significant downregulation can also be observed in cases where myc levels remain high. 
To address the question whether downregulation of HCF in S2 cells significantly changed the levels of 
Myc protein itself, we examined Myc protein levels in hcf-RNAi treated S2 cells by standard Western 
blotting procedures. Figure 17 depicts a Western Blot of whole cell lysates treated with dsRNA. The 
picture shows that downregulation of hcf by two independent dsRNA species has no obvious influence 
on the endogenous Myc protein levels, despite the fact that myc mRNA levels are fluctuating as a 
consequence of hcf-RNAi. This could mean that fluctuations of mRNA levels are “evened out” on the 
protein level by some sort of Myc auto-regulation. Alternatively, small changes in protein abundance of 
roughly 30% (as comparable to the mRNA levels) might not be detectable with standard Western blot 
procedures. 
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4.2.2. Endogenous Myc and HCF interact physically 
After having shown that co-overexpressed HA-tagged Myc and and T7-tagged HCF interact physically 
in S2 cells, we wanted to confirm this specific interaction by coimmunoprecipitation of the endogenous 
proteins. We tried to coimmunoprecipitate HCF and Myc from S2 cell lysates, however we were 
unsuccessful even with large amounts of starting material (2.5×108 cells per sample). Therefore, we 
chose embryonic lysates of 0-18 hour-old yw embryos. This long collection time was selected for two 
reasons. First, our experiences with S2 cells prompted us to use as large an amount of starting 
material as possible (which precluded the use of closely timed embryos), and second, Myc expression 
fluctuates strongly during embryogenesis. Upon collection, the embryos were dechorionated and 
homogenised. Typically 0.5 ml packed embryos was used for one immunoprecipitation, also for the 
mock IP control. The lysate was split into equal halves and precleared. Then the precleared lysate was 
incubated for 3 hours at 4°C with the rabbit anti-dMyc antibody or rabbit non-immune serum before 
adding the protein G-sepharose beads. After SDS-PAGE and Western blotting, the membrane was 
probed with an antibody directed against the C-terminal HCF subunit. A faint HCF band of 62 kDa was 
detected specifically in the Myc immunoprecipitation (Figure 18, lane 1), but not in the control sample 
(lane 2). Reprobing of the membrane with mouse anti-Myc hybridoma supernatant confirmed that Myc 
had been successfully and specifically pulled down by our rabbit anti-dMyc antibody. However, Myc 
was undetectable in the total lysate, most probably because the Myc content is below the detection 
level (about 3% of the total lysate was loaded in lane 3). In summary, these experiments demonstrate 
the physical interaction between endogenous Myc and HCF proteins. 
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4.2.3. The physical interaction between Myc and HCF is direct 
Since we had been able to demonstrate a physical association between the endogenous HCF and 
Myc proteins in embryos, as well as the overexpressed protein variants in a tissue culture cells, we 
turned to the in vitro translation system to further characterise their physical interaction. By expressing 
recombinant GST-Myc fusion protein variants in Escherichia coli and testing their ability to bind an in 
vitro translated 35S-labelled HCF fragment we addressed the question whether the physical interaction 
observed in coimmunoprecipitations was direct or bridged by other proteins. Furthermore we wanted 
to test whether the HCF-binding domains identified in Myc were all mediating a direct HCF:Myc 
interaction or whether there was a single “direct interaction domain”. Because HCF is a very large 
protein with a length of 1500 amino acids, we chose not to clone the full length sequence into the in 
vitro expression vector (pRSet-C). Instead, we only used an N-terminal fragment of 442 amino acids. 
This stretch comprises the conserved Kelch domain (aa 85-375), which was shown to be required for 
interactions with the viral transcriptional coactivator VP16 and various cellular transcription factors 
(Wysocka and Herr, 2003), and the N-terminal self-association sequence SAS1N (aa 401-
442)(Mahajan et al., 2003). As baits for the in vitro translated HCF1-442 fragment various GST-Myc 
fusion proteins were used. First, we could show that the N-terminal part of HCF is being bound by a 
GST-Myc variant that contains amino acids 46 to 507 of Myc (Gallant et al., 1996) (Figure 19). This 
large part of the Myc protein contains the conserved regions Myc-Boxes 1-3 and the HCF-binding 
motif (HBM) (which has been shown to be dispensable for the interaction between HCF and Myc in S2 
cells) but lacks the very C-terminal basic region and the helix-loop-helix leucine zipper (bHLHzip) 
sequences, that are required for heterodimerisation with Max and DNA binding. To narrow down the 
interaction site within the Myc protein, we also tested ten additional smaller Myc fragments for their 
ability to associate with HCF. Figure 20a depicts a schematic drawing of the interactions between 
HCF1-442 and the GST-Myc fragments. These data suggest that there are three independent interaction 
sites for HCF1-442 in Myc. One weakly interacting region is located in the N-terminus, within the first 
176 amino acids, while the strongest interacting region maps to the central portion of the Myc protein. 
This is reflected by the highest affinities of the Myc fragments that contain the MB3 sequence (aa 404 
to 417). Probably a longer sequence is responsible for mediating the interaction, as fragments that are 
truncated at the beginning of MB3 still retain considerable binding to HCF (fragments aa 177-403 and 
aa 295-403). A third weaker interaction site is contained in the C-terminus after amino acid 523, as the 
fragment consisting of the last 200 amino acids (524-719) still is bound by HCF. Thus, the in vitro 
translation experiments revealed three direct HCF-interaction domains in Myc. The strongest affinity is 
mediated by the central part of Myc, whereas the N-terminal and C-terminal interaction sites mediate 
weaker binding to HCF. These data are largely in accordance with coimmunoprecipitations of 
overexpressed full length T7-HCF and various N-terminally HA-tagged Myc truncations (Balbi, 2007). 
Both the strong centrally located interaction site (mapped between amino acids 179 and 403) and the 
C-terminal site (between aa 524 and 626) were also identified by these experiments. However, the N-
terminus (aa 1-179) did not bind to full length T7-HCF. This difference might be explained by in vivo 
conditions that are not conducive for HCF binding to Myc, or the bulk of the full length HCF protein – in 
the presence of both subunits - might sterically hinder an association with Myc. Alternatively, the 
addition of a triple HA-tag to the N-terminus of Myc could result in a “non-native” folding pattern of this 
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short protein stretch. Lastly, the binding of the N-terminus of Myc to HCF seen in the GST-pulldowns 
could be an artificial interaction that is only seen at very high protein concentrations. However, the 
broad correlation between the coimmunoprecipitations from S2 cells and the GST-pulldowns, and 
varying relative binding intensities for different interactors, strongly indicate that the binding between 
Myc and HCF is indeed physiological. 
Taken together, all the data obtained during Mirjam Balbi’s Master thesis as well as additional 
experiments coherently support HCF’s role as a novel cofactor of Myc. Biochemical approaches (co-
immunoprecipitations and binding studies with in vitro translated HCF) confimed a direct physical 
interaction of HCF and Myc at three independent sites within the Myc protein. Furthermore, studies in 
S2 cells revealed that HCF has a direct influence on the expression of known RNA polymerase II-
transcribed target genes of Myc and not only the artifical reporter system used for the screen. In vivo 
assays lead to the conclusion that HCF and Myc synergise and that HCF is required for the proper 
biological activity of Myc. 
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5. RNA Polymerase II Associated Factor 1 (PAF) complex 
In addition to the positive regulators of the luciferase reporters (see Results, Chapters 3 & 4) we have 
also identified nine repressors of the reporter system. Reduction of the mRNA titre of the 
corresponding genes led to an increase in expression of the Myc-responsive luciferase variant. Within 
the group of the nine strongest activator dsRNAs of the reporter system, 3 components of the RNA 
Polymerase II associated factor 1 complex (PAF complex) (Sims et al., 2004; Adelman et al., 2006) 
(hyrax, ctr9, and atms) and one PAF complex associated gene spt6 (Andrulis et al., 2000) were found. 
 
5.1. PAF complex components influence Myc target gene expression 
5.1.1. The Myc activity reporter is influenced by both reduction and overexpression of PAF 
complex components 
To confirm the findings of the screen, we repeated the luciferase assay in response to RNAi against 
PAF complex components using the the CG5033-Myc activity reporter system. S2 cells were 
transiently transfected with the wild-type promoter containing Renilla reporter, the firefly ΔE-Box 
reference and dsRNA corresponding to four of the five Drosophila PAF complex subunits hyrax (hyx) 
(2 independent dsRNA sequences, hyx1 and hyx2; hyx2 was a kind gift of George Hausmann & 
Konrad Basler), atu, atms, and ctr9). The cells were harvested 60 hours after transfection and relative 
luciferase intensities were measured. All values are expressed relative to a gfp dsRNA transfection, 
which serves as a control for unspecific effects of RNA interference. Figure 21 and Table 2 show that 
downregulation of the individual PAF complex components uniformly leads to an activation of the 
reporter system between 1.5 fold for atms and atu and about 3-5 fold for both hyx dsRNAs. Therefore, 
also the fourth subunit tested (Atu), influences the reporter system to a similar extent as the other PAF 
complex components. Indeed, atu-RNAi had an activating effect in 2 of the 3 screen runs but was not 
included in the final candidate list only because it did not comply with the significance criteria in the 
second screen run. In contrast, downregulation of rtf1, which has been reported not to be a stable part 
of the PAF complex in Drosophila (Adelman et al., 2006), did not change the relative luciferase 
expression. 
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 RNA 
interference 
relative luciferase activity 
(compared to gfp in %) 
Standard deviation (in %) 
gfp 100 4 
myc 14 2 
hyx 286 16 
hyx 2 493 64 
atu 157 19 
atms 152 7 
ctr9 176 11 
 
Table 2: RNAi against Paf complex components activates CG5033-driven Myc activity reporter  
S2 cells were subjected to RNAi against PAF complex components and luciferase activity was measured. Values 
are normalised to gfp control RNAi samples. Standard deviation of two individual measurements. 
 
Since downregulation of PAF complex components led to an activation of the dMyc-dependent 
luciferase reporter system, we tested whether overexpression of the individual subunits Hyrax and Atu 
had the opposite effect (Figure 22). Therefore, either a UAS-HA-Atu transgene, driven by tubulin-
GAL4, or HA-hyx under the direct control of a tubulin-promoter (both kindly provided by Ch. 
Mosimann) were expressed in S2 cells together with both CG5033-controlled Myc activity reporters for 
60 hours. Concomitantly, myc levels were modulated either by RNA interference or expression of a 
UAS-HA-myc transgene, to test whether the transcription modulating role of the PAF complex is 
altered by varying Myc levels. hyx and atu downregulation in response to complementary dsRNAs in 
cells with endogenous myc levels resulted in comparable activation of the reporter system as seen 
above (264 ± 17% (hyx) and 150 ± 17% (atu) respectively) compared to non-transfected controls. 
Overexpression of hyx exerted a strong negative effect on the reporter system, as expression levels 
dropped to 29 ± 2%. In contrast, no changes in luciferase expression could be observed upon 
elevation of Atu levels (104 ± 5%). Modulation of PAF complex component titres had similar effects in 
cells with reduced myc levels. RNAi against myc reduced luciferase expression levels to 16 ± 2%. This 
baseline expression could be boosted by about two-fold in response to hyx- and atu-RNAi (31 ± 6% 
and 37 ± 18%). As in cells with unaltered myc abundance, ectopic expression of hyx lowered the 
reporter activity (9 ± 1%), whereas elevated atu levels had the opposite effect (38 ± 3%). In the third 
experimental condition, luciferase intensities were measured in cells that overexpress Myc. An 
increase in luciferase expression of two-fold is observed upon expression of the UAS-HA-myc plasmid 
(193 ± 4%). This boost in reporter activity is further enhanced to 400 ± 12% or 289 ± 13% by reduced 
PAF complex levels. It is suppressed to 67 ± 1% in case of Hyx and 163 ± 8% for Atu overexpression. 
Taken together, lowering of hyx and atu titres reproducibly results in an activation of luciferase activity 
by 1.5-fold for atu and at least twofold for hyx, irrespective of the Myc content of a cell (as long as 
there is some Myc protein present). Coherently, upregulation of hyx by ectopic expression has a 
considerable repressive effect on reporter expression. Overexpression of atu, however, only results in 
slightly reduced luciferase activity (from 193 ± 4% to 163 ± 8% in the case of elevated Myc levels). In 
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cells with endogenous Myc levels it does not influence reporter expression at all, whereas in cells 
which were treated with myc dsRNA, ectopic Atu leads to increased luciferase intensities (16 ± 2% to 
38 ± 3%). 
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5.1.2. The PAF complex is required for the correct expression of endogenous Pol II-
transcribed Myc targets 
The results from the luciferase assay experiments clearly show that downregulation of the four PAF 
complex components hyx, atu, atms, and ctr9 all result in significant activation of the Myc-dependent 
reporter system in the range of 1.5-fold (in the case of atu and atms) to five-fold (hyx). In order to 
characterise the influence of PAF complex reduction on endogenous Myc target genes, qRTPCR 
measurements were performed. Total RNA was extracted from S2 cells that had been treated with 
dsRNA targeting either gfp as a control for unspecific RNAi effects, myc, or the four PAF complex 
components mentioned above. After an incubation time of 48 hours cells were lysed, RNA was 
extracted and analysed for its integrity on a bioanalyzer, cDNA was synthesised, and qRTPCR assays 
were run. As described in chapter 4.2. of the Results section, RNA polymerase II-transcribed Myc 
target genes had been identified by microarray analysis (Hulf et al., 2005). In this experimental setup, 
the levels of two of these targets, CG5033 and CG12295, were determined. Since there are several 
reports of Myc having a role in transcription by RNA polymerase III (Gomez-Roman et al., 2003; 
Steiger et al., 2008) assays for the RNA polymerase III-transcribed genes tRNA(Leu) and snoRNA U3 
were included. Additionally, we monitored the levels of the Pol II-transcribed Myc targets Bekka (Bka), 
which codes for a Trithorax group protein, whose promoter contains a single E-Box at position +33 
relative to the transcription start site, and CG9630, a predicted RNA-helicase without E-Box in its 
regulatory region. These two genes were identified as targets which are suppressed by myc-RNAi and 
upregulated by myc overexpression in the microarray studies mentioned above (Hulf et al., 2005). 
Furthermore, they are positive targets of the PAF complex component Hyrax (Ch. Mosimann, personal 
communication). 
In Figure 23 the expression levels of myc, CG5033, CG12295, Bka, CG9630, tRNA(Leu), and snoRNA 
U3 are depicted. For each assay two independent RNA extractions were performed. The results were 
normalised to the reference gene actin5C and and plotted relative to their expression level in the 
sample treated with gfp control RNA. Downregulation of myc was highly efficient as myc mRNA levels 
are reduced by more than five-fold. However, the depletion of PAF complex components also 
influences myc abundance, as a drop to 75-50% is observed. As expected, the titres of polymerase II-
transcribed targets CG5033, CG12295, CG9630, and Bka were strongly reduced in response to myc- 
RNAi. The polymerase III-transcribed targets tRNA(Leu) and snoRNA U3 were less affected. 
Downregulation of the three PAF components hyx, Atu and atms also resulted in a drop of Myc target 
levels to varying extent. Both CG5033 and CG12295 were most sensitive to hyx reduction as levels 
dropped to under 50%. For all the other cases only moderate reductions were observed. 
In summary, RNA polymerase II-transcribed targets of myc are sensitive to changes in PAF complex 
component abundance. Depletion of hyx, Atu and atms results in reduced expression of selected 
target genes. The observed reduction, ranges from considerable knockdown in the case of CG5033 or 
CG12295, as a consequence of hyx downregulation, to probably not significant changes of 
approximately 25% in the majority of the samples. As already seen upon Myc downregulation the 
polymerase III-transcribed targets are less sensitive to PAF complex reduction; In only two instances 
there is a significant downregulation (tRNA(Leu) upon Atu, and snoRNA U3 upon Atms depletion). 
This indicates that polymerase III-dependent targets are generally less affected by reduced PAF 
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complex levels and a therefore relatively moderate impairment of Myc-activity has no discernable 
effect on them. Alternatively, the PAF complex might only be involved in RNAP II, but not RNAP III-
dependent transcription. Moreover, knockdown of individual PAF complex components has different 
consequences. While depletion of ctr9 does not impact on expression of the tested targets, 
knockdown of atu, atms and hyx generally causes a slight reduction of target levels – with one incident 
of target gene activation in response to reduced hyx levels (Bka). This outcome was unexpected as it 
is in apparent contradiction with the results obtained from the luciferase assays, in which we originally 
identified the PAF complex components as repressive interactors of the Myc-dependent reporter 
system (see Discussion section 2.3.1.). 
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5.2. RNAi against PAF complex components does not detectably decrease 
Myc protein levels 
Prompted by the qRTPCR result that depletion of PAF complex components reduces the abundance 
of myc transcript (see Figure 23) we performed Western blot analyses to determine the Myc protein 
content in response to RNAi against all five PAF complex components. As seen in Figure 24, 
treatment of S2 cells with dsRNA complementary to PAF complex components does not result in 
obvious changes of Myc protein levels. However, it is possible that reductions by 25-50% 
(corresponding to the suppression seen in mRNA abundance) are not detectable with our standard 
enzymatic chemoluminescence detection system. For clarification, thourough quantitation of the band 
intensities would be necessary. Nevertheless, it is unlikely that reduction of PAF complex levels leads 
to a decrease in myc abundance, as Myc-dependent luciferase assays react to depletion of PAF 
complex components with a significant activation of the reporter gene. Moreover, this holds true for 
cells that overexpress myc but also in the context of diminished myc levels.  
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5.3. Myc and the PAF complex subunits Hyrax and Atu interact physically 
Despite the fact that modulations of PAF complex levels have diametrically opposed effects on the 
transactivation of the artificial reporter system and on endogenous Myc targets, both read-outs are 
reactive to changes in PAF complex abundance. These results indicate a functional link between Myc 
and the PAF complex. In order to further investigate this connection, we focussed on characterising a 
potential molecular interaction between the Myc protein and both Atu and Hyx. Since the PAF complex 
presumably does not (largely) affect Myc protein abundance, it is conceivable that it regulates target 
gene expression by altering the activity of Myc. Such an effect might involve a physical interaction with 
Myc. To this end, coimmunoprecipitations between overexpressed forms of Myc and PAF complex 
subunits were performed. S2 cells were transiently transfected with equal amounts of plasmids, coding 
for tagged versions of Myc and Atu and/or Hyx. The UAS-constructs (all except tubulin-HA-hyx) were 
driven by co-transfection of a tubulin-GAL4 plasmid. Lane 1 in the upper panel of Figure 25 reveals a 
strong physical interaction between Atu, fused to an AU1-tag, and HA-tagged Myc. Figure 26 depicts 
interactions between both Atu and Hyx and Myc (Lanes 2-4). Cell lysates were incubated with a rabbit 
anti-HA antibody. 9E10-tagged Myc is precipitated in the samples that contain HA-Atu, HA-Hyx or 
both, but not from lysates lacking HA-tagged proteins, attesting to the specificity of the anti-HA 
immunoprecipitation. The interaction between the Atu and Myc proteins is considerably stronger than 
between Myc and Hyx (compare lanes 2 and 3). Moreover, the strong interaction between Atu and 
Myc is not abrogated in the presence of overexpressed Hyx protein. This indicates a model in which 
Myc and Hyx independently associate with Atu without competing with each other, with the association 
between Hyrax and Myc (faint band in lane 3) being bridged by Atu. Such a model could be tested by 
immunoprecipitating HA-Hyx and assaying the retrieval of Myc or vice versa in the presence of 
different levels of Atu. Since we had detected a specific interaction between Myc and the PAF complex 
component Atu, we raised polyclonal antibodies against the RDKVESQVESAPKEC sequence within 
the Drosophila Atu protein (amino acids 368 to 381). This sequence has been chosen because it was 
is predicted to be antigenic and because it is not located in a region that is conserved amongst Atu 
homologues from different species. This suggests that it might not have an important conserved 
function. A characterisation of the anti-Atu antibody is depicted in Figure 27. 
 69



5.3.1. Conserved Myc domains are not required for physical interaction with Atu in S2 cells 
Coimmunoprecipitations between Atu and Myc have shown that the two proteins interact physically. 
To map the binding site(s) for Atu in the Myc protein, we performed coimmunoprecipitation 
experiments using a series of HA-tagged Myc protein mutants. An overview of the mutant Myc variants 
is presented in Figure 28. Constructs, which expressed Myc variants with individual deletions of the 
Myc-Boxes 1-3 (ΔMB1-3), the leucine zipper (ΔZ), or the entire bHLH-zipper (ΔC) were tested. 
Additionally, a variant lacking the N-terminus (ΔN) and a Myc protein lacking both the N-terminus and 
the bHLH-zipper (ΔNΔC) were included. Individual Myc mutants were transiently co-overexpressed 
with AU1-Atu in S2 cells. Expression of the constructs was driven by tubulin-GAL4. After 48 hours, the 
cells were harvested and lysates were immunoprecipitated with rabbit anti-AU or rabbit anti-Atu 
polyclonal antibodies. Anti-HA Western blotting revealed that all the Myc variants with mutations of the 
conserved domains still retain the ability to physically interact with Atu. Therefore, the well conserved 
domains of Myc are dispensable for this association. (Figure 29). 
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5.3.2. Atu interacts physically with various Myc protein mutants 
Since mutating the conserved domains within Myc did not abrogate the physical interaction with Atu in 
this first series of interaction experiments, we planned to identify the potential interaction domain by 
constructing a larger set of additional deletions. For this purpose the Myc protein was simply divided 
into fragments of roughly equal sizes, for protein alignments between the Myc proteins of twelve 
Drosophilid species and the mosquito Anopheles gambiae revealed neither recognisable domains, nor 
additional regions of higher conservation. Figure 28 shows a schematic depiction of the deletion 
variants used. During a first series of transfection experiments with the newly produced Myc deletion 
mutants we observed that the individual constructs were differentially expressed. While the larger 
fragments were generally well expressed, the shorter fragments, especially the N-terminal truncations, 
were induced at considerably lower levels. We therefore adjusted the amount of plasmid transfected 
so as to achieve as uniform an expression as possible. Immunoprecipitations were again performed by 
transiently expressing UAS-AU1-Atu with the individual triple HA-tagged Myc deletion constructs. A 
polyclonal anti-Atu antibody was used to precipitate AU1-Atu protein and samples were analysed on a 
Western blot using an anti-HA epitope antibody to detect Myc proteins. All the variants except the 
short C-terminal fragment ΔN523 and the smallest fragment ΔN626, which was not expressed in S2 
cells and therefore could not be assessed, still interact with the Atu protein (Figure 30). Despite 
adjusting the amount of transfected plasmid DNA to ensure equal expression levels, the protein 
variants displayed in Figure 30 can be placed in three different groups according to their strength of 
expression in S2 cells. The strongly expressed C-terminal truncations (Δ294C, Δ403C, and Δ523C) 
and ΔN294, moreover the three fragments ΔN403, ΔN523, and the N-terminus, which are all 
expressed at lower levels, and lastly ΔN626 which is not expressed. Of the strongly expressed Myc 
protein mutants the two fragments Δ523C (lane 3) and ΔN294 (lane 4) clearly interact with Atu as 
strongly as a wild-type Myc protein (data not shown), while Δ294C and Δ403C display weaker 
affinities. Within the second group of fragments with reduced expression levels, ΔN523 (lane 6) 
displays the weakest binding to Atu. As mentioned above ΔN626 could not be assessed as it was not 
expressed. Taken together, all the protein mutant forms which contain the central domain of the Myc 
protein, between amino acids 294 and 523 still bind Atu with high affinities. Hereby, the strongest 
interaction seems to be mediated by the stretch between amino acids 294 and 403 (differences 
between Δ294C and Δ403C and between ΔN294 and ΔN403). In addition to the central binding site in 
Myc also an N-terminal interaction is seen, for the N-terminus containing the first 179 amino acids of 
the Myc protein, is coimmunoprecipitated by Atu. 
Even though translation is initiated from identical start sites for all protein mutants, they are expressed 
at vastly different levels. In general, the shorter fragments are not as strongly expressed as the larger 
ones. In particular Δ294C-expression is even higher than that of the wild type myc protein. However, 
size seems not to be the only determinant of the expression level, because mutants of similar size are 
not equally expressed (Δ294C compared to ΔN403). Taking the general size effect into account, this 
suggests differences in protein stability of the various Myc variants. While the stability of protein 
truncations could generally be affected by non-native folding, these observations might also indicate 
the presence of a “destabilizing region” in the central stretch (after residue 403) of the Myc protein, 
since C-terminal fragments seem to be more abundant or stable. This “destabilizing region” could 
 76
correspond to the conserved domain MB 3, since there is data that suggest “destabilising” functions 
for MB 3 (D. Schwinkendorf, personal communication). This stabilisation effect seen with certain Myc 
fragments could be due to the loss of binding to components of the proteasome machinery (e.g. 
ubiquitin-ligases) or binding of factors that negatively influence Myc’s degradation via the ubiquitin-
proteasome pathway. Figure 31 shows a schematic overview of the associations seen between the 
Myc protein mutants and Atu, including their interaction strengths.  
 77


The interaction studies provided strong evidence that the central part of the Myc protein is important 
for the physical interaction with Atu. Therefore, three additional mutants with internal deletions were 
constructed. We combined the C-terminal deletion mutant Δ294C with the N-terminal mutants ΔN403, 
ΔN523, and ΔN626 respectively. The direct combination of the mutant forms was possible as an Mlu I 
restriction site was engineered adjacent to the truncation site of all mutants (for cloning procedures 
see Materials and Methods Section 1). Subsequently, the three resulting Myc proteins with internal 
deletions were tested for their ability to interact with Atu. As seen in Figure 32, all the three mutant 
forms still interact very strongly with Atu. This result suggests that the interaction site in the N-terminus 
of Myc is sufficient to mediate strong physical binding to the Atu protein, even in the absence of the 
whole central stretch of the protein as seen in the mutant form (Δ294C-626) lane 6. 
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5.3.3. The interaction between Myc and Atu is direct 
Coimmunoprecipitation experiments with transiently overexpressed Myc and Atu had revealed a 
strong physical interaction between the two proteins. To address the question if the interaction was 
direct or mediated by additional proteins in a multimeric complex, recombinant GST-Myc fusion protein 
variants were expressed in E. coli and tested for their ability to interact directly with in vitro translated, 
35S-labelled Atu. The entire Atu ORF was cloned into pBlueskript SK and expressed from a phage T7 
RNA polymerase promoter using a coupled rabbit reticulocyte transcription/translation system. GST 
pull-downs showed that the Atu protein expressed in vitro, is being bound by a glutathione sepharose 
bead coupled GST-Myc variant that contains amino acids 46 to 507 of Myc (Figure 33). This large Myc 
fragment includes most of the N-terminal transactivation domain with the conserved Myc Boxes 1-2 
(MB1-2), as well as the centrally located Myc Box 3 (MB3). In contrast, GST alone, which is used as a 
negative control of the binding assay, does not retain Atu in the pull-down assays (compare lanes 2 
and 3 of Figure 33), even though it was used in at least equal concentrations as GST-Myc. This 
experiment shows that the interaction between Myc and Atu is specific and direct. 
Since coimmunoprecipitation experiments performed in S2 cells (Results, sections 5.3.1. & 5.3.2.) 
have revealed two putative Atu-interaction domains in Myc, the corresponding Myc fragments were 
linked to GST in order to assay whether both these domains mediated direct protein-protein 
association. Figure 34 represents a schematic overview of the direct interactions between the various 
GST-Myc fragments and Atu, including the strength of the associations. As shown before, the largest 
Myc fragment (aa 46-507) binds to Atu with intermediate affinity (dark blue). The N-terminal Myc 
fragment that spans the region from the translation start to amino acid 176, interacts most strongly 
with Atu (navy), while the other two N-terminal fragments (aa 66-179 and aa 66-295) display reduced 
interaction capacity. In addition to the N-terminal portion of the Myc protein, also the centrally located 
fractions of Myc mediate physical associations with Atu. The three fragments which include MB3 all 
interact with weak to intermediate affinities. In summary, the in vitro translation experiments suggest 
that Atu directly interacts with Myc at (at least) two sites. These include the N-terminus, the first 180 
amino acids, and the central part of the protein in the vicinity of Myc Box 3. 
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5.4. Functions of the PAF complex in vivo  
Luciferase assays that confirmed the original screen data, as well as expression profiling of direct Myc 
target genes and various binding experiments, constitute evidence that several subunits of the RNA 
Polymerase-associated factor 1 complex are Myc cofactors involved in transcription control. In order to 
assess the function of the PAF complex components in vivo, we examined the effects of PAF complex 
induction or reduction in various tissues of the adult fly, such as the eye and the wing, but also in larval 
imaginal discs and fat body. 
 
5.4.1. RNAi against individual PAF complex components causes a size reduction of bristles 
One of the hallmarks of myc hypomorphic mutants in Drosophila is a thin bristle phenotype. The 
macrochaetae are smaller in relation to overall body size than in wild type animals. This phenotype 
occurs in mutants with defects in protein biosynthesis (e.g. Minute mutants) (Schreiber-Agus et al., 
1997; Gallant et al., 1996). We tested whether bristles are also sensitive to depletion of PAF complex 
components, which might indicate a link of Myc and the PAF complex in the control of bristle growth. 
Indeed, depletion of PAF complex levels also had a clear size effect in scutellar macrochaetae. We 
expressed UAS-hairpin RNA constructs targeting PAF components in bristle progenitor cells with 
scabrous-GAL4 (sca-GAL4). The size of both anterior and posterior scutellar bristles was measured in 
flies with reduced PAF complex levels in comparison to control animals that express lacZ dsRNA 
(Figure 35). atms-RNAi caused a strong reduction of thoracic bristle size by more than 50%. The 
effects of rtf1 and atu reduction were less pronounced. While rtf1 depletion caused a slight size 
reduction of 25-30% in both anterior and posterior scutellar bristles, atu knockdown only had a 
marginal effect in anterior scutellar bristles. 
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5.4.2. hyx shows a weak genetic interaction with the hypomorphic myc allele P0 
As described in Chapter 3 of the Result section, the Drosophila eye is a particularly sensitive system 
to changes in Myc activity. Especially the hypomorphic myc allele dmP0 has previously been used to 
characterise the strong genetic interaction with the essential Myc cofactor Tip49/Pontin (Pont) 
(Bellosta et al., 2005). One hallmark of dmP0 males carrying a heterozygous mutation in the pontin 
gene, is the occurrence of small, irregularly shaped, and slightly rough eyes. We have used the 
ey>dmP0 system (Bellosta et al., 2005) to assay for dominant interactions, since the same phenotype 
as in dmP0, albeit with a higher penetrance, is seen in this background (Results section 3.1.). Four 
strains with reduced or elevated hyx levels were also tested in the ey>dmP0 background. The strong 
hypomorphic hyrax allele hyxEY6898 which is caused by the EP-element insertion EY6898 into the 5’ 
UTR of the hyrax gene, hyraxP9, which contains another EP-element inserted upstream of hyx 
between the two loci neuralised (neur) and hyx, hyx2,a putative null allele, and the hyx overexpression 
line UAS-hyx1.5. These four lines are described in detail in (Mosimann et al., 2006). The offspring from 
all the experimental crosses showed no aberrance in their eye morphology (data not shown), therefore 
neither the reduction nor the increase of hyx levels led to a phenotype similar to the one observed with 
pont. Since changes in hyx levels do not cause obvious phenotypes in the dmP0 background (data not 
shown), the same hyx mutant strains were crossed to ey>dmP0 flies that were in addition heterozygous 
mutant for pont. Indeed, these crosses yield offspring with defective eyes at highly varying frequencies 
(Figure 36). However, in contrast to ey>dmP0; pont+/- animals originating from direct crosses, which 
show an almost complete penetrance of severe eye defects (Bellosta et al., 2005), prolonged 
propagation of an ey>dmP0; pont+/- stock causes strong reduction of the frequency of eye defects. This 
is presumably due to a selective pressure on ey>dmP0; pont+/- flies. Although the allele hyx2 and 
overexpression with the UAS-hyx construct do not cause significantly increased frequencies of eye 
defects, as compared to control crosses with yw (20% and 23%, respectively, of the relevant offspring 
have eye defects, compared to 16% for crosses with the yw control), UAS-hyx seems to affect the 
expressivity. Especially the anterior parts of the eyes show an increased roughness and the eye colour 
is changed. However, the colouration is affected independently of a lesion in pont and could therefore 
be based on a Myc-independent function of hyx or be caused by background mutations. In contrast, 
the two alleles hyxP9 and most potently hyxEY6898, result in eye defects with elevated penetrances of 
30% and 58%. The expressivity of the eye defects seen with the EP-insertions varies vastly from eyes 
displaying a slightly increased roughness to heavily disturbed overall eye morphology. Interestingly, 
both the overexpression construct UAS-hyx1.5 and the EP-insertion EY6898 cause stronger defects in 
the anterior part of the eye. In addition, a variegation of the eye pigmentation is seen with both alleles. 
While the anterior part of the eye is orange, the posterior half is dark red in flies carrying the 
hyraxEY6989 allele and pigmentation is almost completely lost in animals containing the UAS-hyx 
transgene.  
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To analyse the observed eye defects in more detail, we examined scanning electron micrographs 
taken from male ey>dmP0/Y; pon -/+ flies that also carried a mutation in one hyx allele. The eyes were 
then analysed with respect to the size of the ommatidia and the number of ommatidia in an individual 
compound eye. To assess the effects on ommatidial size, the area of 20 centrally located ommatidia of 
five eyes was measured. While none of the four alleles (hyxP9, hyxEY6898, hyx2 and UAS-hyx1.5) caused 
any significant change in ommatidial size in an ey>dmP0; pont -/+ background (Figure 37), ectopic hyx 
expression by UAS-hyx led to a significant reduction of ommatidial number (panel E in Figure 38). 
Conversely, heterozygosity for the hyx null mutation hyx2 resulted in an increased number of 
ommatidia within a single compound eye (D in Figure 38). 
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Taken together, the data presented in this paragraph are difficult to reconcile with each other, and 
have to be interpreted cautiously. One source of suspicion is the low incidence of eye defects in the 
ey>dmP0; pont+/- stock, as compared to its initial description. Moreover, the high variance of the eye 
defects in this line further complicates the statistical analyses of ommatidial size and number, as well 
as the assessment whether eye defects are aggravated by lesions in the hyx locus. Nevertheless, 
there are indications that Hyx acts as a negative cofactor of Myc in vivo. We could show that eyes 
heterozygous for the hyx null mutation hyx2, contain a significantly higher number of ommatidia. While 
the overall number of defective eyes is not decreased, individual eyes seem to look more regularly 
patterned than in control animals. This fact does not necessarily point to a negative genetic interaction 
between hyx and myc. However overexpression of hyx caused a general aggravation of the eye 
defects as well as the most strongly defective eyes of all genotypes examined. The loss of large 
portions of eye-tissue is apparently caused by the significant loss of ommatidia (Figure 38, column E). 
 
5.4.3. Ectopic hyx slightly suppresses myc overexpression phenotypes in the eye 
The cellular consequences of Myc overexpression are increased growth, and at high levels induction 
of apoptosis. While expression of one copy of UAS-myc in the eye leads to larger ommatidia without 
disruption of the regular ommatidial pattern, further increase of Myc levels (by expressing three copies 
of UAS-myc at 25°C) still causes an enhancement in ommatidial size (up to 20% increase). However, 
the ommatidial arrangement is disturbed as a consequence of apoptosis. On a macroscopic level this 
disruption of the ommatidial array is manifested by the rough texture of the eye. At highest levels of 
ectopic Myc expression (3 copies expressed at temperatures higher than 25°C) the appoptosis 
overwhelms the growth-promoting effects and the ommatidial size decreases again, while the 
rougness is even more pronounced. In extreme cases the ommatidial pattern is totally destroyed and 
the eyes take on a glassy appearance (Steiger, 2007; Montero et al., 2008). We tested if increase or 
reduction of hyx levels influenced Myc activity and the resulting overexpression phenotype. Test 
crosses to y w; GMR-GAL4 UAS-myc132/+; UAS-myc132 UAS-myc42/+ animals showed that ectopic 
hyrax expression by driving one copy of the UAS-hyx transgene slightly suppresses the rough-eye 
phenotype. This reduced roughness might indicate a reduction of Myc activity. A similar suppression is 
seen in crosses where pontin function is partially disrupted by crossing in the pontin null mutant 
pont5.1. In contrast, a null mutation in the hyx locus (hyx2) occasionally leads to a reduction in eye size 
and a severly affected eye texture. Individual ommatidia cannot be distinguished anymore, and the 
eye surface becomes smooth with a distinctive glassy appearance, however the relevance of this 
observation is unclear, since only 5% of a total of 80 flies were affected. This phenotype is commonly 
seen in eyes with very high levels of Myc. Taken together, increased hyx levels seem to suppress the 
roughness caused by strong overexpression of myc, while partial disruption of hyx function even 
aggravates the phenotype seen in cases of very high myc levels. 
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 5.4.4. Disruption of Atu, but not of atms, dominantly influences eye morphology 
In addition to hyx, other PAF complex subunits were also tested for genetic interaction with myc. We 
examined the influence of two strong Atu and atms loss of-function alleles respectively. Both alleles 
are caused by the insertions of transposable elements into the 5’ UTR of the corresponding gene, 
resulting in disruption of their functions and recessive lethality. When crossed to ey>dmP0 flies, neither 
Atus1938 nor atmsrK509 causes any eye defects that resemble the ones seen with heterozygous pont 
mutations. However, when the system is being sensitised even further by taking away one copy of the 
pont gene as described above, Atus1938 aggravates the eye phenotype considerably, as 90% of the 
offspring show severly disturbed eye morphology. On the other hand, reduction of atms levels by 
atmsrK509 does not have visible consequences. This suggests that Myc-dependent processes in the 
Drosophila eye seem to be more sensitive to the disruption of Atu function than loss of Atms. 
  
5.4.5. Depletion of PAF complex function by RNAi causes severe eye phenotypes 
All the genetic interaction studies described above were carried out using classic mutations (or 
overexpression transgenes) in genes coding for PAF complex components. Additionally, we also used 
fly strains from the Vienna Drosophila RNAi Center (VDRC). Strains carrying UAS-hairpin RNA 
transgenes targeting PAF complex components were crossed to ey>dmP0 animals. In the ey>dmP0 
background the rescuing myc cDNA is specifically removed in the eyeless-expression domain, 
resulting in a dmP0 mutant situation in the whole head capsule. However, these flip-out events not only 
create a myc mutant situation but also allow GAL4-driven transgene-overexpression in the eye. As a 
further control for the dependence on myc, the same UAS-hairpin RNA transgenes were expressed in 
an ey>dm+ wild type background. We used this experimental setup to assess two characteristics of the 
eyes. On the one hand we examined whether the highly ordered ommatidial pattern was disturbed in 
response to PAF complex-RNAi. On the other hand we measured the RNAi-influence on ommatidial 
size. In contrast to the classic mutations which never showed any dominant interactions in the 
ey>dmP0 background, depletion of atms and rtf1 caused by expression of the UAS-hairpin construct 
specifically in the eye, led to distinct eye defects. Disruption of atms function caused severe rough-eye 
phenotypes in 85% of all offspring (55 animals with distinct eye defects /65 total). However, already 
rft1-RNAi in the wildtype background resulted in a slight rough-eye phenotype in 66% of all animals. 
The effect seen upon rtf1 depletion was less potent as only 55% (37/67) of the animals possessed 
strongly rough eyes in a dmP0 mutant situation, and the great majority of the eyes in an ey>dm+ 
background displayed slightly increased roughness. In both cases (for atms- and rtf1-RNAi in the 
ey>dmP0) the eye defects resembled the effects seen upon mutating one copy of pont. In severely 
affected eyes a large number of ommatidia at the anterior and ventral edge of the eye were lost, 
causing indentations in the eye tissue. In most cases, the entire eyes displayed a strong roughness. 
Additionally, RNAi constructs targeting hyx and Atu were tested but did not cause any eye defects in 
the ey>dmP0 and ey>dm+ backgrounds. As a control for unspecific RNAi effects we used the lacZ-
hairpin line Z-IR M3i (Steiger, 2002). These results show a positive genetic interaction of rtf1 and atms 
with myc, whereas the other two PAF complex components, hyx and Atu, did not genetically interact 
with myc.   
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In addition to overall defects and texture of the eye, we also examined the effect of PAF complex-RNAi 
on ommatidial size. Figure 39 shows an overview on the RNAi effect on ommatidia size. The size 
difference of the two strains expressing lacZ-hairpin RNA (compare column A to A’) depicts the 
published effect of the dmP0 allele on ommatidial size. While this reduction of myc levels by the allele 
dmP0 results in this significant size reduction, no strong additional size reduction is observed upon 
further reduction of myc levels by myc-RNAi in an ey>dmP0 background (column B and B’), suggesting 
that dmP0 already displays strongly reduced Myc activity. Columns A-E depict the size of 20 centrally 
located ommatidia of five indivdual eyes that express UAS-hairpin transgenes in a myc wild type 
background (ey>dm+). In this situation only knockdown of myc leads to a significant reduction of 
ommatidial size (compare A to B), while RNAi against PAF complex components does not significally 
change ommatidial size. However, the ommatidia seem to be slightly increased in size in response to 
PAF complex-RNAi. Since RNAi-mediated knockdown of Atu and atms in both ey>dmP0 and ey>dm+ 
backgrounds does not result in significant size changes as compared to lacZ-RNAi, we have to 
conclude that there is no specific genetic interaction between myc and Atu or atms respectively. 
However, we observe a negative genetic interaction between hyx and myc as the downregulation of 
hyx seems to alleviate the requirement for Myc in the dmP0 situation (compare columns C and C’). In 
contrast to the classic mutants, which only showed genetic interaction in the eye in a heavily 
sensitised background (by mutating one copy of pont), expression of UAS-hairpin RNAi lines have a 
stronger effect, as they already cause defective eyes in an ey>dmP0 situation. This suggests that 
expression of the hairpin-RNAi transgenes lead to a stronger downregulation than heterozygosity for a 
given PAF complex component. 
 
RNAi-line roughness ommatidial size 
hyx - + 
drtf1 ++ - 
atu - - 
atms +++ - 
 
Table 3 summarises the effects of depletion of PAF complex components by RNAi in the ey>dmP0 
situation. While downregulation of rtf1 and atms results in an increase roughness of the eye texture and 
loss of ommatidia, hyx depletion alleviates the requirement for Myc in the dmP0 situation 
To characterise the putative genetic interaction between Myc and the components of the PAF 
complex, we have both tested classic mutants, which disrupt PAF complex function, but also 
transgenic RNAi insertion lines against several PAF complex subunits. Taken together, these 
interaction studies reveal different properties for individual PAF complex subunits. While hyx seems to 
behave as a negative cofactor of Myc, as seen with the genetic interactions of UAS-hyx and hyx2 in 
the eye, the other tested subunits (Rtf1, Atu, and Atms) represent coactivators of Myc in various 
assays. RNAi-mediated depletion of atms and rtf1 strongly reduced bristle growth but also led to 
severe eye defects in an ey>dmP0 background. Knockdown of atu had milder consequences on bristle 
size, while the classic mutation Atus1938 caused severe eye malformation with almost complete 
penetrance.
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5.4.6.  RNAi against PAF complex components in the wing leads to reduced growth 
Slight differences between the sizes of the dorsal and ventral wing epithelia lead to a bent wing 
phenotype. The overexpression of a cDNA with the strong, dorsal compartment-specific GAL4 driver 
apterous-GAL4 (ap-GAL4) therefore reveals growth-promoting or growth-inhibiting abilities of the 
corresponding protein with high sensitivity (Montagne et al., 1999). In order to assess the influence of 
PAF complex depletion on wing development, we expressed UAS-hairpin RNA constructs targeting 
the individual PAF complex subunits by ap-GAL4. While reduction of hyx and atms levels did not alter 
growth of the dorsal wing compartment, a very distinct bent-up wing phenotype was observed upon 
depletion of Atu. This is a strong indication for reduced tissue size in the dorsal wing compartment, 
where apterous-GAL4 is expressed. Reduction of rtf1 levels caused an even more drastic phenotype 
as wings were almost entirely missing, but these flies were still able to eclose. In contrast, myc-RNAi 
was pupal lethal, presumably because adult animals were not able to break out of their pupal case. It 
is surprising that flies that totally lack adult wings (as caused by rtf1-RNAi) can still eclose, whereas 
myc-RNAi causes pupal lethality without concomitant loss of the wings (as observed by opening 
several pupae). This discrepancy could be due to leaky expression of ap-GAL4, which might reduce 
myc abundance in other tissues, in which Myc function is vitally important. Alternatively, myc-RNAi still 
may affect wing morphology to such a degree that eclosion is impeded.  
As a second assay, we tested whether RNAi against PAF complex subunits could suppress the wing 
defects caused by Myc overexpression. Elevated Myc abundance in the apterous expression domain 
in a small percentage of the offspring causes overgrowth of the dorsal wing compartment. This is 
manifested by a slight bent-down phenotype. The majority, however, displays severely disturbed 
wings. The two wing blade epithelia do not adhere with each other anymore, the interstitium between 
the epithelial sheets is often filled with fluid and in older flies the wings become necrotic. These 
phenotypes are presumably largely caused by Myc’s growth-promoting activity, but may also by 
influenced by increased apoptosis and loss of cell-cell adhesion, since both these processes are 
known to be associated with high Myc levels. This phenotype is clearly myc-dependent as depletion of 
myc in response to RNAi, suppresses the defects, and the wings are bent upwards. Not only RNAi 
against myc itself, but also against Atu and rtf1 leads to a clear bent up wing phenotype and the 
overall wing defects are rescued. These experiments indicate a positive genetic interaction of the PAF 
complex components atu and rtf1 with Myc, since depletion of rtf1 and atu causes bent-up wings and 
more importantly an almost complete suppression of Myc overexpression-induced defects. In contrast, 
wings in which hyx had been depleted in the dorsal compartment still exhibited a clear bent-down 
phenotype, as observed upon Myc overexpression. In addition, about one third of the wings displayed 
necrotic patches, which might be due to increased apoptosis rates in response to elevated Myc 
activity. Therefore, knockdown of hyx does not impair growth, however the defects caused by Myc 
overexpression seemed to be slightly suppressed. Lastly, downregulation of atms caused pupal 
lethality with complete penetrance. 
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5.4.7. Depletion of PAF complex components modulates growth properties of imaginal disc 
clones and polyploid fat body nuclei 
Experiments in which the abundance of PAF complex components was reduced either by expressing 
complementary UAS-hairpin RNA or introducing classic mutants, suggest a growth promoting role for 
the Rtf1, Atms, and Atu subunits, while Hyx behaves antagonistically. To characterise the role of the 
single PAF complex components with respect to cellular growth, we observed growth of wing imaginal 
disc clones with reduced PAF complex abundance. In contrast to the other tissues examined, here we 
analyse the role the PAF complex in undifferentiated cells before metamorphosis, with respect to cell 
size, and in a precisely timed manner. To do so, we used a line carrying an act>CD2>GAL4 cassette 
in combination with UAS-GFP and hs-FLP transgenes. Upon heat-shock, FLP recombinase-mediated 
recombination takes place in individual cells. Clones descending from these cells concomitantly 
express the hairpin RNA transgene and GFP. Hence, they can be easily detected by fluorescence 
microscopy. To assess the dependence on Myc function, crosses were also performed with a line that 
in addition to the other transgenes expresses Myc from a UAS-myc transgene. Crosses with RNAi 
targeting PAF complex subunits were set up and a lacZ-hairpin RNA line was included both as a 
control for non-specific RNAi effects but more importantly for possible titration effects of GAL4. 
Seventy-two hours after egg deposition the larvae were subjected to a heatshock of 8 minutes at 
37°C. After another 45 hours, larvae were dissected, wing discs were isolated, and the area of 
individual clones was assessed in fluorescence micrographs. 
Figure 40 depicts the result from one individual clonal analysis and clearly shows that clone growth is 
enhanced upon concomitant overexpression of Myc. Clones coexpressing Myc were on average twice 
as large as their counterparts with endogenous myc titre (compare panels A and B). This is in 
agreement with the previous observation that overexpression of Myc in clones in wing imaginal discs 
strongly enhances growth (Johnston et al., 1999). Moreover, in the Myc overexpression situation, 
RNAi against all the PAF complex components causes significant reduction of the clones’ growth 
potential. This points to a positive genetic interaction between the PAF complex components and Myc. 
Furthermore, the PAF complex seems to become limiting in the presence of high levels of Myc. In 
contrast, depletion of PAF complex components in the absence of Myc overexpression leads to rather 
moderate size changes in clones. Downregulation of some PAF complex components even increases 
the size of control clones (Figure 40 panel B; compare hyx- and atms-RNAi with rtf1-RNAi). Taken 
together, depletion of PAF complex components clearly influences clonal growth potential and has a 
solid growth limiting effect. Moreover this reduction of clonal growth is far more pronounced in 
situations with high Myc abundance.  
Since Myc has previously been reported to play an important role in endoreplication (Maines et al., 
2004), not only imaginal wing discs but also fat bodies from the very same larvae were extracted. Myc 
overexpressing polyploid cells were reported to contain greatly enlarged nuclei, whereas nuclei in myc 
mutant polyploid tissue are smaller (Pierce et al., 2004). During endoreplicative cycles polyploid fat 
body nuclei undergo rapid rounds of DNA synthesis without intermittent mitoses. In keeping with this 
observation, Myc overexpressing fat body cells have enlarged nuclei compared to fat body tissue with 
physiological Myc levels (Figure 41). However, depletion of PAF complex components had no 
repressive effect on the nuclear size under these conditions (Figure 41). 
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Discussion 
 
In this work, we describe the establishment of a Myc-dependent Dual luciferase reporter system, 
based on reporter constructs under the control of the Myc target gene promoters. This system allowed 
us to perform an RNA interference screen in Drosophila S2 cells, which led to the identification of 
several novel cofactors in Myc-dependent transcription regulation. Subsequent to the screen we have 
analysed three groups of cofactors in more detail. We could show a genetic interaction of subunits of 
the 19S proteasome regulatory complex with Myc. Furthermore, we give clear evidence for an 
involvement of the Drosophila host cell factor (HCF) and the Polymerase II-associated factor 1 
complex (PAF complex) in Myc-dependent transcription regulation. 
In the first part of this discussion, the set up of the screen and the resulting candidate list are 
recapitulated and described. In the following parts we discuss the specific roles of the candidates 
analysed more thoroughly. 
 
1. RNAi screen for dMyc cofactors 
We performed an RNA interference (RNAi) screen in embryonic hematopoietic Schneider 2 (S2) cells 
and identified 33 significant modulators of the system. The screen was based on a directly Myc-
dependent Dual luciferase reporter system, in which the reporter genes are under the control of either 
the nnp-1 or CG5033 gene promoters. The ability of myc RNAi to inhibit wild type nnp-1 and CG5033 
promoter driven luciferase expression confirms these two genes as targets of Myc. The single E-Box 
present in both regulatory sequences is important for the transcription of the genes, and hence the 
reporter, as the mutation of the E-Box leads to a 3 to 4 fold reduction in reporter gene expression in 
the case of CG5033 (Figure 6b) and 1.5 to 2.5 fold reduction for the nnp-1 reporter (Figure 6a). 
Moreover, Myc’s control on nnp-1 and CG5033 reporter expression is exclusively mediated via the E-
Box, since mutating the E-Box renders the promoters unresponsive to myc RNAi (Figures 3a & b). For 
these reasons we considered the ratio of the luciferase reporters to be strictly dependent on Myc and 
reflect its overall activity. Since the CG5033 reporter system is more sensitive to changes of Myc 
levels it was used as the primary screening reporter pair.  
The motivation to conduct an RNAi screen was to identify cofactors that are essential for the 
physiological regulation of Myc targets (in Drosophila). Even though many transcriptional cofactors 
that physically bind to Myc have been identified - mostly in vertebrate tissue culture systems - the 
physiological relevance of very few of these proteins has been demonstrated. To minimise the scale of 
the screen, we chose not to conduct a genome-wide RNAi screen but tested a preselection of 752 
transcription-associated factors. This selection included factors that had been shown to be involved in 
Myc-dependent processes in various model organisms. Furthermore, general transcription-associated 
factors, and as a third group uncharacterised proteins with potential involvement in transcription, as 
inferred from their gene ontology annotation, were included (see Results, section 1.2.).  
The use of the E-Box/ΔE-Box-luciferase system ensured a Myc-dependent readout, as only the input 
through the E-Box is measured. For this reason – and because their inclusion would have doubled the 
number of candidates – we did not include sequence-specific transcription factors in the screen. This 
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strategy excludes the identification of transcription factors that would act together with Myc in the 
regulation of the Myc activity reporter by binding to DNA cooperatively with Myc. However, we would 
expect such hypothetical factors only to influence a restricted number of other Myc targets, since the 
Myc binding sites in Myc targets genes do not share any sequences outside an extended 10 
nucleotide E-box (AACACGTGCG) (Hulf et al., 2005), whereas our screen was aimed at identifying 
more generally acting cofactors of Myc.  
Out of the 752 factors tested in the screen, we identified 33 as significant modulators of the Myc-
dependent reporter; 19 candidates had a “Myc-like” effect, as their depletion led to a reduction of the 
relative reporter activity, whereas RNAi against 14 other factors led to an activation of the reporter 
system (Table 1). The fact that only 4.5% of all the candidates were identified as significant 
modulators of the reporter system suggests a high specificity of the screen, even more so as a biased 
preselection of candidates was used. As a validation of the targets the final candidate compilation of 
33 factors was retested with the nnp-1-driven reporter system. All the three PAF complex components 
identified with the CG5033 reporter (Hyx, Ctr9, and Atms) were also found using the nnp-1 reporter 
constructs. Moreover, the PAF-associated factor Spt6 and the HDAC component Sin3A were 
positively identified with both reporter variants. The activators of the reporter system also had an effect 
on the nnp-1 reporters, however it was less signifcant than in the screen and, therefore they were not 
picked up using the same significance criteria as in the screen. This is probably due to the lower 
sensitivity of the nnp-1 reporter pair compared to CG5033 and the strong variability of the RNAi effect 
for certain factors. However, the dsRNAs causing the strongest downregulation of the reporters (i.e. 19 
RC components of the proteasome) reduced nnp-1 reporter activity to the same extent as myc-RNAi. 
We had previously analysed derivatives of the nnp1-luciferase reporter, in which the native E-box had 
been replaced by an E-box at different positions upstream of the transcription start site (TSS). These 
experiments had shown that an E-box at position -40 does not mediate transactivation by Myc, 
whereas an E-box at -320 partially substituted for a native E-box and transactivated the reporter to 
about 70% of the native E-box; as a transfection control in these experiments we had used a Renilla 
luciferase driven by a tubulin promoter (Hulf, 2004; Hulf et al., 2005). RNAi against the PAF complex 
components and Sin3A also activated the expression of an nnp-1 reporter with an E-Box at position     
-320 to some extent. Typically, the luciferase values are increased by almost two-fold. The luciferase 
ratios upon PAF complex and sin3A-RNAi were almost identical in both experiments, in which the 
luciferase ratios between -320 firefly and wild type Renilla reporter on one hand, and ΔE firefly and 
wild type Renilla luciferase on the other were compared to gfp-RNAi controls (data not shown). This 
might indicate that they are Myc cofactors that are not exclusively recruited to target gene promoters in 
which the E-Box is located proximally to the transcription start site. However, the influence of RNAi 
against Paf complex components needs to be further addressed in additional experiments, for 
example in comparison between the -320 reporter with the ΔE-Box variant. As a side, hcf knockdown 
did not show any influence on the -320 reporter, pointing to an exclusive role at downstream E-Boxes. 
As mentioned above, the position of the E-Box proximal to the TSS can be crucial in order for a Myc 
regulated gene to achieve the required expression level, since E-Boxes at different positions upstream 
of TSS cannot recapitulate the full reporter activity. Positioning the E-Box at -40, renders the reporter 
gene inactive, probably by interfering with the binding of the basal transcription machinery. E-Boxes 
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positioned distal to TS sites can function to promote gene expression through recruitment of other 
factors like chromatin remodellers but will be unable to enhance gene expression through molecular 
interaction with basal transcriptional elements. It has been demonstrated that c-Myc can activate 
expression of the cad gene via a post-RNA polymerase II recruitment mechanism by interacting with 
P-TEFb (Eberhardy and Farnham, 2001, 2002). It is possible that Myc target genes with an E-Box 
downstream of the TSS in general are activated by interaction of Myc with the engaged (and possibly 
paused) RNAP II complex. In addition to the reports from Eberhardy et al., other studies describe that 
activation of targets by Myc can rely to varying extent the recruitment of different co-factors (e.g. 
interaction with P-TEFb vs. chromatin remodellers). The three basally expressed genes CAD, CDK4 
and HSP60 do not strictly depend on the recruitment of TRRAP and HAT activity for Myc-dependent 
induction. Myc variants with mutated MB2 domains are still capable of activating transcription from 
these loci (Nikiforov et al., 2002b). 
Taken together, the factors identified in the primary RNAi screen clearly influence the expression of a 
number of Myc targets. They impact on the expression of two Myc-dependent reporter constructs with 
downstream E-Boxes, as well as endogenous targets of Myc (shown by qRTPCR experiments). 
 
2. Putative Myc cofactors 
In addition to PAF complex components, we have also identifed Spt6, a transcription elongation factor 
originally identified in yeast (Bortvin and Winston, 1996). Spt6 was shown to mediate chromatin 
disassembly during transcription elongation and re-establishment of chromatin structure after the 
polymerase has passed through (Adkins and Tyler, 2006; Hartzog et al., 1998; Saunders et al., 2003). 
In yeast it has been shown that nucleosome reassembly by Spt6 is involved in trancriptional 
repression (Kaplan et al., 2003; Adkins and Tyler, 2006).  
In Drosophila Spt6 is rapidly recruited to sites of active transcription. Spt6 co-purifies with the 
exosome, a complex of 3' to 5' exoribonucleases that is implicated in the processing of structural RNA 
and in the degradation of improperly processed pre-mRNA. Immunoprecipitation assays of Drosophila 
nuclear extracts show that the exosome also associates with the elongation factor dSpt5 and RNA 
polymerase II. A clear link between the PAF complex and Spt6 was revealed in Drosophila where 
depletion of the PAF complex leads to a significant decrease in the recruitment of Spt6 to actively 
transcribed hsp70 promoters (Adelman et al., 2006). This suggests that the PAF complex associates 
with Spt6 to maintain proper chromatin architecture during transription.   
 
2.1. The 19S proteasome RC is an activator of Myc-dependent target 
expression 
Depletion of six out of eight non-ATPase subunits of the 19S proteasome regulatory complex tested, 
resulted in a marked drop of reporter activity by roughly three-fold compared to GFP control RNAi 
(Figure 8). However, not only the Myc-reporter system proved to be sensitive to downregulation of the 
proteasome components. tubulin-GAL4 driven expression of RNAi hairpin lines in the eyeless 
expression domain in a Myc hypomorphic background caused severe eye defects. With almost 
complete penetrance eyes became considerably smaller and most often displayed irregular shapes 
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due to the loss of a large number of ommatidia. Also the classic P-element insertion mutant Rpn6k00103 
caused mild eye aberrations similar to the observed RNAi phenotype, whereas other Rpn6 mutants 
and Rpn11 had no effect on the overall eye structure. Moreover, the insertions Rpn6k00103 and 
Rpn11BG01694 both suppressed the size increase as well as the disruption of the ommatidial array 
caused by Myc overexpression. The difference in phenotypic strength between the RNAi-mediated 
downregulation and the classic mutations used is noticeable. While the classic mutations have a rather 
mild impact on eye morphology, six of seven RNAi lines lead to severest eye defects (loss of the 
majority of ommatidia or even complete loss of eye structures). The mildness of the phenotype seen 
with the classic mutants is probably due to sufficient levels of gene product in a heterozygous mutant 
animal to ensure normal eye development. Conversely, RNAi-mediated knockdown, although it may 
not be complete, leads to a stronger reduction of rpn levels. 
The experiments clearly point to an activating role of the 19S proteasome regulatory complex on Myc 
activity, since reduction of Rpn levels leads to decreased reporter expression, suppression of Myc 
overexpression effects, and severe eye defects specifically in myc hypomorphic animals. This is 
surprising since a partial loss of proteasome function leads to a slow-down or loss of protein 
degradation and presumably a prolonged half-life of its targets, including Myc. Since Myc is a short-
lived protein that is rapidly degraded by the proteasome, we would have thought that inhibition of the 
proteasome increases Myc levels, and hence activity. It is known from in vitro studies that the complex 
consisting of the 19S RC base and the 20S core proteasome can still perform ATP-dependent 
degradation of unfolded proteins, but it can no longer degrade polyubiquitin-tagged substrates (Pickart 
and Cohen, 2004; Glickman et al., 1998). As the majority of the Rpn subunits found in the screen are 
part of the 19S lid subcomplex (all except Rpn2 which forms part of the base subcomplex), RNAi 
against these components may result in impaired substrate recognition and disruption of proteasome 
function. However, analyses of Myc by Western blots revealed that RNAi against proteasome 
components had no obvious impact on Myc abundance in S2 cells (Figure 9). 
Several lines of evidence suggest that disruption of proteasome function leads to reduction of reporter 
activity and lowered Myc activity. It has been proposed that in order to keep the activity of transcription 
factors under control, their ability to drive high-level gene expression is tightly coupled to their 
degradation, i.e. they are only fully active when they have been "marked" for later destruction. One 
component involved in such a process is the F box protein Skp2, an E3 ubiquitin ligase, which not only 
regulates the stability of Myc in vivo, but also acts as a cofactor that is necessary for full activity of Myc 
(Muratani and Tansey, 2003). There are reports that monoubiquitination of the artificial activator LexA-
VP16 can increase its ability to recruit the elongation factor P-TEFb (Kurosu and Peterlin, 2004). Also 
the efficiency of posttranscriptional processes, such as recruitment of the RNA processing machinery 
to produce functional mRNAs, may be stimulated by activator ubiquitination (Muratani et al., 2005). 
Furthermore, it has been shown for several transcriptional activators that their activation domains 
closely correspond to the degrons (motifs required for turnover via the ubiquitin-proteasome pathway). 
This “licensing event” of ubiquitination in order to gain full activity might explain why reduction of 
proteasome function can oppose Myc activity.  
There are two proposed models that try to link activator potential and proteasome activity (Kodadek et 
al., 2006). These have been termed “timer” or “black widow” mechanisms. While the two models differ 
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in how ubiquitination and then degradation is triggered, both models incorporate a positive effect of 
ubiquitination on transcription. In the “timer” mechanism the monoubiquitinated activator is of crucial 
importance. It is the substrate for the chain extenders – E4 ubiquitin-ligases that add K48-linked 
ubiquitin molecules – and deubiquitinases that remove ubiquitin moieties to antagonise chain growth. 
It has been shown that at least four K48-linked ubiquitin molecules are required to promote 
proteasome-mediated degradation (Thrower et al., 2000). The action of both these types of enzymes, 
which can work at different rates, provides a “window of opportunity” during which the activator has full 
activation potential (i.e. the time it takes to stably couple three or more ubiquitins to the substrate). Of 
central importance for this model is the assumption that the ubiquitinated activators are significantly 
more active than the non-ubiquitinated form. On the other hand, the “black widow” mechanism 
suggests that activator polyubiquitination and subsequent destruction are an inevitable consequence 
of physical interaction with the RNA polymerase holoenzyme. As shown for the yeast activator Gcn4, 
“mating” with the polymerase leads to phosphorylation by the Mediator component cdk8 and 
subsquent SCFCdc4-dependent polyubiquitination (Chi et al., 2001). Thus, by carrying out its function 
the activator Gcn4 is presented to the protein kinase that triggers its destruction. 
Two other implication for the positive role of the 19S proteasome in transcription comes from the 
observation in Saccharomyces cerevisiae that the 19S base subcomplex ATPases Sug1 (also termed 
Rpt6) and Sug2 (Voges et al., 1999) participate directly in transcription. It was shown in yeast that at 
least five subunits of the 19S proteasome are recruited to transcriptionally active genes. They stay 
associated with the polymerase throughout the entire transcribed sequence of the gene (Kim et al., 
1994; Gonzalez et al., 2002). Disruption of the 19S RC complex by mutating the Rpt4 or Rpt6 subunits 
abrogates histone H2B-monoubiquitination and, as a consequence also histone H3K4 and H3K79 
methylation (Ezhkova and Tansey, 2004). Moreover, Brower et al. established that ubiquitin-ligase 
activity is directly linked to the RNAP II holoenzyme by Mediator in vertebrates (Brower et al., 2002). 
Additionally, it was shown that the lid subcomplex of the 19S proteasome RC can act as a 
transcription coactivator by directly recruiting the SAGA histone acetyltransferase complex to target 
promoters (Lee et al., 2005), and that the SAGA complex contains the ubiquitin protease Upb8 that 
deubiquitylates H2B to allow transcription initiation (Henry et al., 2003). 
These data argue that short-lived transcriptional activators, like Myc, only gain their full activity when 
they are being marked for later degradation and therefore, could explain why depletion of proteasome 
components leads to reduced transactivation potential of Myc. 
 
2.2. Host cell factor (HCF) 
Experiments presented in this study and Mirjam Balbi’s master thesis (Balbi, 2007) identified HCF as a 
positive cofactor of Myc-dependent transcription control. We showed a direct physical interaction 
between the HCF and Myc proteins and revealed a requirement for HCF in Myc-dependent gene 
expression in S2 cells. In vivo HCF synergises with Myc in promoting growth in the eye and in wing 
imaginal discs. HCF depletion by RNAi has the potential to partially revert Myc overexpression 
phenotypes in the wing and in the eye. These data coherently indicate that Myc requires HCF to reach 
its full transcriptional activity during proliferation and differentiation. 
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2.2.1. Effect of HCF on the epxression of Myc targets in S2 cells 
The original observation from the screen that RNAi-mediated depletion of HCF leads to a decrease of 
Myc-reporter expression was confirmed with additional independent dsRNAs. Knockdown of HCF 
resulted in a decrease of luciferase expression to about 60%, while RNAi against Myc typically 
reduces reporter expression to 15-30% (Figure 10). This indicates that Myc is dependent on HCF to 
attain full transcriptional activity. However, this dependence is not complete, since in the situation of 
HCF depletion Myc still retains reduced activity. Interestingly, hcf-RNAi only slightly reduces reporter 
activity in a Myc overexpression situation (from 200% to 180% as compared to gfp-RNAi), most 
probably because the HCF-independent activation of Myc-targets is potent enough to ensure strong 
reporter expression. On the other hand a strong boost in luciferase expression induced by ectopic 
HCF expression can be reversed by myc-RNAi, indicating that this activation is Myc-dependent. This 
could imply that the overexpression effect of Myc on the luciferase reporter is mediated by HCF-
independent mechanisms. Thus, hcf-RNAi would only affect the basal luciferase activity but not the 
boost resulting from ectopic Myc expression. These assumptions fit with the luciferase expression 
levels, since hcf-RNAi causes a reduction in luciferase activity of about 30%, irrespective of the 
presence of ectopic Myc. Under physiological conditions HCF seems to be limiting in S2 cells, 
because ectopic HCF expression leads to a four-fold increase of luciferase expression, whereas 
overexpression of Myc only leads to a doubling of expression levels (Figure 10). Therefore, ectopic 
HCF could strongly enhance reporter expression in the presence of excess Myc. However, the strong 
effects seen upon myc-RNAi on the reporter expression, argues against the presence of excess Myc 
protein levels. As an alternative explanation for the strong boost of luciferase expression by HCF-
overexpression, HCF could be more potent than other hypothetical coactivators for Myc and efficiently 
compete with these cofactors for Myc binding. Interestingly, co-overexpression of Myc and HCF did 
not result in a further enhancement of reporter expression but to a decrease from 400 to 250% activity 
(as compared to HCF overexpression alone), which might be due to a drop in HCF protein abundance 
in cells that co-overexpress Myc compared to HCF overexpression alone (data not shown). Therefore, 
the maximal HCF-independent activity of Myc and only basal HCF-dependent activity would be 
observed in this case. Up to now it is not clear whether this reduction of HCF protein levels is caused 
by a repression through Myc or simply is an experimental artefact, even though it was seen 
repeatedly.  
A reduction of HCF levels by RNAi not only has an influence on the expression of a Myc-dependent 
reporter gene but also on endogenous RNA polymerase II-transcribed Myc targets (nnp-1, CG5033, 
CG12295, and fibrillarin) (Figure 16). hcf-RNAi leads to reduced mRNA abundance of established Myc 
targets by about 30%, a decrease that is comparable to the effect seen on the artificial Myc-reporter. 
In contrast, the levels of the RNA polymerase III-transcribed targets 5sRNA, snoRNA U3, and 
tRNA(Leu) are not reduced upon hcf-RNAi, but are slightly elevated (Figure 16). This increase in Pol 
III target levels might be due to background experimental variability and may not have any biological 
significance. Potentially, HCF could play a role in recruiting Myc to RNAP II target genes, rather than 
vice versa. Under such circumstances loss of HCF might be expected to increase the pool of Myc that 
is available for the activation of RNAP III targets. Therefor, an activation of RNAP III-transcribed Myc 
targets would be observed. To investigate the influence of Myc on HCF levels or vice versa, we 
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performed qRTPCR and Western blot experiments. Endogenous hcf RNA levels were reduced by 20% 
in response to myc-RNAi as seemed to be the abundance of ectopic HCF, although the latter changes 
were not rigorously quantitated (Figures 16 & data not shown). This slight repressive effect of RNAi 
against myc on hcf levels stands in contrast to the observation that co-overexpression of Myc and 
HCF results in markedly lower HCF levels. This repressive effect of ectopic Myc on the abundance of 
ectopically expressed HCF – but not on endogenous HCF - is unlikely to stem from the saturation of 
the overexpression system. Myc expression is driven by tubulin-GAL4, while ectopic HCF is under the 
control of an actin promoter. On the other hand modulation of HCF titres caused fluctuations in myc 
mRNA levels (to 69% and 130% of control, respectively, for individual experiments). However, Myc 
target genes did not show such a variable response to hcf-RNAi; instead, hcf-RNAi decreases the 
expression of Myc targets in a sample where myc levels are elevated (Figure 16). Myc protein levels 
appear to be constant in response to HCF depletion (Figure 17). This finding could imply that 
fluctuations of myc RNA levels are evened out by some sort of auto-regulation of Myc, or that small 
changes in protein content (of +/- 30%) are not detected with conventional Western blots. 
 
2.2.2. HCF and Myc interact physically 
Coimmunoprecipitations revealed a physical interaction of HCF and Myc in an overexpression system 
(Figure 12). We could confirm that the association is indeed physiological, since the endogenous 
proteins were found to be interacting as well (Figure 18). The use of Myc protein mutants (variants 
with individual deletions of the Myc Boxes 1-3, or of the whole C-terminal bHLHzip domain) showed 
that the stable interaction between HCF and Myc does not require the characterised conserved motifs 
within the Myc protein. Furthermore, a truncated Myc protein lacking the entire N-terminus still 
interacted with HCF. In order to identify putative HCF-interaction domains within the Myc protein 
sequence, additional Myc truncations were tested for their ability to retain HCF in 
coimmunoprecipitations. Myc truncations containing the protein stretch between amino acids (aa) 179 
and 403 conferred the strongest binding to HCF. However, N-terminal deletion variants that include 
the region between aa 523 and 626 also interact weakly with HCF (Figure 20b). Therefore we predict 
two HCF-binding sites within the Myc protein; a strong one in the central portion of the protein between 
aa 179 and 403 and a weaker one in the C-terminus between aa 523 and 626. 
Interestingly, the Drosophila Myc protein was found to contain a conserved four amino acid sequence 
DHSY that conforms to the so-called “HCF-binding motif” (HBM) consensus sequence D/EHxY. The 
HBM was identified in VP16 and the cellular transcription factor LZIP (Freiman and Herr, 1997), and 
was also show to be of importance in the E2F-family of transcription factors for binding to HCF (Tyagi 
et al., 2007). The HBM is contained within the protein stretch interacting most strongly with HCF 
(amino acids 387-390). However, mutating the HBM did not affect Myc’s ability to interact with HCF. 
This suggests that additional sequences are sufficient for stable binding of Myc to HCF. In order to 
characterise the Myc:HCF interaction in more detail, we performed pull-downs of in vitro translated 
HCF with GST-Myc fusion protein variants. First, we could show that the interaction between Myc and 
HCF is direct and not bridged by other proteins, since a GST-fusion of a large fragment of Myc 
strongly retains HCF (Figure 19). Second, we could broadly confirm the findings from the 
coimmunoprecipitations in S2 cells concerning the HCF-interaction domains (Figure 20a): The central 
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Myc region between aa 295 and 523 interacts most strongly with HCF; additionally, two weaker 
binding regions between aa 176 and 295, and aa 523 and 626, respectively, were identified with both 
assays. Therefore, all the interaction sites between Myc and HCF identified in tissue culture cells 
directly confer association. In vitro translation experiments identified one additional HCF-interaction 
region within Myc. In contrast to the coimmunoprecipitations in S2 cells the very N-terminus is able to 
bind HCF with intermediate affinity. There are several possible explanations for this discrepancy. The 
presence of the C-terminal subunit of HCF (HCF-C) in S2 cell lysates might interfere with the physical 
association with Myc’s N-terminus. Furthermore the in vivo conditions might not be suitable for HCF 
binding to the N-terminus - e.g. because of additional proteins competing with HCF for binding to Myc, 
or because of conditions that do not allow interaction (e.g. by differing buffer composition, ionic 
strength, pH, etc.). Alternatively, an interaction of HCF with the N-terminus of Myc might be artificial 
and only be seen at very high protein concentrations, that are never reached in the cell. Moreover, 
posttranslational modifications of Myc that are absent from the IVT experiments might prevent the 
binding to HCF. 
 
2.2.3. HCF is required in vivo during proliferation and differentiation 
To assess the physiological importance of the Myc:HCF interaction in vivo, we characterised HCF’s 
influence on wing and eye development as well as the impact on cellular growth during 
endoreplication and wing disc development. All data obtained from the in vivo studies are consistent 
with the notion that HCF is an important positive cofactor for Myc function. 
Induction of hcf-RNAi in differentiating tissues with physiological Myc levels has relatively mild 
consequences. Ommatidial size is barely affected by hcf depletion, either induced by using the 
eyeless-flp system or driven by a GMR-Gal4 line. Rather mild effects are seen in the wing, as all the 
individual hcf-RNAi lines used cause only a slight but distinct aberration of the wing morphology (for a 
detailed description see Balbi (2007). With high penetrance the longitudinal veins L1 and L2 are 
merged and additional vein-like structures are present (Figure 13). Also, larval tissues are at most 
slightly affected by a reduction of HCF levels. RNAi induced depletion of HCF in imaginal wing disc 
clones did not consistently reduce clonal size in a Myc wild type background. Moreover, no significant 
size reduction of endoreplicating salivary gland nuclei could be observed in response to hcf-RNAi. 
These mild consequences of hcf-RNAi for the development of various tissues suggest only slightly 
decreased transcriptional activity in the presence of endogenous Myc levels. 
HCF depletion in eyes with physiological Myc levels has no significant effect on ommatidia size (see 
above). However, it leads to a slight but significant size reduction of 10% in a background with 
reduced myc levels; as seen in the hypomorphic background of ey>dmP0 (Balbi, 2007). This reduction 
upon hcf depletion is comparable to the effect of myc-RNAi in an ey>dmP0 background. Moreover, 
reduction of hcf and myc levels causes a disruption of the regular ommatidial array. Presumably, a 
reduction of HCF levels further impinges on Myc activity, which – in a hypomorphic myc background, 
but not at physiological myc titre – is potent enough to cause further reduction of ommatidia size and 
increased roughness of the eyes.  
Analyses of flies that ectopically express Myc have shown that HCF is needed by Myc for its full 
functionality. Induction of hcf-RNAi in the presence of ectopically expressed Myc significantly 
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decreases the Myc-induced overgrowth of the ommatidia by 35% and rescues the rough-eye 
phenotype (Figure 14). HCF depletion also suppresses Myc overexpression phenotypes in the wing 
(Figure 13). Typically, strong overexpression of Myc under the control of apterous-GAL4 leads to 
severe wing defects. These defects are due to the imbalanced growth of wing compartments, 
increased apoptosis, and potentially disruption of cell-cell adhesion, which results in dissociation of the 
two wing blade epithelia. Fluid-filled bubbles are formed between the two wing compartments and very 
often large parts of the wing become necrotic. While hcf-RNAi on its own has only mild effects on wing 
morphology (Figure 13), it can almost completely suppress the phenotypes caused by ectopically 
expressed Myc. Another piece of evidence that hcf-RNAi restricts Myc’s activation potential stems 
from measurements of nuclear sizes in endoreplicating tissue. Myc was shown to play a crucial role 
during endoreplication (Pierce et al., 2004) and ectopic expression of Myc vastly increases the size of 
endoreplicating nuclei – including salivary gland nuclei. We showed that hcf-RNAi significantly 
decreases the size of nuclei in Myc overexpressing cells, indicating that HCF is also needed for full 
Myc activity during endoreplication. This suggests that Myc retains some activity in the absence of 
HCF – probably through HCF-independent mechanisms. However, in order to reach its full 
transcriptional activity Myc needs HCF in differentiating as well as in endoreplicating tissue. 
Co-overexpression experiments of both Myc and HCF by GMR-GAL4 indicate a synergism between 
the two proteins. While overexpression of HCF alone does not change ommatidial size, ectopic Myc 
expression (using one UAS-Myc transgene) leads to an increase in ommatidia size by about 30%. The 
concomitant overexpression of HCF and Myc in wing disc clones supports this hypothesis. Analogous 
to the situation in the eye, ectopically expressed HCF alone does not influence clone size, however it 
leads to a marked size increase together with elevated Myc levels as compared to Myc-
overexpression alone. In contrast, the co-overexpression effects seen in the wing cannot be 
interpreted as clearly, since individual overexpression of Myc and HCF already cause strong wing 
defects. However, in this situation ectopic coexpression of Myc and HCF affects wings more severely 
than expression of either protein alone. 
Taken together the data obtained from the in vivo experiments indicate that HCF is an important 
cofactor of Myc. Myc partly functions independently of HCF but depends on HCF presence for full 
activity, since even excessive levels of Myc cannot bypass the requirement for HCF.  
 
2.2.4. HCF-associated proteins 
In order to modulate transcription, Myc and HCF have to recruit additional co-activators, since neither 
of them possesses intrinsic enzymatic activities. Several chromatin-modifying complexes have been 
reported to interact with HCF in vertebrates and/or in Drosophila. These are the most likely candidates 
to lend transcription modulating potential to Myc:HCF complexes. 
Coimmunoprecipitations confirmed HCF to be a stable subunit of the ATAC-histone-acteyltransferase 
complex in Drosophila (Guelman et al., 2006). However, we have not been able to show a physical 
interaction between ATAC-components and Myc, which is probably due to technichal problems and 
does not rule out an association between Myc and ATAC. Induction of RNAi against the ATAC 
components Ada2A, Atac1 and Gcn5 had no influence on the Myc activity reporter in S2 cells, while 
dada3-RNAi slightly increased luciferase levels. We have shown that RNAi against Ada2A and Atac1 
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causes a potent reduction of the corresponding protein levels. Therefore, the lack of effect on the Myc 
activity reporter upon depletion of ATAC components is not due to the inefficiency of RNAi. On the 
other hand, RNAi against ATAC components in the dorsal compartment of the wing led to a wide 
variety of phenotypes. While atac1-RNAi lines were not available, dada2-RNAi caused pupal lethality, 
irrespective of Myc-expression levels. Expression of two RNAi-hairpin transgenes against Gcn5 gave 
conflicting results, since one RNAi insertion (Gcn5-T1-IR) resulted in severe wing defects and the 
second insertion of the same RNAi-hairpin construct did not affect wing development (Gcn5-T2-IR). 
Strikingly, expression of Gcn5-T2-IR, and not Gcn5-T1-IR, by apterous-GAL4 led to a strong reversion 
of the Myc overexpression phenotypes in the wing, as it had already been observed for HCF. The fact 
that depletion of Gcn5 strongly suppresses Myc overexpression phenotypes, suggests that Gcn5 
indeed can specifically influence Myc activity in vivo. However, for the lack of data about other 
complex components, we cannot draw any conclusions whether the ATAC complex could play a role 
in Myc-dependent transcription regulation. It is possible that downregulation of ATAC components 
does not affect Myc-dependent readouts for reasons of redundancy. Recently, a second histone-
acetyltransferase subunit of the ATAC complex, termed Atac2/KAT14, has been identified by mass 
spectrometry (Suganuma et al., 2008). Therefore, even knockdown of the catalytic subunit Gcn5 might 
leave the ATAC complex function partially intact. 
As another possibility Gcn5 may influence Myc function independently of the ATAC complex, since it is 
associated with a number of multisubunit HAT complexes. One of these complexes, the SAGA HAT 
complex, has been shown to interact with c-Myc via its subunit TRRAP (McMahon et al., 2000). At 
least part of the transcriptional activation exerted by Myc is dependent on the recruitment of Gcn5 
(McMahon et al., 2000; Liu et al., 2003). Therefore, it is well possible that the suppression of Myc 
overexpression phenotypes by RNAi-mediated depletion of Gcn5 is due to the disruption of SAGA-, 
and not ATAC-function. Still, depletion of another SAGA subunit (Spt3) neither affected luciferase 
expression nor the Myc overexpression phenotype in wings.  
A second complex found to be associated with HCF in vertebrates and Drosophila, is the Sin3A-
associated histone-deacetylase complex HDAC1. In both the in vivo assays and luciferase reporter 
assays in S2 cells Sin3A functions as an antagonist of Myc function, and RNAi against Sin3A leads to 
strong increase in reporter gene expression, as well as to an overgrowth of the dorsal wing 
compartment when expressed by apterous-GAL4 or the ommatidial cells when driven by GMR-GAL4. 
However, Sin3A is a negative regulator of the Myc-dependent reporter system, and therefore an 
HCF:Sin3A complex is not likely to be the link to the growth promoting properties of HCF and Myc. 
The most obvious explanation for the increase in growth and luciferase expression is the loss of Mnt-
dependent target gene repression that is mediated by Sin3A, since Sin3A-associated histone-
deacetylases were shown to interact with the Myc antagonist Mnt (Loo et al., 2005). A second 
explanation for the growth promoting effect of sin3a-depletion comes from the observation that HCF is 
tethered to both the Sin3 HDAC complex and to the Set1/Ash2 HMT complex in a context-dependent 
manner (Wysocka et al., 2003). While it was shown that HCF-1 can simultaneously bind to the Sin3 
HDAC and Set1 H3K4 HMT transcription regulatory complexes and form a “supercomplex”, it is known 
that the transcriptional activator VP16 preferentially interacts with HMT- but not HDAC-interacting 
HCF-1 (Wysocka et al., 2003). Also, data from Tyagi et al. demonstrate that HCF-1-E2F1 and HCF-1-
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H2F4 complexes display selective association with HMT and HDAC activities. Whereas activator 
E2F1-bound HCF-1 associates with Set1 H3K4 HMT complexes, repressor E2F4-associated HCF-1 
recruits HDAC complexes (Tyagi et al., 2007). Thus, a decrease in Sin3A levels could shift the 
equilibrium to facilitate the formation of activating HCF:HMT complexes and activation of growth. In a 
more speculative scenario Sin3A would act as an activator in the context of Myc:HCF:Sin3A 
complexes and thereby antagonize the known Mnt:Sin3A complex. There is evidence that Sin3-
associated HDAC complexes can also lead to gene activation (reviewed in Rottmann and Luscher, 
2006). In such a situation, RNAi against Sin3A would have different consequences from RNAi against 
HCF, since both the activating Myc:HCF:Sin3A and repressive Mnt:Sin3A functions would be lost upon 
depletion of Sin3A. The resulting activation would be due to the repressive function in a Mnt:Sin3A 
complex being more prominent. An experiment to test this hypothesis would be to first eliminate the 
repressive Mnt:Sin3 complex by mnt-RNAi and assay the effects on the Myc activity reporter, and then 
additionally deplete Sin3 (by RNAi). We would expect to see a hyperactivation of the reporter system 
by the depletion of Mnt, since only repression by Sin3 was lost. According to the hypothesis mnt-RNAi 
together with sin3-RNAi would result in lower reporter activity than mnt-RNAi alone. RNAi-mediated 
depletion of mnt, leads to an activation of the nnp-1 Myc activity reporter 48 hours after dsRNA 
addition (Hulf et al., 2005). Therefore, Mnt indeed seems to antagonise Myc function in S2 cells.  
As mentioned above HCF is also found in association with Ash2/Set1-histone methyltransferase 
complexes, which are involved in methylation of histone H3K4 residues – a modification that is 
correlated with actively transcribed regions. While ash2-RNAi only causes a slight reduction of Myc-
acitvity reporter expression, it potently suppresses the Myc overexpression phenotype in the wing. 
Conversely, co-overexpressed Ash2 and Myc synergise, causing most strongly defective wings. ash2-
RNAi on its own has no consequences for wing or eye development, nor can it suppress the 
overgrowth of ommatidia containing high Myc levels. There are reports providing a link between Ash2-
containing H3K4 methyltransferase complexes and HCF in Drosophila (Beltran et al., 2007). 
Therefore, it is possible that the growth promoting effects of HCF could be the consequence of its 
recruiting of an Ash2-containing HMT complex to Myc. A recent report indeed has also demonstrated 
a physical genetic interaction between Myc and Ash2 in Drosophila (Secombe et al., 2007). Myc was 
found to interact with Ash2 in a complex with the trimethyl histone H3K4 demethylase Little imaginal 
discs (Lid). However, based on comparisons to biochemical purification experiments in 
Schizosaccharomyces pombe, the authors claim that Ash2:Lid complexes are distinct from Ash2:Set1 
HMT complexes. It is not clear yet, whether the genetic interaction between Ash2 and Myc is caused 
by an Ash:Lid complex. The observation that Ash2 is found both in H3K4 methylating (Set1 in yeast; 
TAC1 in Drosophila) and demethylating complexes suggests that it may be crucial modulator of H3K4 
methylation status. It is tempting to speculate that Ash2 also might interact with Myc in a HMT 
complex.  
Taken together, all the three putative chromatin-modifying complexes tested for their genetic 
interaction with Myc have an influence on certain Myc-dependent processes, and we cannot rule out 
an involvement of any in linking HCF to Myc-dependent transcriptional regulation. Both HCF and Myc 
were found in association with Ash2 (Beltran et al., 2007; Secombe et al., 2007), an interaction that is 
also conserved in mammals (Wysocka et al., 2003); the same holds true for the interaction between 
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the Sin3A HDAC complex with the Myc antagonist Mnt. A third common interactor between HCF and 
Myc is the BTB-POZ domain protein Miz-1 (Piluso et al., 2002). Given the diversity of transcriptional 
targets of Myc it is intriguing to speculate that HCF might link several multisubunit chromatin modifiers 
to Myc in order to control the expression of target genes. Moreover, Myc has long been shown to 
apply several distinct modes of interaction with chromatin and with the transcriptional apparatus. 
However, it is possible that some of the detected interactions do not reflect a physiological 
requirement. Depending on the biological context (e.g. in different cell types or in different phases of 
the cell cycle) Myc might recruit different types of cofactors to its target genes. Alternatively, the 
various complexes might act redundantly at the same target. Our results with HCF have not identified 
a differential requirement for individual cofactors (at least for the different targets we have looked at). 
Moreover, the rather mild phenotype of hcf-RNAi in vivo and the limited effect of hcf knockdown on 
overexpressed Myc in S2 cells could be explained by the redundant action of several coactivator 
complexes at the same target.  
 
2.2.5. Possible mechanisms of an HCF:Myc interaction 
We have identified a novel role for HCF as a positive cofactor of Myc-dependent transcription control. 
This involvement is compatible with previous observations that HCF-1 plays a critical role both in cell 
growth and division (Julien and Herr, 2003). The growth regulating role of HCF appears largely to be 
mediated by its chromatin-modifying activities. Thus, HCF influences cell proliferation and growth by 
regulating chromatin structure. HCF was shown to associate with both HDAC and H3K4 HMT 
transcription regulatory complexes in a context-dependent manner (Wysocka et al., 2003; Tyagi et al., 
2007). Moreover, these interactions are conserved between human HCF-1 and Drosophila HCF 
(Beltran et al., 2007). Intriguingly, some of the components of the chromatin modifying complexes that 
associate with HCF also interact with the Max network (see Discussion section 2.2.4.). 
In addition to the interactions with the chromatin modifiying machinery, HCF was also reported to play 
a direct role in transcription regulatory complexes formed around several sequence-specific 
transcription factors, such as Sp1 (Gunther et al., 2000), GABP (Vogel and Kristie, 2000), and E2F 
proteins (Tyagi et al., 2007; Knez et al., 2006). HCF is a key player in cell proliferation by repressing 
and activating the transcription of genes required for cell-cycle progression. While the amino-terminal 
subunit of HCF-1 (HCF-1N) has been shown to promote passage through G1 phase and thus 
promotes cell growth, the carboxy-terminal part (HCF-1C) ensures proper exit from mitosis and faithful 
cell division (Julien and Herr, 2003). The properly timed transition from G1 to S Phase is dependent 
the interaction of HCF with E2F transcription factors, namely on the switch from “repressive” HCF-
E2F4 complexes to “activating” HCF-E2F1 complexes and subsequent recruitment of MLL H3K4 HMT 
complexes (Tyagi et al., 2007). One of the characteristics of Myc is to drive the transition from G1 to S 
phase by promoting growth (Johnston et al., 1999). However, Myc’s ability in Drosophila to augment 
cellular growth but not cell-cycle rates differs markedly from the properties of Drosophila E2F, which 
upon overexpression, accelerates the cell cycle but not cellular growth (Neufeld et al., 1998). 
Therefore, it is tempting to speculate that concerted regulation of both Myc and E2F target genes by 
HCF might constitute a means to coordinate proliferation by coupling cell-cycle progression and 
growth. Indeed, there is evidence that E2F and Myc proteins collaborate in the control of proliferation. 
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Ectopic c-Myc was shown to contribute to S phase entry by activating the expression of E2F genes 
(Leone et al., 1997). In contrast, c-Myc is not able to promote S phase entry in the absence of E2F 
(Leone et al., 2001). Moreover Myc target genes frequently harbour E2F binding sites (Grandori et al., 
2000). However, the CG5033 promoter does not contain a canonical dE2F binding site, and we could 
not detect such a synergy concerning our Myc activity reporter system, since RNAi-mediated depletion 
of E2F led to a slight (1.8 fold) increase in luciferase expression.  
The preceding experiments and discussion points are based on the assumption that HCF is being 
recruited to target promoters by Myc. This is also the prevailing view from several studies with 
sequence-specific transcription factors. In case of the HCF-1:E2F interactions it could be shown that 
hcf-1 depletion does not lower ChIP signals for E2Fs, and that E2F binding to responsive promoters is 
a prerequisite for HCF-1 association (Tyagi et al., 2007). However, it might be possible that the 
recruitment mechanism between HCF and Myc is reversed. In such a concept, Myc would be recruited 
to target sites by other proteins and not merely via DNA sequence recognition. Such a notion complies 
with the results from the study of Guccione et al., in which the authors determined that c-Myc binding 
to target promoters is indeed based on epigenetic features, namely elevated histone H3K4 
methylation, and that E-box recognition is secondary to the recognition of specific chromatin states 
(Guccione et al., 2006). Therefore, Myc cofactor complexes that contain chromatin-binding domains 
would contribute to chromatin recognition and “lead” Myc to its target promoters. Several chromatin 
modifying complexes could be plausible candidates for such a Myc recruitment. Especially H3K4 HMT 
complexes might recruit Myc, since Myc binding sites strongly correlate to chromatin regions with 
elevated H3K4 methylation levels. Moreover a concerted action of HCF and HCF-associated factors 
(e.g. E2F) could contribute to Myc binding. Under these circumstances the major function of HCF 
would be to tether Myc to chromatin and mutations in the catalytic subunits of the HCF-associated 
complexes would not necessarily affect the functionality of HCF with respect to Myc-dependent 
processes. However, given the fact that RNAi-mediated downregulation of HCF causes reduced 
expressions of both the endogenous Myc targets and the artificial luciferase reporter system it is 
probable that HCF not only mediates chromatin-association of Myc. In order to investigate the 
mechanism by which Myc and HCF act at target gene promoters, chromatin immunoprecipitation 
experiments will be performed. Depletion of either Myc or HCF would address the question whether 
the recruitment of Myc to its target promoters is dependent on HCF or vice versa.  
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2.3. RNA Polymerase II-associated factor complex (PAF complex) 
The PAF complex was identified as a negative modulator of the Myc activity reporter in the initial RNAi 
screen. In this work we present evidence that the PAF complex physically interacts with Myc by 
directly binding it via its Atu subunit. Moreover, it is required for the proper activation of endogenous 
RNA polymerase II-transcribed Myc target genes. The PAF complex seems to play a dual role in the 
regulation of a number of in vivo processes. While the three subunits Atms, Atu and Rtf1 act as 
coactivators of Myc, Hyx acts both as an activator and repressor of Myc function depending on the 
context.   
 
2.3.1. Depletion of PAF complex components activates the Myc activity reporter but 
represses endogenous Myc target genes 
RNAi-mediated depletion of the four PAF complex components Hyrax, Atu, Atms, and Ctr9 leads to an 
activation of the Myc activity reporter in the range of 1.5- to two-fold for Atu, atms, and ctr9, and five-
fold for hyrax knockdown (Figure 21). These observations confirm the initial RNA-interference screen, 
in which we identified Hyrax, Atms, and Ctr9 as specific interactors, and present the PAF complex as a 
negative modulator of Myc-dependent transcription. Nevertheless they were unexpected, since the 
PAF complex had been described in Drosophila as an essential complex that is broadly involved in 
transcription elongation. Depletion of the fifth PAF complex subunit Rtf1 does not influence reporter 
gene activity. In contrast to the situation in yeast, Rtf1 is not an integral component of the PAF 
complex in Drosophila. However, it was found to be PAF complex-associated during transcription 
elongation (Adelman et al., 2006) and to be required in a subset of PAF complex mediated functions 
(e.g. histone modification) (Tenney et al., 2006). In keeping with the activating effect of hyx-RNAi, 
ectopic expression of Hyx represses the Myc activity reporter (Figure 22). This repressive function can 
partly be suppressed by depleting Myc, indicating its dependence on Myc. In contrast, overexpression 
of Atu produces ambiguous results (Figure 22). While it does not alter luciferase ratio in cells with 
endogenous Myc levels, it exerts opposite effects in Myc-depletion and –overexpression situtations; 
being an activator of the reporter in the presence of low Myc levels and a repressor together with 
ectopic Myc. So far it is unknown whether the differences seen in behaviour between ectopically 
expressed Hyx and Atu are due to artificial effects caused by overexpression (e.g. gain-of-function or 
dominant-negative effects), or if they are really reflecting the biological functions of the two proteins. 
The varying effects of ectopic Atu could theoretically be explained by Myc-independent activation of 
the reporter, which is uncovered upon myc-RNAi. This possibility is rather unlikely, because changes 
in the luciferase ratio of the Myc activity reporter are largely caused by influencing the E-Box reporter 
variant. However, the ΔE-Box is not completely inert to increased Atu levels. 
The effect of PAF complex depletion on endogenous Myc targets is opposite to the effect on the 
luciferase reporter system, since depletion of PAF complex components caused a repression of Myc 
target genes to varying extent (Figure 23). While RNAi-mediated knockdown of ctr9 had no impact on 
Myc targets, depletion of Atu, atms, and (most strongly) hyx, leads to reduced expressions of RNA 
polymerase II-transcribed Myc target genes. The strongest effect of Hyx depletion is observed on the 
expression of CG5033 and CG12295, whose expressions in response to reduced hyx levels drop to 
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below 50%. Less affected is CG9630, even though it was identified as a positive target of both Myc 
and Hyx in microarray studies. Depletion of Atu and atms typically leads to a reduction of Myc target 
gene expression by one quarter. Such a limited effect on target gene expression seems to be a 
characteristic of PAF complex RNAi, since Adelman et al. report a maximal reduction of target 
expression to 75% for rtf1 depletion and 50% for atms knockdown (Adelman et al., 2006). Unlike 
RNAP II-transcribed targets, RNA polymerase III-transcribed small RNA genes are not sensitive to 
RNAi against PAF complex components. This suggests an RNAP II specific involvement of the PAF 
complex or a strongly relaxed requirement for PAF complex (and Myc) function for RNAP III-
dependent transcription (Figure 23). An alternative explanation might be that both the PAF complex 
components and the RNAP III targets could be relatively stable. In such a case RNAi against PAF 
complex components would only lead to delayed protein loss and the titre of stable targets would drop 
even later. In addition to characterised Myc target genes, also the mRNA levels of myc itself are 
reduced to 50-75% by PAF complex RNAi. Therefore the slight reduction seen on the targets could be 
indirect. However, there is evidence that there is a role for the PAF complex is not restricted to the 
control of myc abundance, because neither levels of RNAP III-transcribed genes, nor Myc protein 
levels are reduced at all by PAF complex depletion (Figure 24). More importantly, the expression of 
the Myc activity reporter is enhanced upon depletion of PAF complex components. 
Taken together depletion of several PAF complex components results in increased expression of the 
Myc activity reporter. At the same time reduced PAF complex levels have a slight negative effect on 
the expression of endogenous RNAP II-transcribed Myc targets. These apparently contradictory 
results might be reconciled by the influence of the chromatin-environment. The PAF complex is 
essential for processive transcription for the majority of loci embedded in native chromatin. It acts 
during several phases during transcription initiation and elongation by sequenctially recruiting 
chromatin modifying complexes, such as Rad6 H2B ubiquitinases (Wood et al., 2003, 2005), the Set1 
histone H3-K4 HMT (Dover et al., 2002; Krogan et al., 2003b; Ng et al., 2003), and the Dot1 histone 
H3-K79 HMT (Krogan et al., 2003b; Krogan et al., 2003a). Loss of the PAF complex leads to defects in 
transcription elongation that are compatible with the effects we see upon PAF RNAi in vivo. In 
contrast, the Myc activity reporter, which is transiently expressed in S2 cells and not embedded in 
chromatin, is activated in response to PAF complex RNAi. Most likely, Myc does not require PAF 
complex action in order to drive transcription from the artificial reporter. Speculatively, a partial loss of 
PAF complex function could allocate more Myc protein to the Myc activity reporter, while transcription 
from endogenous targets is reduced. Such a scenario would imply that Myc is (at least partially) 
dependent on the PAF complex (or other associated factors) for its recruitment to the target. 
Alternatively, some of the PAF complex functions might be required for the expression of the Myc 
activity reporter. While depletion of individual components would be deleterious for the expression of 
endogenous targets, such a partially defective PAF complex might still be functional in the context of 
the reporter gene. 
 
2.3.2. Atu and Myc are directly interacting 
Myc interacts with the PAF complex by physically binding to the Atu subunit. We detected a strong 
interaction by coimmunoprecipitating ectopically expressed Myc and Atu (Figure 25). Moreover 
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overexpressed Hyx is also found in association with Myc, albeit at lower levels than Atu (Figure f, lane 
3). Since the interaction between Myc and Atu is not abrogated by the presence of ectopically 
expressed Hyx (Figure 26, lane 4), this suggests a model in which both Myc and Hyx are 
independently associated with Atu, without competing with each other. Furthermore, the interaction 
between the PAF complex component Atu and Myc does not rely on the presence of any of the 
characterised conserved motifs in Myc, as individual mutants lacking the Myc-Boxes 1-3 (ΔMB1-3), 
the leucine zipper (ΔZ), or the entire bHLH-zipper (ΔC) still retain the ability to bind to Atu protein. In 
addition, a variant lacking the N-terminus (ΔN) and a Myc protein lacking both the N-terminus and the 
bHLH-zipper (ΔNΔC) are still coimmunoprecipitated with Atu (Figure 29). This finding prompted us to 
construct a larger set of additional deletion mutants of Myc, in order to identify the interaction site(s) 
within the Myc protein. Further immunoprecipitation experiments showed that the central portion of the 
Myc protein, ranging from aa 295 to aa 626, exhibits strong binding to Atu, whereby a stretch between 
aa 295 and 403 seems to confer the strongest affinity (Figure 30). Additionally, we predict a second 
interaction in the N-terminus because a protein truncation containing only the first 179 amino acids of 
Myc is coimmunoprecipitated with Atu. This N-terminal interaction domain is potent enough to sustain 
stable binding to Atu, and a Myc protein deletion lacking the central portion of the protein from aa 295 
to 626, still is strongly retained by Atu (Figure 32). As described in Results (section 5.3.2.), individual 
Myc mutants are not expressed at equal levels which hampers the assessment of the interaction 
strength (e.g the mutant protein ΔN403 only interacts weakly with Atu, even though it contains parts of 
the sequence conferring strong binding). Pulldown of in vitro translated Atu protein with various GST-
Myc fragments revealed the interaction between Myc and Atu to be direct (Figures 33 & 34), and 
furthermore confirmed the interaction sites identified in the coimmunoprecipitations (Figure 34).  
Information gleaned from interaction studies with several proteins (e.g. HCF, Atu, Brf, and Chinmo) 
revealed physical binding with Myc at multiple interaction sites (P. Gallant & D. Schwinkendorf, 
personal communication). Even though there are proteins known to interact with several sites within 
Myc (e.g. Skp2) (Vervoorts et al., 2006), non-specific binding cannot be ruled out for some of the Myc 
truncations. Especially in the in vitro experiments the N-terminal Myc fragments retained the 35S-
labelled IVT-proteins, which could suggest non-specific “stickiness” of this domain. Moreover, we have 
not identified small mutations in Myc that would abrogate interactions with other proteins tested. 
However varying relative binding intensities for different interactors, indicate that the binding is indeed 
specific and physiological (compare Figures 20a (HCF) and 34 (Atu)). In addition, more stringent 
conditions with increased salt concentrations did not abrogate any of the interactions between Atu and 
internal Myc truncations. However, some interactions are weakened by increased stringency. Still, the 
fact that binding is retained under stringent conditions implies that the interactions (also with the N-
terminal portion of Myc) are specific and not due to general stickiness. We furthermore see a broad 
correlation between the interaction data obtained from ectopically expressed Myc in S2 cells and from 
GST-pulldowns; two systems in which buffer conditions and protein concentrations are different, which 
further suggests that the observed interactions are specific. This especially holds true for endogenous 
HCF and Myc, for which we have shown an interaction (Figure 18). Taken together, the interaction 
studies suggest that Atu directly interacts with Myc at (at least) two sites. These include the N-
terminus and the central part of the protein in the vicinity of Myc Box 3. To definitely rule out putative 
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unspecific interactions with Myc further tests using additional negative controls would be needed. For 
example AU1- or GST-tagged GFP could be used in coimmunoprecipitations or IVTs. 
 
2.3.3. Reduction of Atu, Atms, and Rtf1 levels affects Myc-dependent growth promotion   
To characterise the importance of the interaction between Myc and the PAF complex in vivo, we 
downregulated individual components by RNAi and assessed the influence on the development of 
several organs such as macrochaetae, wings and eyes. Moreover, we measured the impact on clonal 
growth in imaginal wing discs and endoreplication in fat body cells.  
When expressing hairpin-RNAi constructs by scabrous-GAL4 to target Atu, atms or rtf1 in bristle 
precursor cells, growth of bristles is significantly impaired. Scutellar macrochaete size is largely 
reduced, with atms-RNAi showing the strongest effect (Figure 35). Since bristle growth is heavily 
dependent on Myc - small, slender bristles are one of the characteristcs of hypomorphic myc mutants; 
(Johnston et al., 1999) we speculated that the PAF complex cooperates with Myc to promote growth. 
To address this question, the same hairpin constructs were expressed in the ey>dmP0 strain (Results, 
section 5.4.5.). While depletion of Atu did not affect eye development, reduction of atms and rtf1 levels 
caused eye defects of a broad variety, ranging from increased roughness to the loss of a large number 
of ommatidia, particularly in the arterior half of the eyes. Therefore, depletion of both myc and atms or 
rtf1 leads to disruption of the regular eye pattern due to a reduction of ommatidial number, while in the 
case of the PAF complex the size of individual ommatidia is not affected. This is an indication that pre-
ommatidial proliferation – a process which is known to rely on Myc function - is disturbed. Eye defects 
upon PAF complex RNAi in control flies with endogenous myc levels are far less pronounced than in 
the ey>dmP0 background. Therefore, we concluded that ommatidial proliferation is synergistically 
affected by Myc and PAF complex components. In addition to RNAi-mediated depletion of PAF 
complex components, heterozygosity for Atu, but not atms, also leads to severe eye defects. This is 
surprising because loss of yLeo1, the yeast homologue of Atu does not affect PAF complex integrity, 
whereas mutations in yPaf1, the Atms homologue, cause disruption of the complex. If we assume the 
same to be true in Drosophila, the defects seen upon Atu depletion do not reflect a general loss of 
PAF complex function. Instead, they might by caused by the reduced recruitment of PAF (and possibly 
other associated factors not present in yeast) to Myc, since Atu constitutes the physical link between 
Myc and the PAF complex, as inferred from the interaction studies. However the experiment was 
based on one mutation in the atms locus and heterozygosity for atmsrK509 might not result in a 
sufficient reduction of protein levels to produce a phenotype. When compared to the RNAi-hairpin 
transgenes, the classical mutations only produced an effect in a strongly sensitised background 
(ey>dmP0 ;pont+/-). This lack of an observed dominant interaction in case of the classic Atu mutation in 
the ey>dmP0 background does not rule out a functional relationship, but might indicate that the protein 
level has not sufficiently been lowered. Therefore, it is likely that RNAi leads to a stronger 
downregulation of Atu levels than the loss of one gene copy. 
Another process that is affected by PAF complex downregulation is the formation of wings. 
Knockdown of either rtf1 or Atu severely impairs development of wings, whereas atms-RNAi has no 
phenotypic consequences. Expression of Atu-RNAi in the dorsal wing compartment results in strongly 
bent-up wings, presumably because of reduced tissue size in comparison to the ventral compartment. 
 115
rtf1-RNAi seems to affect wing development more severely, since adult wing structures are completely 
missing. This reduction of growth in the wing still might be independent of Myc action. However, RNAi 
against Atu or rtf1 also suppresses the effects caused by Myc overexpression, indicating a strong 
positive genetic interaction with Myc. 
Not only adult organs are affected by the downregulation of Atu, atms, and rtf1. The size of 48 hour-
old Myc overexpressing imaginal wing discs clones is also significantly reduced (Figure 40). In 
contrast, the effect on clones of the same age containing endogenous myc levels is marginal. These 
data suggest a limiting role for the PAF complex in cells with high myc titres and a concomitant 
reduction of growth upon PAF complex depletion. Interestingly, the size of endoreplicating fat body 
nuclei is not affected by reduced PAF complex levels. This might be due to elevated PAF complex 
levels in this polyploid tissue as compared to diploid imaginal disc cells. As a consequence RNAi 
would not reduce PAF complex levels sufficiently to impart a phenotype. However, it is tempting to 
speculate that Myc controls different target genes in endoreplicating cells. In keeping with such an 
assumption that proliferating tissue is more sensitive to PAF reduction is the fact that RNAi-mediated 
depletion of PAF complex components in dmP0 eyes showed a proliferation defect, whereas growth of 
the ommatidia was not affected.  
Taken together, the three PAF complex components Atu, Atms, and Rtf1 show a positive genetic 
interaction with Myc in several in vivo assays. In addition they also play a role in the correct expression 
of endogenous Myc target genes. These findings therefore point to a role for these subunits as 
coactivators in Myc dependent processes. Reduction of individual components leads to a broad variety 
of phenotypes. This is presumably due to differences in RNAi efficiency and varied sensitivity of the 
single assays to the downregulation of individual components. Additionally, the abundance of PAF 
complex components might vary in different tissues, which would further increase the variation of 
RNAi. However, the broad variation could also reflect the differential requirement for individual PAF 
complex components for different processes. While the depletion of rtf1 consistently yields strong 
effects in all assays tested, the downregulation of atms leads to severe effects in most assays - with 
exception of the downregulation in the dorsal compartment of the wing, and the lack of phenotype for 
atmsrK509. In contrast, the phenotypes resulting from Atu depletion show the broadest variation. While it 
causes strong effects in both adult wings and larval wing imaginal discs, eye structure is not affected 
by reduction of Atu levels.  
As mentioned above, characterisation of individual mutations of all PAF complex components in yeast 
revealed large differences in phenotypic strength. While deficiency for yPaf and yCtr9 causes the 
strongest phenotypes and affects various cellular processes, loss of yRtf1, yLeo1 and Cdc73 has 
milder consequences (Betz et al., 2002). This is presumably due to the fact that loss of yPaf and yCtr9 
causes disruption of the whole PAF complex, whereas mutations in the three other components do not 
affect PAF complex integrity. 
 
2.3.4. Hyx acts as a negative cofactor of Myc (in a subset of processes) in vivo 
While the three PAF complex subunits Atu, Atms and Rtf1 presented themselves as coactivators of 
Myc, there is evidence that the fourth subunit Hyrax has opposite effects. In contrast to the other PAF 
complex components, expression of hyx-hairpin RNA neither caused growth defects in bristles nor did 
 116
it interfere with the the development of ommatidia or adult wing structures. This absence of effect 
might be due to insufficient downregulation of hyx levels. However, it could reflect Hyx’s biological 
properties. By comparing the size of ommatidia in both ey>dmP0 and ey>dmP0 ;pont+/- backgrounds, we 
observed that depletion of hyx leads to an alleviation for the need of Myc, indicating a negative genetic 
interaction between myc and hyx (Figure 39). Another piece of evidence for such a negative 
interaction stems from the observation that ectopic expression of Hyx in the eye slightly suppresses 
the rough-eye phenotype caused by Myc overexpression. There are several reports from the literature 
that Hyx homologues from yeast and humans have growth inhibiting effects. Both Cdc73 and 
Parafibromin are known to induce cell cycle arrest in the G1 phase by blocking the expression of cyclin 
D1 (Zhang et al., 2006; Woodard et al., 2005; Yart et al., 2005). 
There is also data that Hyx works as a coactivator of Myc like the other PAF complex components. In 
imaginal wing disc clones hyx depletion reduces growth, albeit to a lesser extent than depletion of the 
other PAF complex subunits. This is consistent with the results from Mosimann and colleagues who 
report a clear positive role for Hyx in clonal growth (homozygous mutant hyxEY6898 clones grow at 
slower rates than their wild type twinsposts) (Mosimann et al., 2006). Furthermore qRTPCR 
experiments revealed that RNA polymerase II-transcribed targets of Myc are slightly downregulated in 
response to hyx depletion in S2 cells. 
 
2.3.5. The PAF complex exerts both growth-promoting and –repressing functions 
The analysis of the genetic interaction between Myc and the PAF complex produced apparently 
ambiguous data. Not only did the depletions of individual components vary in their phenotypic 
strength, they also resulted in converse effects. While the subunits Atu, Atms and Rtf1 generally acted 
as coactivators of Myc, Hyx behaved contrarily. How can these findings be reconciled?  
It is known from studies in yeast with the yPAF complex that deletion mutants of the individual 
components cause distinct phenotypes (Betz et al., 2002). Even though different organisms are 
concerned, there is evidence that processes are conversely regulated by individual PAF complex 
components. The yCtr9 and yPaf1 were shown to be involved in transcriptional activation of G1 phase 
cyclins (Koch et al., 1999), whereas Cdc73 has the potential to block cell-cyle progression by 
repressing the expression of cyclin D1 (Zhang et al., 2006). This situation is even more pronounced in 
metazoan species. It is likely that individual components of the PAF complex have adopted additional 
functions on top of the general control in transcription elongation. Therefore, the PAF complex could 
have evolved novel metazoan-specific functions that go beyond the general transcription elongation. 
This is illustrated by sequence comparisons between the yeast protein Cdc73 and its fly and human 
homologues Hyx and Parafibromin. While the C-terminus is conserved between all the three species, 
novel N-terminal sequences were “acquired” in Drosophila and humans. It was shown that a confined 
domain within the N-terminus of both Parafibromin and Hyx interacts with β-catenin/Armadillo and 
exerts an essential function in Wg/Wnt-signal transduction (Mosimann et al., 2006). Likewise, 
recruitment to specific targets by Myc might constitute a so far uncharacterised function of the PAF 
complex.  
Strikingly, individual PAF complex subunits are involved in the formation of cancers with opposite 
roles, since some were characterised as proto-oncogenes, while others seem to work as tumour 
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suppressors. For instance, the human homologue of Atms, termed hPAF1, was shown to be amplified 
in pancreatic adenocarcinoma cell lines (Chaudhary et al., 2007) and targeted overexpression has the 
potential to induce transformation in NIH3T3 cells (Moniaux et al., 2006). Moreover hLeo1, the human 
homologue of Atu, is involved in the formation of colorectal cancer (Camps et al., 2006), constituting a 
potential link to Wnt-signalling (which fits with the observation that Atu binds β-catenin in Drosophila). 
In contrast Parafibromin has been shown to act as a tumor suppressor. The gene coding for 
Parafibromin, termed HRPT2 for Hyperparathyroidism-Jaw Tumor Syndrome (HTP-JT) tumor 
suppressor gene, is mutated in hereditary and sporadic forms of parathyroid neoplasias (Carpten et 
al., 2002). However, Hyx clearly plays a positive role in Wg/Wnt-signalling (Mosimann et al., 2006). 
These data illustrate that individual PAF complex components can exert independent functions. 
Therefore the opposing roles observed for Atu, atms, and Rtf1 on one hand and Hyx on the other 
hand, could reflect physiological properties of the individual components. Depending on the context 
and the organ that is examined the PAF complex as a whole and its individual subunits may exert 
various functions. While Atu, Atms, and Rtf1 activate growth - whether by metazoan-specific functions 
or by facilitating general transcription elongation needs to be addressed – Hyx also exerts growth 
repressing functions. In order to further elucidate and clarify the role of the PAF complex as a whole, 
and of the individual subunits in particular, further in vivo experiments will be required.  
 
3. Conclusion and Outlook 
In this study, we describe the identification and characterisation of two novel physiological cofactors of 
Myc-dependent transcription control.  
We show that the RNA polymerase II-associated factor 1 (PAF) complex is associated with Myc by 
making direct physical contact with its Atu subunit. Moreover, the PAF complex is required for correct 
expression of direct Myc target genes and depletion of the PAF complex has strong consequences on 
Myc-dependent processes in vivo. Strikingly, the PAF complex seems to play a dual role in the 
regulation of a number of in vivo processes, since the individual subunits exert differential functions. 
While Atms, Atu and Rtf1 act as coactivators of Myc in the assays used, there is evidence that Hyx 
can act both as an activator and repressor of Myc function depending on the context and/or tissue. 
The further elucidation of the interaction between Myc and the PAF complex could be of great 
importance since both Myc and the PAF complex are involved in the formation of a variety of human 
cancers. 
Experiments presented in this study and Mirjam Balbi’s master thesis (Balbi, 2007) clearly identified 
HCF as a positive cofactor of Myc-dependent transcription control. We have shown a direct physical 
interaction between endogenous HCF and Myc proteins and revealed an influence of HCF on 
expression of Myc target genes in S2 cells. In vivo HCF synergises with Myc in the promotion of 
growth in the eye and wing. HCF depletion by RNAi has the potential to revert Myc overexpression 
phenotypes in the wing and, to a lesser extent, also in the eye. These data coherently indicate that 
Myc requires HCF to reach its full transcriptional activity during proliferation and differentiation. In 
order to activate Myc-dependent transcription HCF has to recruit additional complexes with enzymatic 
activity. The molecular nature of such a mechanism needs to be elucidated. 
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Taken together, we present evidence that both the PAF complex and HCF are physiologically 
relevant modulators of Myc-dependent transcription. Further characterisation of the interplay between 
these proteins will be of importance to understanding the biology of Myc. 
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Materials and Methods 
 
1. Cloning 
1.1. Luciferase reporter constructs 
1.1.1. Construction of the CG5033 and CG4364 reporters 
Promoter sequences from -322 to +61 relative to the transcription start site of CG5033 (E-box at +21, 
ATG at +56) and from -561 to +131 relative to the transcription start site of CG4364 (E-box at –421, 
ATG at +133), respectively, were fused to the firefly luciferase ORF. Corresponding promoter 
sequences were PCR amplified with the following primers: 
CG5033-upstream: 5’- GTAGAGATCTGAATTTCGCTGAAAATGGTTCGTTG-3’ (Bgl II site)  
CG5033-downstream: 5’- ATGTTCCATGGGGTCATTTTGAGGTA-3’ (Nco I site)  
CG4364-upstream: 5’-CCCCAGATCTTCAAGAACACGACACAAG-3’ (Bgl II site)  
CG4364-downstream: 5’-CCAACCATGGTGCCGGTTTATGAAAATG-3’ (Nco I site)  
PCR products were subjected to Bgl II and Nco I restrictions and cloned into the firefly ORF containing 
vector pGL3-Basic (Promega). 
 
In the ΔE-Box mutants, the sequence “CACGTG” was replaced by “GAATTC”. The following 
oligonucleotides were used:  
CG5033-ΔE-Box:  
5’-ATCGCTATCGCTGACTGCAAGAATTCCGCCGCGTTAGTTTTGTTTTTACC–3’; 
CG4364-ΔE-Box upstream:  
5’-CAATTTGGAACTGGTCACACTTCCTTTCGAATTCAAACCAACAAC ACAAAAAACGTGTGTTTTG-3’ 
CG4364-ΔE-Box downstream:  
5’-CAAAACACACGTTTTTTGTGTTGTTGGTTTGAATTCGAAAGG AAGTGTGACCAGTTCCAAATTG-3’ 
 
For the mutagenesis of the CG5033 E-Box sequence the GeneEditor in vitro Site-directed 
Mutagenesis System (Promega), for the CG4364 E-Box the QuikChange Site-Directed Mutagenesis 
Kit (Stratagene) was used. 
 
To clone the wild type CG5033 promoter fragment into the Renilla luciferase ORF containing vector 
pRL (Promega), the promoter was reamplified using the upstream primer from above and the 
downstream primer CG5033_NheI: 5’-AGTGGCTAGCATTTTGAGGTAAAAACAAAACTAACGCGG 
CGCAC-3’ (Nhe I site) 
 
The sequences printed in bold indicate the beginnings of the luciferase ORF, the underlined 
sequences the individual restriction sites and the sequences labelled in red mutated E-boxes 
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1.1.2. Construction of the mfas reporter 
The promoter sequence from -859 to +503 relative to the transcription start site of midline fascicline 
(mfas) (ATG at +504) was fused to the firefly luciferase ORF. Sequences were PCR amplified with the 
following primer pair: 
mfas-upstream: 5’-TCAACGCGTCTCGAGCGGATGATTACGAT-3’ (Xho I site) 
mfas-downstream: 5’-GAGTCCATGGAGTTTGGTATCACAAT-3’ (Nco I site) 
The sequences printed in bold indicate the beginning of the luciferase ORF, the underlined sequences 
the individual restriction sites. After amplification the PCR product was restricted with Xho I and Nco I 
and cloned into pGL3-Basic (Promega). 
 
1.2. Overexpression constructs 
1.2.1. AU1-tagged Atu 
For coimmunoprecipitations between overexpressed Atu and HA-tagged dMyc proteins, an AU1-
epitope tag was fused to Atu ORF with the following two-step strategy. The AU1-epitope tag 
containing vector pUAST-AU1 was restricted with Bgl II and a short primer hybrid adapter with Bgl II 
compatible overhangs was inserted to introduce a Nhe I restriction site. These primers were hybridised 
to form the primer adapter (the Nhe I site is depicted by bold letters. The 5’ primer ends were 
phosphorylated to allow ligation into pUAST-AU1). 
BglNhe_f: P5’-GATCTCGCTAGCGT-3’ 
BglNhe_r: P5’-GATCACGCTAGCGA-3’ 
In a second step the complete Atu ORF excised from the UAS-HA-Atu vector and cloned into the new 
UAS-AU1 vector variant, using Nhe I and Xba I restriction enzymes. 
 
1.2.2. HA-tagged Myc deletion mutants 
The cloning strategy for the triple HA-tagged Myc deletion mutants is described in detail in 
(Schwinkendorf, 2008). 
The three internal deletion mutants Δ294C-403, Δ294C-523 and Δ294C-626, which lack the central 
part of the Myc protein, spanning from amino acid 294 to aa 403, 523 and 626 respectively, were 
cloned as follows. The Mlu I site introduced into the C-terminal deletion Δ294C was used to combine 
an N-terminal Xba I – Mlu I dMyc fragment with the N-terminally located Mlu I site of the N-terminal 
deletions ΔN403, ΔN523 and ΔN626. Therefore, an Xba I – Mlu I fragment was introduced into the 
three N-terminal deletion vectors. To restore the open reading frame a primer adapter was inserted. 
Primer sequence of Mlu I fillin: P5’-CGCGAGCCTCGAGGCT-3’ 
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1.2.3. Cloning of pBSK-Atu and pRSet-HCF for in vitro expression 
The entire Atu ORF without the triple HA-tag (3030 bp) was excised from the UAS-HA-Atu vector 
(Städeli, 2006), using Nhe I and Xba I restriction enzymes.Subsequently the fragment was cloned into 
Xba I linearised pBluescript II SK(+).  
 
The HCF-expression plasmid was cloned as follows. The N-terminal part of the hcf ORF, comprising 
the first 1424 base pairs was PCR amplified using the following primers: 
HCF-IVT-Kelch_fwd:  5’-CATCAGATCTACGAAGGCTCAGACTTTGTG-3’ (Bgl II site) 
HCF-IVT-Kelch_rev: 5’-GTAGCCATGGTCATGCTGCAAAAGTGGTCG-3’ (Nco I site) 
 
The PCR product was restricted with Bgl II and Nco I enzymes and cloned Bam HI – Nco I into the 
pRSetC expression vector. 
 
2. Tissue culture and biochemistry 
2.1. Cell culture conditions 
Drosophila S2 cells were cultured in 1x Schneider‘s Drosophila medium (Gibco/BRL), supplemented 
with 10% fetal bovine serum (heat-inactivated), 1% Penicillin/Streptomycin (Invitrogen), at 24°C.  
 
2.2. Synthesis of double stranded RNA 
dsRNA was produced by in vitro transcription of PCR products of approximately 600 bp in length 
amplified from the gene of interest. Target sequences were subjected to BLAST analysis to ensure 
minimal homology with unrelated transcripts. PCR primers each contained a 5’ T7 RNA polymerase 
binding site (TAATACGACTCACTATAGGGAGA) followed by the sequences specific for the targeted 
genes. The primer sequences were as follows: 
 
dsRNA  primer name  primer sequence (5’ → 3’) 
 
myc T7_dmyc_f CCGGCTCTGATAG 
 T7_dmyc_r TGCTCATCATGGA 
gfp T7_gfp_f TGAGCAAGGGCGAGG 
 T7_gfp_r GCGGCGGTCACGAAC 
hcf2 T7_HCF_fwd2 GACAGTGCCTGGAAGT 
 T7_HCF_rev2 TTTTCTGGCACTCAGC 
hcf3 T7_HCF_fwd GAGAGCCCAAAACCTATAG 
 T7_HCF_rev GAAAGATCCTTAAACACACC 
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hcf1 corresponds to the sequence targeted in the screen and the primary gene specific PCR product 
was reamplified using the primers complementary to the Eurogentech tag-sequences. 
 
hcf1 S tail 3 TGAGGTACGCGTGGG 
 R tail TGGCGCCCCTAGATG 
 
For all the other RNAi experiments dsRNA from the original RNAi screen plates was used. 
 
2.3. RNAi-mediated depletion of endogenous mRNA  
Schneider 2 (S2) cells were cultured as described above. RNAi experiments were performed by 
incubation of 5×106 cells in a 3 cm cell-culture dish (6 well plates) with 10µg dsRNA in 1ml serum-free 
medium for 30 minutes. After addition of 2ml complete medium cells were incubated and harvested at 
time points indicated. 
 
2.4. Luciferase reporter assays 
Luciferase reporter assays were carried out as follows. Schneider 2 (S2) cells were plated out in 24 
well culture plates at a density of 2×106 cells/ml in 650µl complete medium. The cationic lipid cellfectin 
(Invitrogen) was used as a transfection reagent at a final concentration of 10µl/ml. Per transfection 
sample 21µl of a 1:5 cellfectin dilution in serum free medium (SFM) was prepared and incubated for 
45 minutes at room temperature. Constant amounts of 1.3µg experimental plasmid DNA were 
prepared in a volume of 21µl SFM and added to the cellfectin in 1:1 mixture of wild type-Renilla 
luciferase and ΔEbox-firefly luciferase reporters (i.e. 0.5µg of each reporter per 106 cells). tubulin-
Renilla luciferase control DNA was used at 0.1 μg/106 cells. In case of overexpression studies, 1.3µg 
of a 1:1 mix tub-GAL4 and UAS-plasmids was added. To ensure equal DNA concentrations between 
individual samples pCaSpeR4 vector was added where needed. RNAi was induced by 40ng of 
dsRNA. The cellfectin-DNA mixture was incubated for 15 minutes at room temperature and made up 
to the final transfection volume of 420µl with SFM. Complete growth medium was aspirated from the 
sample wells and cells were washed once with SFM. After aspirating, the transfection medium was 
added and the cells were incubated for 16 hours at 24°C. Transfection solution was exchanged with 
650µl complete medium and the cells were incubated for the desired time to ensure proper expression 
of the transgenes and/or efficient RNAi. Each experiment was performed in duplicate. To harvest the 
cells, experimental samples were washed in 1x PBS, lysed for 15 minutes in 100µl 1x Passive Lysis 
Buffer (Dual-Luciferase Reporter Assay System, Promega). 10µl lysate was transferred to 
luminometric 96 well plates (Greiner) and relative reporter gene expression was determined on a 
Wallac luminometer. The luminometer protocol was adjusted to disperse 50µl of each luciferase 
substrate per measurement. Average of duplicates was calculated and all values are indicated with 
standard deviations. 
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2.5. RNAi screening process  
In order to carry out an RNA interference based reverse genetic screen, to identify specific cofactors of 
dMyc, a list of putative cofactors was compiled (P. Gallant & K. Basler, personal communication). 
Specific primer pairs for all the 752 selected candidates were ordered from Eurogentech. Primers were 
selected to guarantee very high specificity by exclusion of common sequences between Drosophila 
melanogaster genes within the amplicons. This measure was taken to avoid RNAi off-target effects. 
The average amplicon length was set to 400 base pairs. To allow for reamplification of the primary 
PCR products, universal sequences were added to the primers. All 3’-primers contained the same tag 
sequence, while 5’-primers contained 9 different sequences. Therefore, the whole set of sequence-
specific amplicons could be re-amplified using only 10 primer pairs. The secondary primers used for 
re-amplification also ontained a 5’ 23bp T7 promoter sequence, resulting in PCR products with T7 
promoter sequences added to both ends of the amplicons. The primary PCR was performed on 
genomic Drosophila DNA as template and the resulting amplicons were reamplified and T7 ends were 
introduced. Subsequently, dsRNA was generated. For over 95% of the candidate genes sufficient 
amounts of dsRNA were obtained and analysed on agarose gels (R. Städeli, personal 
communication). Tests revealed that unpurified dsRNA showed the best efficiency in knocking down 
selected luciferase reporter genes (R. Städeli, personal communication). The whole amplification 
procedure and generation of dsRNAs was performed by Peder Zipperlen in the laboratory of Prof. K. 
Basler. The dsRNAs were diluted, and an estimated content of 1µg dsRNA in 10µl nuclease-free water 
was plated out into 96 well plates. The transient transfection protocol described above was adapted as 
follows: 4.5µl Cellfectin-DNA solution was prepared per sample, containing 50ng of each reporter 
plasmid and 0.5µl cellfectin. The mixture was incubated for 45 minutes at room temperature to assure 
association of the plasmid DNA with the cellfectin. The mixture was added to S2 cells in suspension in 
serum-free medium and plated out. Per well 105 cells in a volume of 45.5µl SFM were seeded out and 
incubated for 12 hours. In contrast to the general protocol, the transfection medium was not removed, 
but 50µl of full-medium was added to each well and cells were allowed to proliferate for 48 hours 
before lysis and subsequent luciferase measurements. The screen was performed in duplicate and 
plates with a clear positional bias in expression levels across the plate were subjected to an additional 
third run. 
 
2.6. Transient overexpression of tagged proteins in Schneider 2 cells 
Drosophila S2 cells were seeded at a density of 5×106 cells per well of a 6-well culture plate. 
Subsequently, cells were transfected in 1ml of serum-free medium containing 10µl cellfectin 
(Invitrogen) and a constant total amount of 10µg plasmid DNA made up of 3.3µg tub-GAL4 and 3.3µg 
of each UAS-plasmid (or tub-HA-hyx). In cases of a single overexpressions pCaSpeR4 plasmid DNA 
was used to top the DNA content up to 10µg. As expression varied for the cloned UAS-HA-myc 
deletion mutants, DNA content was changed to reach level expression. 15-16 hours later, 2ml 
complete was added for 48 hours, before cells were either directly processed for SDS-PAGE or 
preceding coimmunoprecipitation.  
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2.7. Western blotting 
Cells were harvested at the indicated time points and washed with 1x PBS, lysed in Laemmli sample 
buffer by boiling for 5 minutes at 95°C and analysed by SDS-PAGE and immunoblotting. Standard 
conditions were: Electrophoretic separation of the lysates on 10% SDS-PAGE gels at 120 V for 2 
hours, followed by transfer onto nitrocellulose membranes with a constant current of 30 V for 2 hours 
at 4°C. Subsequently, membranes were blocked with 1x TBS, containing 5% fat free milk powder. 
Incubation with primary antibodies was performed overnight at 4°C in 1x TBS 5% milk powder. Then 
the membranes were exposed to the secondary antibodies for 1-2 hours at room temperature. 
Washing steps were performed with 1x TTBS (TBS + 0.2% Tween-20). Western blots were then either 
exposed on X-ray films (using multiple exposures for each experiment) or scanned with a CCD 
camera (Fuji LAS-3000). For detection the enhanced chemiluminescence kit (Amersham) was used. 
 
Primary antibodies used for Western blotting were: 
 
Epitope Species Source Dilution 
anti-dMyc hybridoma supernatant mouse A. Orian 1:5 
anti-α-tubulin mouse Sigma 1:25’000 
anti-HCF (C-terminal subunit) rat J. Workman 1:3000 
anti-HA epitope mouse BAbCO 1:1000 
anti-HA epitope rabbit Dunn Labortechnik GmbH 1:10’000 
anti-Atu rabbit New England Peptide LLC 1:1000 
 
The polyclonal rabbit anti-Atu antibody was raised against the epitope RDKVESQVESAPKEC, wich 
corresponds to the amino acids 368 to 381 of the Drosophila Atu sequence. 
 
Secondary antibodies: 
 
Antibody Species Source Dilution 
HRP-coupled anti-mouse goat JacksonImmunoResearch 1:10’000 
HRP-coupled anti-rat goat Amersham 1:3000 
HRP-coupled anti-rabbit donkey Amersham 1:3000 
 
2.8. Coimmunoprecipitations of overexpressed proteins from cell samples 
Transfections were performed as described in (Materials and Methods, sectioin 2.6.) and harvested 
after 48 hours. Pelleted cells were washed once with cold 1× PBS and lysed on ice for 30 minutes in 
lysis buffer (250mM NaCl, 50mM Tris-HCl (pH 8.0), 5mM EDTA (pH 8.0), 0.5% (w/v) Nonidet NP-40 
(Rozenblatt-Rosen et al., 2005)) containing protease inhibitors (Protease Inhibitor cocktail tablets, 
Roche). Insoluble contents were precipitated by centrifuging for 10 minutes at 13’000 rpm. The lysates 
were precleared for 1 hour at 4°C with protein G Sepharose bead suspension (GE Healthcare) and 
5% of the lysate was set aside as input control. The incubations with 0.2-1μl of the primary antibodies 
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were performed at 4°C for 3 hours, followed by a 1 hour precipitation of the epitope antibody 
complexes with protein G Sepharose beads. The immunoprecipitated material was washed three 
times for 5 minutes in lysis buffer on ice, SDS sample buffer was added, and the samples were 
analysed by SDS-PAGE and immunoblotting as described under (2.7.). 
 
2.9. Coimmunoprecipitations of endogenous HCF and Myc from embryos 
Overnight collections of 0-18 hour-old yw embryos were dechorionated for 1 minute and washed 
extensively with NaCl-Tx (0,7% (w/v) NaCl, 0,1% (w/v) Triton X-100). The embryos were homogenised 
at 4°C in 4 volumes 1× LPA lysis buffer (50mM HEPES, pH 7.5, 60mM NaCl, 3mM MgCl2, 1mM CaCl2, 
0.2% Triton X-100, 0.2% Nonidet NP-40, 10% glycerol) containing protease inhibitors (Protease 
Inhibitor cocktail tablets, Roche), using a 1ml glass douncer. The raw extract was centrifuged 15 
minutes at 13’000 rpm to pellet cell debris. The clear middle layer was taken out, centrifuged again to 
get rid of the lipids, and precleared for 90 minutes with protein G Sepharose slurry. In the meantime 
mouse anti-dMyc hybridoma tissue culture supernatant and control mouse anti-lacZ supernatant were 
bound to protein G Sepharose beads at room temperature. After having taken out 3% of the whole 
lysate as input control, lysates were incubated 3 hours with the antibody bound protein G Sepharose 
beads at 4°C. Beads were washed three times with 1× LPA lysis buffer, followed by 3 washing steps 
each with WPS salt wash buffer (LPA with 300mM NaCl) and WPD detergent wash buffer (LPA with 
0,4% NP-40 and 0,4% Triton X-100). SDS sample buffer was added, and the samples were analysed 
by SDS-PAGE and immunoblotting. Primary antibody used for Western blotting: rat anti-dHCF (kind 
gift of J. Workman) and secondary antibody HRP-coupled goat anti-rat antibody (Amersham). 
 
2.10. GST-pulldowns 
The original protocol from (Mosimann, 2007) was modified and carried out as follows: 
 
Protein induction: The IPTG-inducable E. coli strain BL21 was transformed with the various pGEX-
Myc constructs and 50 ml cultures were grown until they reached an OD of 0.5-07. IPTG was added to 
a final concentration of 1mM and the cultures were incubated for another 3 hours at 37°C to ensure 
GST-dMyc fusion protein expression.  
Lysis: The bacteria were then pelleted for 30 minutes at 4500 rpm and the pellets were lysed in 
bacterial GST-lysis buffer (10mM Tris-HCl, pH 8.0, 150mM NaCl, 1.5% N-Laurylsarcosine) containing 
protease inhibitors (Protease Inhibitor cocktail tablets, Roche). After 10 minute incubation on ice, DTT 
was added to a final concentration of 5mM and the suspension was sonicated until the solution 
becomes completely transparent (1 minute). Triton X-100 was added to the sonicated lysate to a final 
concentration of 2%. Cell debris was pelleted and the cleared lysate was bound to Gutathione 
Sepharose beads overnight at 4°C. The next day, the beads were washed three times in GST Wash 
Buffer (20mM Tris-HCl, pH 8.0, 200mM NaCl, 1mM EDTA, 1mM DTT, 0.5% Nonidet NP-40) and then 
resuspended in 250μl GST Binding Buffer (200mM NaCl, 1mM EDTA, 1mM DTT, 0.5% NP-40, 10% 
glyerol) containing Protease inhibitors. 
 126
In vitro translation of Atu and HCF 
 
[35S] methionine labelled in vitro expressed Atu and HCF proteins were produced according to the TNT 
Coupled Reticulocyte lysate Transcription/Translation System manual (Promega). Expression of the 
radioactively labelled proteins was performed for 90 minutes at 30°C. 10% of each sample was set 
aside as a loading control. 
 
GST pulldowns 
 
For the GST pulldowns we used 30μl GST-dMyc coupled Glutathione sepharose beads per reaction. 
GST-only coupled beads served as a control. Bead-coupled GST-fusion proteins were incubated for 2 
hours in GST Binding Buffer in the presence of 0.05% BSA, followed by two-hour’s incubation at 4°C 
with 7.5μl 35S-labelled protein. The samples were washed five times in GST Wash Buffer, taken up in 
sample buffer and SDS-PAGE gels were run. The acrylamide gels were stained with Coomassie Blue, 
fixed and dried under vaccum for 2 hours at 80°C. Exposition of the gels was performed on X-ray films 
for several days or using a Phosphorimager (Fujifilm FLA-7000) screen overnight. 
 
2.11. qRTPCR 
Drosophila Schneider 2 cells were treated with dsRNA against PAF complex components or hcf as 
described in (2.3.). The pelleted cells were lysed in 1ml TRIZOL reagent (Invitrogen) and total RNA 
was extracted and purified according to the protocol supplied with the TRIZOL reagent. After 
precipitation, RNA was redissolved in 20μl RNase-free water. The concentration of the purified RNA 
was measured with a Nanodrop ND-1000 spectrophotometer. To remove traces of genomic DNA, 
10μg of RNA were subjected to a DNase digestion, using the Ambion TURBO DNA-free-kit. 
Subsequently, the quality of the purified RNA was analysed using Bioanalyzer chips (Agilent). The 
Bioanalyzer electropherograms also served as confirmations for the Nanodrop concentration 
measurements. cDNA was synthesised with the Omniscript Reverse Transcription Kit (Qiagen) using 
random hexamer primers. 1μg of template RNA was used in the reverse transcription step. Mock RT 
reactions (containing 1μg of template RNA) were performed in order to control for remaining traces of 
genomic DNA. qRTPCR reactions were performed on an ABI 7900 Real Time PCR Instrument 
(Applied Biosystems) using the SYBR GREEN PCR Master Mix (Applied Biosystems). Dissociation 
curve measurements were included in the PCR run to ascertain the specificity of the amplification 
reaction. Data were analysed with SDS 2.0 software (Applied Biosystems), subsequent analyses and 
relative target gene quantification was performed using Microsoft Excel. The amount of target was 
normalised to actin5C for (Paf complex dsRNA Figure 23) and actin5C and Sec24 for (HCF dsRNA 
Figure 16). Relative expression levels comparded to the gfp dsRNA treated samples are given by 2-
ΔΔCt, where. ΔΔCt= ΔCt(sample) – ΔCt(gfp), and ΔCt is the Ct of the target gene subtracted from the Ct 
of the actin5C or the combined actin5C and Sec24 reactions. The following primer pairs were used in 
the qRTPCR reactions: 
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Assay/Gene   Primer name   Sequence (5‘→3‘) 
actin5C  PG_act5C_F1  GCCCATCTACGAGGGTTATGC 
  PG_act5C_R1  AATCGCGACCAGCCAGATC 
Sec24    Sec24forw  CCACTCCCCTGCCATCCT 
 Sec24rev  ACCCCAAACCCAGCAACA  
myc dmyc_RTPCR_f GAATCGCGCTCGGTTAGTG 
 dmyc_RTPCR_r CTACGCCGCCGCTTTAAG 
nnp1 PG_nnp1_F1 CTATACACACGAAAGTTTCCATGCTATA 
 PG_nnp1_R1 CCCTTGCTCTTGGAGAATGG 
CG5033 PG_CG5033_F1  TAACCGCTCGGCTTTAATTCA 
 PG_CG5033_R1 CCCTTGCTCTTGGAGAATGG  
CG12295 CG12295_RTPCR_f GGCGGAAGATGGATTTAGCTT 
 CG12295_RTPCR_r CCTCGATTGCCCTTCGTATATAA 
fibrillarin fib.Left ACGACAGTCTCGCATGTGTC 
 fib.Right  ATGCGGTACTTGTGTGGATG 
hcf MF_HCF_qPCR_f AATTCTTGCGGACGAGGAGAA 
 MF_HCF_qPCR_r CCCTCCTTGACATCCTTGGAA 
Bka MF_Bka_fwd GACCTTAAGAATCGCATCCGG 
 MF_Bka_rev TTGACTCCATACGCTTCTGGC 
CG9630 MF_CG9630_fwd AGGAAATAGGTGCCCTCGTCA 
 MF_CG9630_rev TTCAGGTGCTCCAAGTCTTCG 
5sRNA 5sRNA_fw CGTCCGATCACCGAAATTAAG 
 5sRNA_rev CCAAGCGGTCCCTCATCTAA 
snoRNA U3 PG_U3_f   TTTCACACTAGCTGAAAGCCAAGT 
 PG_U3_r   CCTCACGCTGCCGAATAGAA 
tRNA(Leu) tRNALeu.L  TAAGGCGCCAGACTCAAGAT 
 tRNALeu.R  CCTCAAAGAGGACCAGAAC 
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3. Fly culture 
Flies were kept on standard Drosophila medium. Test crosses were performed in climate chambers at 
25°C. 
 
3.1. Fly lines 
UAS-hairpin-RNAi lines and overexpression constructs for hcf and associated factors are described in 
(Balbi, 2007). 
dmP0 (Johnston et al., 1999) 
y w; dmP0 tub>myc y+<GAL4 ey-flp/FM7i, act-GFP 
y w; tub>myc y+<GAL4 ey-flp/FM7i, act-GFP 
y w; dmP0 tub>myc y+<GAL4 ey-flp/FM7i, act-GFP; pont5.1/TM6B, Tb 
y w; GMR-GAL4w+/CyO, y+ 
y w; GMR-GAL4w+ UAS-Myc132w+/CyO, y+ 
y w; GMR-GAL4w+ UAS-Myc132w+; UAS-Myc132w+ UAS-Myc42w+/(SM5^TM6B, Tb) 
y w; ap-GAL4w+/CyO, act-GFP 
y w; ap-GAL4w+ UAS-Myc132 w+/CyO, act-GFP 
y w; sca-GAL4/CyO 
y w hs-flp; +; act>CD2>GAL4w+ UAS-GFPw+/TM6B, Tb 
y w hs-flp; UAS-Myc132 w+; act<CD2>GAL4w+ UAS-GFPw+/TM6B, Tb 
y w; Z-IR M-3i  (UAS-lacZ hairpin insertion on the second chromosome. (Steiger, 2007) 
w; UAS-lacZ B4-1-2 w+
w; +; UAS-hyx-RNAi (VDRC transformant ID 28318) 
w;+; UAS-atms RNAi (VDRC transformant ID 20876) 
w;+; UAS-rtf1 RNAi (VDRC transformant ID 27341) 
w; UAS-atu RNAi (VDRC transformant ID 17490) 
w; UAS-rpn6-RNAi (VDRC transformant ID 18021) 
w; UAS-rpn6-RNAi (VDRC transformant ID 18022) 
w; UAS-rpn5-RNAi (VDRC transformant ID 20104) 
w; +; UAS-rpn5-RNAi (VDRC transformant ID 18676) 
w; UAS-rpn12-RNAi (VDRC transformant ID 21799) 
w; UAS-rpn7-RNAi (VDRC transformant ID 22103) 
w; +; UAS-rpn7-RNAi (VDRC transformant ID 22104) 
w; Rpn62F/CyO, P{w+mC =ActGFP}JMR1 (Bloomington Stock Center) 
w; Rpn620F/CyO, P{w+mC =ActGFP}JMR1 (Bloomington Stock Center) 
y1 w67c23; P{w+mC =lacW}Rpn6k00103/CyO (Bloomington Stock Center) 
w1118; P{w+mGT =GT1}Rpn11BG01694/CyO (Bloomington Stock Center) 
w1118; P{w+mC =lacW}Atus1938/TM3, Sb1 (Bloomington Stock Center) 
P{ry+t7.2=PZ}atmsrK509 ry506/TM3, Sb1 (Bloomington Stock Center) 
y w hs-flp;+; FRT82hyxEY6989, y+w+/TM6B, Tb (Mosimann et al., 2006) 
y w hs-flp;+; FRT82 hyx2, y+/TM6B, Tb (Mosimann et al., 2006) 
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y w; +; hyxP9 (Mosimann et al., 2006) 
y w hs-flp; UAS-hyx1.5 (Mosimann et al., 2006) 
 
4. Determination of bristle size 
Scutella were removed, cleaned from attaching muscle tissue and mounted on glass slides, in 
glycerol. Pictures were taken with a Zeiss Axiophot microscope (Objective magnification: 5×). Bristle 
size was determined as the total pixel count a bristle covers in a picture. Pixel counts were determined 
with Adobe Photoshop. 
 
5. Determination of ommatidial size 
Flies were frozen at –20° C for at least one day, slowly defrosted at 0°C and directly used for electron 
microscopy. The pictures were acquired with a JEOL JSM-6360 LV scanning electron microscope at a 
magnification of 180×. For determination of ommatidial size, the area of 20 centrally located ommatidia 
was measured from 5 flies of the same genotype using Adobe Photoshop. The same 
photomicrographs were also used to determine the total number of ommatidia per eye. Obvious 
fusions of two ommatidia were counted as two individual ommatidia. The Student’s t-test was applied 
to assess statistical relevance of observed differences. 
 
6. Analysis of clone size in imaginal wing discs and fat body 
To analyse the size of clones with downregulated dPaf complex levels in wing discs and fatbody virgin 
females of the strain yw hs-flp; +; act>CD2>GAL4w+ UAS-GFPw+ /TM6B, Tb were crossed to males 
from the following UAS-hairpin RNA expressing lines:  
 
y w; Z-IR M-3i  (UAS-lacZ hairpin insertion on the second chromosome. (Steiger, 2007) 
w; +; UAS-hyx-RNAi (VDRC transformant ID 28318) 
w;+; UAS-atms RNAi (VDRC transformant ID 20876) 
w;+; UAS-rtf1 RNAi (VDRC transformant ID 27341) 
w; UAS-atu RNAi (VDRC transformant ID 17490) 
 
Crosses with the same UAS-hairpin RNA males were performed in a dMyc overexpression 
background, by using virgin females of the following genotype: yw hs-flp; UAS-dmyc132,w+; 
act>CD2>GAL4w+ UAS-GFPw+ /TM6B, Tb 
 
16-24 hour long egglays were performed and the clones were induced by heatshocking the larvae 72 
hours AED for 8 minutes in a water bath at 37°C. The wandering third instar larvae were dissected 45 
hours after clone induction, fixed in 4% paraformaldehyde for 20 minutes, and washed three times in 
1× PBX (1× PBS + 0.1% Triton X-100). During the second washing step 0.5μg/ml of the DNA dye 
Hoechst 33342 was added to the wash buffer. Subsequently, wing discs and fatbody tissue was 
extracted and mounted in Vectashield mounting solution (Vector). Pictures were taken with a Leica 
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DMRA fluorescence microscope (objective Magnification: 10×). Clones were identified by presence of 
GFP expression and the clone or nuclear size was determined as the total pixel count a clone or 
nucleus covers in a picture. Pixel counts were determined with Adobe Photoshop. For each genotype 
25-50 clones/nuclei were measured. The Student’s t-test was applied to assess the statistical 
significance of the average size changes. 
 131
References 
Adelman, K., Wei, W., Ardehali, M.B., Werner, J., Zhu, B., Reinberg, D., and Lis, J.T. (2006). 
Drosophila Paf1 Modulates Chromatin Structure at Actively Transcribed Genes. Mol Cell Biol 26, 250-
260. 
 
Adkins, M.W., and Tyler, J.K. (2006). Transcriptional activators are dispensable for transcription in the 
absence of Spt6-mediated chromatin reassembly of promoter regions. Mol Cell 21, 405-416. 
 
Amati, B. (1998). Myc and the cell cycle. Frontiers in Bioscience 3, 250-268. 
 
Amati, B., Brooks, M.W., Levy, N., Littlewood, T.D., Evan, G.I., and Land, H. (1993a). Oncogenic 
activity of the c-Myc protein requires dimerization with Max. Cell 72, 233-245. 
 
Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I., and Land, H. (1992). Transcriptional 
activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423-
426. 
 
Amati, B., Littlewood, T.D., Evan, G.I., and Land, H. (1993b). The c-Myc protein induces cell cycle 
progression and apoptosis through dimerization with Max. EMBO Journal 12, 5083-5087. 
 
Andrulis, E.D., Guzman, E., Doring, P., Werner, J., and Lis, J.T. (2000). High-resolution localization of 
Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and 
transcription elongation. Genes Dev 14, 2635-2649. 
 
Armelin, H.A., Armelin, M.C., Kelly, K., Stewart, T., Leder, P., Cochran, B.H., and Stiles, C.D. (1984). 
Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310, 655-660. 
 
Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. (1991). Constitutive c-myc 
expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates 
apoptosis. Oncogene 6, 1915-1922. 
 
Ayer, D.E., and Eisenman, R.N. (1993). A switch from Myc:Max to Mad:Max heterocomplexes 
accompanies monocyte/macrophage differentiation. Genes & Development 7, 2110-2119. 
 
Ayer, D.E., Kretzner, L., and Eisenman, R.N. (1993). Mad: a heterodimeric partner for Max that 
antagonizes Myc transcriptional activity. Cell 72, 211-222. 
 
Balbi, M. (2007). Characterization of dHCF as a Novel Co-Factor of dMyc in Drosophila melanogaster. 
In Zoologisches Institut (Zürich, Universität Zürich), pp. 104. 
 
Barone, M.V., and Courtneidge, S. (1995). Myc but not fos rescue of pdgf signalling block caused by 
kinase inactive src. Nature 378, 509-512. 
 
Bellosta, P., Hulf, T., Diop, S.B., Usseglio, F., Pradel, J., Aragnol, D., and Gallant, P. (2005). Myc 
interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during 
Drosophila development. Proc Natl Acad Sci U S A 102, 11799-11804. 
 
Belotserkovskaya, R., Oh, S., Bondarenko, V.A., Orphanides, G., Studitsky, V.M., and Reinberg, D. 
(2003). FACT facilitates transcription-dependent nucleosome alteration. Science 301, 1090-1093. 
 
Beltran, S., Angulo, M., Pignatelli, M., Serras, F., and Corominas, M. (2007). Functional dissection of 
the ash2 and ash1 transcriptomes provides insights into the transcriptional basis of wing phenotypes 
and reveals conserved protein interactions. Genome Biol 8, R67. 
 
Benassayag, C., Montero, L., Colombie, N., Gallant, P., Cribbs, D., and Morello, D. (2005). Human c-
Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster. Mol Cell 
Biol 25, 9897-9909. 
 
Bernstein, E., Denli, A.M., and Hannon, G.J. (2001). The rest is silence. RNA 7, 1509-1521. 
 
 132
Betz, J.L., Chang, M., Washburn, T.M., Porter, S.E., Mueller, C.L., and Jaehning, J.A. (2002). 
Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle 
regulation, protein synthesis, and lipid and nucleic acid metabolism. Mol Genet Genomics 268, 272-
285. 
 
Blackwell, T.K., Huang, J., Ma, A., Kretzner, L., Alt, F.W., Eisenman, R.N., and Weintraub, H. (1993). 
Binding of myc proteins to canonical and noncanonical DNA sequences. Molecular & Cellular Biology 
13, 5216-5224. 
 
Blackwood, E.M., and Eisenman, R.N. (1991). Max: a helix-loop-helix zipper protein that forms a 
sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217. 
 
Boon, K., Caron, H.N., van Asperen, R., Valentijn, L., Hermus, M.C., van Sluis, P., Roobeek, I., Weis, 
I., Voute, P.A., Schwab, M., et al. (2001). N-myc enhances the expression of a large set of genes 
functioning in ribosome biogenesis and protein synthesis. EMBO Journal 20, 1383-1393. 
 
Bortvin, A., and Winston, F. (1996). Evidence that Spt6p controls chromatin structure by a direct 
interaction with histones. Science 272, 1473-1476. 
 
Bouchard, C., Dittrich, O., Kiermaier, A., Dohmann, K., Menkel, A., Eilers, M., and Luscher, B. (2001). 
Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP 
recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15, 2042-2047. 
 
Braakhuis, B.J., Brakenhoff, R.H., and Leemans, C.R. (2005). Second field tumors: a new opportunity 
for cancer prevention? Oncologist 10, 493-500. 
 
Bray, S., Musisi, H., and Bienz, M. (2005). Bre1 is required for Notch signaling and histone 
modification. Dev Cell 8, 279-286. 
 
Bridges, C.B. (1935). Drosophila melanogaster: Legend for symbols, mutants, valuations. Drosophila 
Information Service 3, 5-19. 
 
Brower, C.S., Sato, S., Tomomori-Sato, C., Kamura, T., Pause, A., Stearman, R., Klausner, R.D., 
Malik, S., Lane, W.S., Sorokina, I., et al. (2002). Mammalian mediator subunit mMED8 is an Elongin 
BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Proc 
Natl Acad Sci U S A 99, 10353-10358. 
 
Camps, J., Armengol, G., del Rey, J., Lozano, J.J., Vauhkonen, H., Prat, E., Egozcue, J., Sumoy, L., 
Knuutila, S., and Miro, R. (2006). Genome-wide differences between microsatellite stable and unstable 
colorectal tumors. Carcinogenesis 27, 419-428. 
 
Carpten, J.D., Robbins, C.M., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-Wilson, J., Simonds, 
W.F., Gillanders, E.M., Kennedy, A.M., Chen, J.D., et al. (2002). HRPT2, encoding parafibromin, is 
mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32, 676-680. 
 
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-
Tikhonenko, A., and Mendell, J.T. (2008). Widespread microRNA repression by Myc contributes to 
tumorigenesis. Nat Genet 40, 43-50. 
 
Chaudhary, K., Deb, S., Moniaux, N., Ponnusamy, M.P., and Batra, S.K. (2007). Human RNA 
polymerase II-associated factor complex: dysregulation in cancer. Oncogene Advance Online 
Publication, doi:10.1038/sj.onc.1210582. 
 
Cheng, J.Q., Ruggeri, B., Klein, W.M., Sonoda, G., Altomare, D.A., Watson, D.K., and Testa, J.R. 
(1996). Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and 
tumorigenicity by antisense RNA. Proc Natl Acad Sci U S A 93, 3636-3641. 
 
Cheng, S.W., Davies, K.P., Yung, E., Beltran, R.J., Yu, J., and Kalpana, G.V. (1999). c-MYC interacts 
with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Genetics 22, 
102-105. 
 
 133
Chi, Y., Huddleston, M.J., Zhang, X., Young, R.A., Annan, R.S., Carr, S.A., and Deshaies, R.J. (2001). 
Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes 
Dev 15, 1078-1092. 
 
Chin, L., Schreiber-Agus, N., Pellicer, I., Chen, K., Lee, H.W., Dudast, M., Cordon-Cardo, C., and 
DePinho, R.A. (1995). Contrasting roles for Myc and Mad proteins in cellular growth and 
differentiation. Proceedings of the National Academy of Sciences of the United States of America 92, 
8488-8492. 
 
Cho, Y., Griswold, A., Campbell, C., and Min, K.T. (2005). Individual histone deacetylases in 
Drosophila modulate transcription of distinct genes. Genomics 86, 606-617. 
 
Ciechanover, A. (1998). The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17, 
7151-7160. 
 
Cowling, V.H., and Cole, M.D. (2006). Mechanism of transcriptional activation by the Myc 
oncoproteins. Seminars in Cancer Biology 16, 242. 
 
Dang, C.V., O'Donnell, K.A., Zeller, K.I., Nguyen, T., Osthus, R.C., and Li, F. (2006). The c-Myc target 
gene network. Seminars in Cancer Biology 16, 253. 
 
Davis, A.C., Wims, M., Spotts, G.D., Hann, S.R., and Bradley, A. (1993). A null c-myc mutation causes 
lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female 
mice. Genes & Development 7, 671-682. 
 
De La Cova, C., Abril, M., Bellosta, P., Gallant, P., and Johnston, L.A. (2004). Drosophila myc 
regulates organ size by inducing cell competition. Cell 117, 107-116. 
 
Dezfouli, S., Bakke, A., Huang, J., Wynshaw-Boris, A., and Hurlin, P.J. (2006). Inflammatory Disease 
and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells. Mol Cell Biol 26, 
2080-2092. 
 
Dominguez-Sola, D., Ying, C.Y., Grandori, C., Ruggiero, L., Chen, B., Li, M., Galloway, D.A., Gu, W., 
Gautier, J., and Dalla-Favera, R. (2007). Non-transcriptional control of DNA replication by c-Myc. 
Nature 448, 445-451. 
 
Dover, J., Schneider, J., Tawiah-Boateng, M.A., Wood, A., Dean, K., Johnston, M., and Shilatifard, A. 
(2002). Methylation of histone H3 by COMPASS requires ubiquitination of histone H2B by Rad6. J Biol 
Chem 277, 28368-28371. 
 
Dugan, K.A., Wood, M.A., and Cole, M.D. (2002). TIP49, but not TRRAP, modulates c-Myc and E2F1 
dependent apoptosis. Oncogene 21, 5835-5843. 
 
Eberhardy, S.R., and Farnham, P.J. (2001). c-Myc mediates activation of the cad promoter via a post-
RNA polymerase II recruitment mechanism. J Biol Chem 276, 48562-48571. 
 
Eberhardy, S.R., and Farnham, P.J. (2002). Myc recruits P-TEFb to mediate the final step in the 
transcriptional activation of the cad promoter. J Biol Chem 277, 40156-40162. 
 
Eilers, M., Picard, D., Yamamoto, K.R., and Bishop, J.M. (1989). Chimaeras of myc oncoprotein and 
steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66-68. 
 
Etard, C., Gradl, D., Kunz, M., Eilers, M., and Wedlich, D. (2005). Pontin and Reptin regulate cell 
proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1. Mech Dev 122, 545-556. 
 
Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., 
and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128. 
 
Ezhkova, E., and Tansey, W.P. (2004). Proteasomal ATPases link ubiquitylation of histone H2B to 
methylation of histone H3. Mol Cell 13, 435-442. 
 
 134
Fernandez, P.C., Frank, S.R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., and Amati, B. 
(2003). Genomic targets of the human c-Myc protein. Genes Dev 17, 1115-1129. 
 
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998). Potent and 
specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-
811. 
 
Frank, S.R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H.M., Livingston, D.M., and 
Amati, B. (2003). MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 
4, 575-580. 
 
Freiman, R.N., and Herr, W. (1997). Viral mimicry: common mode of association with HCF by VP16 
and the cellular protein LZIP. Genes Dev 11, 3122-3127. 
 
Freytag, S.O. (1988). Enforced expression of the c-myc oncogene inhibits cell differentiation by 
precluding entry into a distinct predifferentiation state in G0/G1. Molecular & Cellular Biology 8, 1614-
1624. 
 
Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W.S., Nakatani, Y., and 
Livingston, D.M. (2001). The p400 complex is an essential E1A transformation target. Cell 106, 297-
307. 
 
Gallant, P. (2006). Myc / Max / Mad in invertebrates - the evolution of the Max network CTMI 302, 237-
254. 
 
Gallant, P., Shiio, Y., Cheng, P.F., Parkhurst, S.M., and Eisenman, R.N. (1996). Myc and Max 
homologs in Drosophila. Science 274, 1523-1527. 
 
Glickman, M.H., Rubin, D.M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W., Fried, V.A., 
and Finley, D. (1998). A subcomplex of the proteasome regulatory particle required for ubiquitin-
conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94, 615-623. 
 
Gomez-Roman, N., Grandori, C., Eisenman, R.N., and White, R.J. (2003). Direct activation of RNA 
polymerase III transcription by c-Myc. Nature 421, 290-294. 
 
Gonzalez, F., Delahodde, A., Kodadek, T., and Johnston, S.A. (2002). Recruitment of a 19S 
proteasome subcomplex to an activated promoter. Science 296, 548-550. 
 
Grandori, C., Cowley, S.M., James, L.P., and Eisenman, R.N. (2000). The Myc/Max/Mad network and 
the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16, 653-699. 
 
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z.A., Ngouenet, C., Galloway, D.A., Eisenman, R.N., 
and White, R.J. (2005). c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA 
genes by RNA polymerase I. Nat Cell Biol 7, 311-318. 
 
Grandori, C., Mac, J., Siebelt, F., Ayer, D.E., and Eisenman, R.N. (1996). Myc-Max heterodimers 
activate a DEAD box gene and interact with multiple E box-related sites in vivo. Embo J 15, 4344-
4357. 
 
Grant, P.A., Duggan, L., Cote, J., Roberts, S.M., Brownell, J.E., Candau, R., Ohba, R., Owen-Hughes, 
T., Allis, C.D., Winston, F., et al. (1997). Yeast Gcn5 functions in two multisubunit complexes to 
acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) 
complex. Genes Dev 11, 1640-1650. 
 
Grant, P.A., Schieltz, D., Pray-Grant, M.G., Yates, J.R., and Workman, J.L. (1998). The ATM-Related 
Cofactor Tra1 Is a Component of the Purified SAGA Complex. Molecular Cell 2, 863-867. 
 
Gregory, M.A., and Hann, S.R. (2000). c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: 
Stabilization of c-Myc in Burkitt's Lymphoma Cells. Mol Cell Biol 20, 2423-2435. 
 
 135
Grewal, S.S., Li, L., Orian, A., Eisenman, R.N., and Edgar, B.A. (2005). Myc-dependent regulation of 
ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 7, 295-302. 
 
Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall' Olio, V., Zardo, G., Nervi, C., 
Bernard, L., and Amati, B. (2006). Myc-binding-site recognition in the human genome is determined by 
chromatin context. Nat Cell Biol 8, 764-770. 
 
Guelman, S., Suganuma, T., Florens, L., Swanson, S.K., Kiesecker, C.L., Kusch, T., Anderson, S., 
Yates, J.R., III, Washburn, M.P., Abmayr, S.M., et al. (2006). Host Cell Factor and an Uncharacterized 
SANT Domain Protein Are Stable Components of ATAC, a Novel dAda2A/dGcn5-Containing Histone 
Acetyltransferase Complex in Drosophila. Mol Cell Biol 26, 871-882. 
 
Gunther, M., Laithier, M., and Brison, O. (2000). A set of proteins interacting with transcription factor 
Sp1 identified in a two-hybrid screening. Mol Cell Biochem 210, 131-142. 
 
Guo, S., and Kemphues, K.J. (1995). par-1, a gene required for establishing polarity in C. elegans 
embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81, 611-620. 
 
Hartzog, G.A., Wada, T., Handa, H., and Winston, F. (1998). Evidence that Spt4, Spt5, and Spt6 
control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev 12, 
357-369. 
 
Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L., and Ayer, D.E. (1997). Histone Deacetylase 
Activity Is Required for Full Transcriptional Repression by mSin3A. Cell 89, 341-347. 
 
Hatton, K.S., Mahon, K., Chin, L., Chiu, F.C., Lee, H.W., Peng, D.M., Morgenbesser, S.D., Horner, J., 
and Depinho, R.A. (1996). Expression and activity of l-myc in normal mouse development. Molecular 
& Cellular Biology 16, 1794-1804. 
 
Henriksson, M., and Luscher, B. (1996). Proteins of the Myc network: essential regulators of cell 
growth and differentiation. [Review] [267 refs]. Adv Cancer Res 68, 109-182. 
 
Henry, K.W., Wyce, A., Lo, W.S., Duggan, L.J., Emre, N.C., Kao, C.F., Pillus, L., Shilatifard, A., Osley, 
M.A., and Berger, S.L. (2003). Transcriptional activation via sequential histone H2B ubiquitylation and 
deubiquitylation, mediated by SAGA-associated Ubp8. Genes Dev 17, 2648-2663. 
 
Hollis, G.F., Mitchell, K.F., Battey, J., Potter, H., Taub, R., Lenoir, G.M., and Leder, P. (1984). A 
variant translocation places the [lambda] immunoglobulin genes 3[prime] to the c-myc oncogene in 
Burkitt's lymphoma. Nature 307, 752-755. 
 
Holzl, H., Kapelari, B., Kellermann, J., Seemuller, E., Sumegi, M., Udvardy, A., Medalia, O., Sperling, 
J., Muller, S.A., Engel, A., et al. (2000). The Regulatory Complex of Drosophila melanogaster 26S 
Proteasomes: Subunit Composition and Localization of a Deubiquitylating Enzyme. J Cell Biol 150, 
119-130. 
 
Hulf, T. (2004). dMyc and the Control of Gene Expression. In Zoologisches Institut (Zürich, Universität 
Zürich), pp. 140. 
 
Hulf, T., Bellosta, P., Furrer, M., Steiger, D., Svensson, D., Barbour, A., and Gallant, P. (2005). Whole-
genome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes. Mol Cell Biol 
25, 3401-3410. 
 
Hurlin, P.J., and Huang, J. (2006). The MAX-interacting transcription factor network. Seminars in 
Cancer Biology 16, 265. 
 
Hurlin, P.J., Queva, C., and Eisenman, R.N. (1997). Mnt, a novel Max-interacting protein is 
coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes & 
Development 11, 44-58. 
 
Hurlin, P.J., Queva, C., Koskinen, P.J., Steingrimsson, E., Ayer, D.E., Copeland, N.G., Jenkins, N.A., 
and Eisenman, R.N. (1995). Mad3 and Mad4: novel Max-interacting transcriptional repressors that 
 136
suppress c-myc dependent transformation and are expressed during neural and epidermal 
differentiation. EMBO Journal 14, 5646-5659. 
 
Hurlin, P.J., Steingrimsson, E., Copeland, N.G., Jenkins, N.A., and Eisenman, R.N. (1999). Mga, a 
dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. 
Embo J 18, 7019-7028. 
 
Hurlin, P.J., Zhou, Z.Q., Toyo-oka, K., Ota, S., Walker, W.L., Hirotsune, S., and Wynshaw-Boris, A. 
(2003). Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. Embo J 22, 4584-4596. 
Iritani, B.M., and Eisenman, R.N. (1999). c-Myc enhances protein synthesis and cell size during B 
lymphocyte development. Proceedings of the National Academy of Sciences of the United States of 
America 96, 13180-13185. 
 
Johnston, L.A., Prober, D.A., Edgar, B.A., Eisenman, R.N., and Gallant, P. (1999). Drosophila myc 
regulates cellular growth during development. Cell 98, 779-790. 
 
Julien, E., and Herr, W. (2003). Proteolytic processing is necessary to separate and ensure proper cell 
growth and cytokinesis functions of HCF-1. Embo J 22, 2360-2369. 
 
Kanazawa, S., Soucek, L., Evan, G., Okamoto, T., and Peterlin, B.M. (2003). c-Myc recruits P-TEFb 
for transcription, cellular proliferation and apoptosis. Oncogene 22, 5707-5711. 
 
Kaplan, C.D., Laprade, L., and Winston, F. (2003). Transcription elongation factors repress 
transcription initiation from cryptic sites. Science 301, 1096-1099. 
 
Karn, J., Watson, J.V., Lowe, A.D., Green, S.M., and Vedeckis, W. (1989). Regulation of cell cycle 
duration by c-myc levels. Oncogene 4, 773-787. 
 
Kato, G.J., Barrett, J., Villa, G.M., and Dang, C.V. (1990). An amino-terminal c-myc domain required 
for neoplastic transformation activates transcription. Molecular & Cellular Biology 10, 5914-5920. 
 
Kato, G.J., Lee, W.M., Chen, L.L., and Dang, C.V. (1992). Max: functional domains and interaction 
with c-Myc. Genes Dev 6, 81-92. 
 
Kelly, K., Cochran, B.H., Stiles, C.D., and Leder, P. (1983). Cell-specific regulation of the c-myc gene 
by lymphocyte mitogens and platelet-derived growth factor. Cell 35, 603-610. 
 
Kim, S.Y., Herbst, A., Tworkowski, K.A., Salghetti, S.E., and Tansey, W.P. (2003). Skp2 regulates Myc 
protein stability and activity. Mol Cell 11, 1177-1188. 
 
Kim, Y.J., Bjorklund, S., Li, Y., Sayre, M.H., and Kornberg, R.D. (1994). A multiprotein mediator of 
transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. 
Cell 77, 599-608. 
 
Kleine-Kohlbrecher, D., Adhikary, S., and Eilers, M. (2006). Mechanisms of transcriptional repression 
by Myc. Curr Top Microbiol Immunol 302, 51-62. 
 
Knez, J., Piluso, D., Bilan, P., and Capone, J.P. (2006). Host cell factor-1 and E2F4 interact via 
multiple determinants in each protein. Mol Cell Biochem 288, 79-90. 
 
Koch, C., Wollmann, P., Dahl, M., and Lottspeich, F. (1999). A role for Ctr9p and Paf1p in the 
regulation G1 cyclin expression in yeast. Nucleic Acids Res 27, 2126-2134. 
 
Kodadek, T., Sikder, D., and Nalley, K. (2006). Keeping Transcriptional Activators under Control. Cell 
127, 261. 
 
Kohl, N.E., Kanda, N., Schreck, R.R., Bruns, G., Latt, S.A., Gilbert, F., and Alt, F.W. (1983). 
Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35, 
359-367. 
 
 137
Komarnitsky, P., Cho, E.J., and Buratowski, S. (2000). Different phosphorylated forms of RNA 
polymerase II and associated mRNA processing factors during transcription. Genes Dev 14, 2452-
2460. 
 
Koskinen, P.J., Ayer, D.E., and Eisenman, R.N. (1995). Repression of Myc-Ras cotransformation by 
Mad is mediated by multiple protein-protein interactions. Cell Growth & Differentiation 6, 623-629. 
 
Kretzner, L., Blackwood, E.M., and Eisenman, R.N. (1992). Myc and Max proteins possess distinct 
transcriptional activities. Nature 359, 426-429. 
 
Kristie, T.M., and Sharp, P.A. (1990). Interactions of the Oct-1 POU subdomains with specific DNA 
sequences and with the HSV alpha-trans-activator protein. Genes Dev 4, 2383-2396. 
 
Krogan, N.J., Dover, J., Wood, A., Schneider, J., Heidt, J., Boateng, M.A., Dean, K., Ryan, O.W., 
Golshani, A., Johnston, M., et al. (2003a). The Paf1 complex is required for histone H3 methylation by 
COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol Cell 11, 721-729. 
 
Krogan, N.J., Kim, M., Ahn, S.H., Zhong, G., Kobor, M.S., Cagney, G., Emili, A., Shilatifard, A., 
Buratowski, S., and Greenblatt, J.F. (2002). RNA Polymerase II Elongation Factors of Saccharomyces 
cerevisiae: a Targeted Proteomics Approach. Mol Cell Biol 22, 6979-6992. 
 
Krogan, N.J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D.P., Beattie, B.K., 
Emili, A., Boone, C., et al. (2003b). Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is 
linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol 23, 4207-4218. 
 
Kurosu, T., and Peterlin, B.M. (2004). VP16 and ubiquitin; binding of P-TEFb via its activation domain 
and ubiquitin facilitates elongation of transcription of target genes. Curr Biol 14, 1112-1116. 
 
Lee, D., Ezhkova, E., Li, B., Pattenden, S.G., Tansey, W.P., and Workman, J.L. (2005). The 
proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with 
transcriptional activators. Cell 123, 423-436. 
 
Leone, G., Degregori, J., Sears, R., Jakoi, L., and Nevins, J.R. (1997). Myc and ras collaborate in 
inducing accumulation of active cyclin e/cdk2 and e2f. Nature 387, 422-426. 
 
Leone, G., Sears, R., Huang, E., Rempel, R., Nuckolls, F., Park, C.H., Giangrande, P., Wu, L., 
Saavedra, H.I., Field, S.J., et al. (2001). Myc requires distinct E2F activities to induce S phase and 
apoptosis. Mol Cell 8, 105-113. 
 
Liu, X., Tesfai, J., Evrard, Y.A., Dent, S.Y., and Martinez, E. (2003). c-Myc transformation domain 
recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for 
transcription activation. J Biol Chem 278, 20405-20412. 
 
Loo, L.W., Secombe, J., Little, J.T., Carlos, L.S., Yost, C., Cheng, P.F., Flynn, E.M., Edgar, B.A., and 
Eisenman, R.N. (2005). The transcriptional repressor dMnt is a regulator of growth in Drosophila 
melanogaster. Mol Cell Biol 25, 7078-7091. 
 
Luscher, B., and Larsson, L.G. (1999). The basic region/helix-loop-helix/leucine zipper domain of Myc 
proto-oncoproteins: Function and regulation [Review]. Oncogene 18, 2955-2966. 
 
Mahajan, S.S., Johnson, K.M., and Wilson, A.C. (2003). Molecular cloning of Drosophila HCF reveals 
proteolytic processing and self-association of the encoded protein. J Cell Physiol 194, 117-126. 
 
Maines, J.Z., Stevens, L.M., Tong, X., and Stein, D. (2004). Drosophila dMyc is required for ovary cell 
growth and endoreplication. Development 131, 775-786. 
 
McMahon, S.B., Van, B.H., Dugan, K.A., Copeland, T.D., and Cole, M.D. (1998). The novel ATM-
related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374. 
 
McMahon, S.B., Wood, M.A., and Cole, M.D. (2000). The essential cofactor TRRAP recruits the 
histone acetyltransferase hGCN5 to c-Myc. Molecular & Cellular Biology 20, 556-562. 
 
 138
Menssen, A., and Hermeking, H. (2002). Characterization of the c-MYC-regulated transcriptome by 
SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A 99, 6274-6279. 
 
Meyer, N., Kim, S.S., and Penn, L.Z. (2006). The Oscar-worthy role of Myc in apoptosis. Seminars in 
Cancer Biology 16, 275. 
 
Moniaux, N., Nemos, C., Schmied, B.M., Chauhan, S.C., Deb, S., Morikane, K., Choudhury, A., 
Vanlith, M., Sutherlin, M., Sikela, J.M., et al. (2006). The human homologue of the RNA polymerase II-
associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. 
Oncogene 25, 3247-3257. 
 
Montagne, J., Stewart, M.J., Stocker, H., Hafen, E., Kozma, S.C., and Thomas, G. (1999). Drosophila 
S6 kinase: A regulator of cell size. Science 285, 2126-2129. 
 
Montero, L., Muller, N., and Gallant, P. (2008). Induction of apoptosis by Drosophila Myc. Genesis 46, 
104-111. 
 
Moreno, E., and Basler, K. (2004). dMyc transforms cells into super-competitors. Cell 117, 117-129. 
 
Mosimann, C. (2007). The Role of Parafibromin/Hyrax in Nuclear Wnt/Wg and Hedgehog Signal 
Transduction. In Institut für Molekularbiologie (Zürich, Universität Zürich). 
 
Mosimann, C., Hausmann, G., and Basler, K. (2006). Parafibromin/Hyrax activates Wnt/Wg target 
gene transcription by direct association with beta-catenin/Armadillo. Cell 125, 327-341. 
 
Mueller, C.L., Porter, S.E., Hoffman, M.G., and Jaehning, J.A. (2004). The Paf1 complex has functions 
independent of actively transcribing RNA polymerase II. Mol Cell 14, 447-456. 
 
Muratani, M., Kung, C., Shokat, K.M., and Tansey, W.P. (2005). The F box protein Dsg1/Mdm30 is a 
transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell 
120, 887-899. 
 
Muratani, M., and Tansey, W.P. (2003). How the ubiquitin-proteasome system controls transcription. 
Nat Rev Mol Cell Biol 4, 192-201. 
 
Napoli, C., Lemieux, C., and Jorgensen, R. (1990). Introduction of a Chimeric Chalcone Synthase 
Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell 2, 
279-289. 
 
Narayanan, A., Ruyechan, W.T., and Kristie, T.M. (2007). The coactivator host cell factor-1 mediates 
Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. 
Proc Natl Acad Sci U S A 104, 10835-10840. 
 
Nau, M.M., Brooks, B.J., Battey, J., Sausville, E., Gazdar, A.F., Kirsch, I.R., McBride, O.W., Bertness, 
V., Hollis, G.F., and Minna, J.D. (1985). L-myc, a new myc-related gene amplified and expressed in 
human small cell lung cancer. Nature 318, 69-73. 
 
Nesbit, C.E., Tersak, J.M., and Prochownik, E.V. (1999). MYC oncogenes and human neoplastic 
disease [Review]. Oncogene 18, 3004-3016. 
 
Neufeld, T.P., de la Cruz, A.F., Johnston, L.A., and Edgar, B.A. (1998). Coordination of growth and 
cell division in the Drosophila wing. Cell 93, 1183-1193. 
 
Ng, H.H., Robert, F., Young, R.A., and Struhl, K. (2003). Targeted recruitment of Set1 histone 
methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. 
Mol Cell 11, 709-719. 
 
Nikiforov, M.A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J.M., and 
Cole, M.D. (2002a). A functional screen for Myc-responsive genes reveals serine 
hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 22, 
5793-5800. 
 
 139
Nikiforov, M.A., Chandriani, S., Park, J., Kotenko, I., Matheos, D., Johnsson, A., McMahon, S.B., and 
Cole, M.D. (2002b). TRRAP-dependent and TRRAP-independent transcriptional activation by Myc 
family oncoproteins. Mol Cell Biol 22, 5054-5063. 
 
Nilsson, J.A., and Cleveland, J.L. (2003). Myc pathways provoking cell suicide and cancer. Oncogene 
22, 9007-9021. 
 
Nilsson, J.A., Maclean, K.H., Keller, U.B., Pendeville, H., Baudino, T.A., and Cleveland, J.L. (2004). 
Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol 
24, 1560-1569. 
 
O'Connell, B.C., Cheung, A.F., Simkevich, C.P., Tam, W., Ren, X., Mateyak, M.K., and Sedivy, J.M. 
(2003). A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278, 
12563-12573. 
 
O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., and Mendell, J.T. (2005). c-Myc-regulated 
microRNAs modulate E2F1 expression. Nature 435, 839-843. 
 
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M., and Nakatani, Y. (2002). A complex with 
chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296, 1132-
1136. 
 
Orian, A., Van Steensel, B., Delrow, J., Bussemaker, H.J., Li, L., Sawado, T., Williams, E., Loo, L.W., 
Cowley, S.M., Yost, C., et al. (2003). Genomic binding by the Drosophila Myc, Max, Mad/Mnt 
transcription factor network. Genes Dev 17, 1101-1114. 
 
Oster, S.K., Ho, C.S., Soucie, E.L., and Penn, L.Z. (2002). The myc oncogene: MarvelouslY Complex. 
Adv Cancer Res 84, 81-154. 
 
Papaioannou, V.E., and Silver, L.M. (1998). The T-box gene family. BioEssays 20, 9-19. 
 
Parada, L.A., Hallen, M., Tranberg, K.G., Hagerstrand, I., Bondeson, L., Mitelman, F., and Johansson, 
B. (1998). Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes 
Chromosomes Cancer 23, 26-35. 
 
Patel, J.H., Du, Y., Ard, P.G., Phillips, C., Carella, B., Chen, C.J., Rakowski, C., Chatterjee, C., 
Lieberman, P.M., Lane, W.S., et al. (2004). The c-MYC oncoprotein is a substrate of the 
acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24, 10826-10834. 
 
Pavri, R., Zhu, B., Li, G., Trojer, P., Mandal, S., Shilatifard, A., and Reinberg, D. (2006). Histone H2B 
Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase II. 
Cell 125, 703. 
 
Penheiter, K.L., Washburn, T.M., Porter, S.E., Hoffman, M.G., and Jaehning, J.A. (2005). A 
posttranscriptional role for the yeast Paf1-RNA polymerase II complex is revealed by identification of 
primary targets. Mol Cell 20, 213-223. 
 
Pickart, C.M., and Cohen, R.E. (2004). Proteasomes and their kin: proteases in the machine age. Nat 
Rev Mol Cell Biol 5, 177-187. 
 
Pierce, S.B., Yost, C., Britton, J.S., Loo, L.W., Flynn, E.M., Edgar, B.A., and Eisenman, R.N. (2004). 
dMyc is required for larval growth and endoreplication in Drosophila. Development 131, 2317-2327. 
 
Piluso, D., Bilan, P., and Capone, J.P. (2002). Host Cell Factor-1 Interacts with and Antagonizes 
Transactivation by the Cell Cycle Regulatory Factor Miz-1. J Biol Chem %R 101074/jbcM206226200 
277, 46799-46808. 
 
Prendergast, G.C., Lawe, D., and Ziff, E.B. (1991). Association of Myn, the murine homolog of max, 
with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65, 395-407. 
 
 140
Queva, C., Hurlin, P.J., Foley, K.P., and Eisenman, R.N. (1998). Sequential expression of the MAD 
family of transcriptional repressors during differentiation and development. Oncogene 16, 967-977. 
 
Rottmann, S., and Luscher, B. (2006). The Mad side of the Max network: antagonizing the function of 
Myc and more. Curr Top Microbiol Immunol 302, 63-122. 
 
Roussel, M.F., Cleveland, J.L., Shurtleff, S.A., and Sherr, C.J. (1991). Myc rescue of a mutant CSF-1 
receptor impaired in mitogenic signalling. Nature 353, 361-363. 
 
Rozenblatt-Rosen, O., Hughes, C.M., Nannepaga, S.J., Shanmugam, K.S., Copeland, T.D., 
Guszczynski, T., Resau, J.H., and Meyerson, M. (2005). The Parafibromin Tumor Suppressor Protein 
Is Part of a Human Paf1 Complex. Mol Cell Biol 25, 612-620. 
 
Saunders, A., Werner, J., Andrulis, E.D., Nakayama, T., Hirose, S., Reinberg, D., and Lis, J.T. (2003). 
Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo. Science 
301, 1094-1096. 
 
Sawai, S., Shimono, A., Hanaoka, K., and Kondoh, H. (1991). Embryonic lethality resulting from 
disruption of both N-myc alleles in mouse zygotes. New Biologist 3, 861-869. 
 
Sawai, S., Shimono, A., Wakamatsu, Y., Palmes, C., Hanaoka, K., and Kondoh, H. (1993). Defects of 
embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. 
Development 117, 1445-1455. 
 
Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I., and DePinho, 
R.A. (1995). An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts 
with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786. 
 
Schreiber-Agus, N., Stein, D., Chen, K., Goltz, J.S., Stevens, L., and DePinho, R.A. (1997). Drosophila 
Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc Natl Acad Sci 
U S A 94, 1235-1240. 
 
Schuhmacher, M., Staege, M.S., Pajic, A., Polack, A., Weidle, U.H., Bornkamm, G.W., Eick, D., and 
Kohlhuber, F. (1999). Control of cell growth by c-Myc in the absence of cell division. Current Biology 9, 
1255-1258. 
 
Schwinkendorf, D. (2008). Mutational Identification of cis- and trans-acting Determinants of dMyc 
Protein Function. In Zoologisches Institut (Zürich, Universität Zürich), pp. 211. 
 
Secombe, J., Li, L., Carlos, L., and Eisenman, R.N. (2007). The Trithorax group protein Lid is a 
trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21, 537-551. 
 
Sheiness, D., Fanshier, L., and Bishop, J.M. (1978). Identification of nucleotide sequences which may 
encode the oncogenic capacity of avian retrovirus MC29. J Virol 28, 600-610. 
 
Sheldon, K.E., Mauger, D.M., and Arndt, K.M. (2005). A Requirement for the Saccharomyces 
cerevisiae Paf1 complex in snoRNA 3' end formation. Mol Cell 20, 225-236. 
 
Shen, X., Mizuguchi, G., Hamiche, A., and Wu, C. (2000). A chromatin remodelling complex involved 
in transcription and DNA processing. Nature 406, 541-544. 
 
Shibuya, H., Yoneyama, M., Ninomiya, T.J., Matsumoto, K., and Taniguchi, T. (1992). IL-2 and EGF 
receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a 
novel role for c-myc. Cell 70, 57-67. 
 
Shilatifard, A. (2006). CHROMATIN MODIFICATIONS BY METHYLATION AND UBIQUITINATION: 
Implications in the Regulation of Gene Expression. Annual Review of Biochemistry 75, 243-269. 
 
Sierra, J., Yoshida, T., Joazeiro, C.A., and Jones, K.A. (2006). The APC tumor suppressor counteracts 
beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20, 586-600. 
 
 141
Simpson, P., and Morata, G. (1981). Differential mitotic rates and patterns of growth in compartments 
in the Drosophila wing. Dev Biol 85, 299-308. 
 
Sims, R.J., III, Belotserkovskaya, R., and Reinberg, D. (2004). Elongation by RNA polymerase II: the 
short and long of it. Genes Dev 18, 2437-2468. 
 
Smith, S.T., Petruk, S., Sedkov, Y., Cho, E., Tillib, S., Canaani, E., and Mazo, A. (2004). Modulation of 
heat shock gene expression by the TAC1 chromatin-modifying complex. Nat Cell Biol 6, 162-167. 
 
Sontheimer, E.J. (2005). Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol 6, 
127-138. 
 
Sorrentino, V., Drozdoff, V., McKinney, M.D., Zeitz, L., and Fleissner, E. (1986). Potentiation of growth 
factor activity by exogenous c-myc expression. Proceedings of the National Academy of Sciences of 
the United States of America 83, 8167-8171. 
 
Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Moroy, T., Bartek, J., 
Massague, J., Hanel, F., et al. (2001). Repression of p15INK4b expression by Myc through 
association with Miz-1. Nat Cell Biol 3, 392-399. 
 
Stange, D.E., Radlwimmer, B., Schubert, F., Traub, F., Pich, A., Toedt, G., Mendrzyk, F., Lehmann, 
U., Eils, R., Kreipe, H., et al. (2006). High-resolution genomic profiling reveals association of 
chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast 
cancer. Clin Cancer Res 12, 345-352. 
 
Steiger, D. (2007). Analysis of the Max Network in Drosophila. In Zoologisches Institut (Zürich, 
Universität Zürich), pp. 173. 
 
Steiger, D., Furrer, M., Schwinkendorf, D., and Gallant, P. (2008). Max-independent functions of Myc 
in Drosophila melanogaster. Nat Genet advanced online publication. 
 
Stern, D.F., Roberts, A.B., Roche, N.S., Sporn, M.B., and Weinberg, R.A. (1986). Differential 
responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-
transfected cells by epidermal growth factor. Mol Cell Biol 6, 870-877. 
 
Suganuma, T., Gutierrez, J.L., Li, B., Florens, L., Swanson, S.K., Washburn, M.P., Abmayr, S.M., and 
Workman, J.L. (2008). ATAC is a double histone acetyltransferase complex that stimulates 
nucleosome sliding. Nat Struct Mol Biol 15, 364-372. 
 
Tarkkanen, M., Larramendy, M.L., Bohling, T., Serra, M., Hattinger, C.M., Kivioja, A., Elomaa, I., Picci, 
P., and Knuutila, S. (2006). Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by 
comparative genomic hybridisation and C-MYC expression by immunohistochemistry. Eur J Cancer 
42, 1172-1180. 
 
Tenney, K., Gerber, M., Ilvarsonn, A., Schneider, J., Gause, M., Dorsett, D., Eissenberg, J.C., and 
Shilatifard, A. (2006). Drosophila Rtf1 functions in histone methylation, gene expression, and Notch 
signaling. Proc Natl Acad Sci U S A 103, 11970-11974. 
 
Thrower, J.S., Hoffman, L., Rechsteiner, M., and Pickart, C.M. (2000). Recognition of the polyubiquitin 
proteolytic signal. EMBO J 19, 94-102. 
 
Toyo-oka, K., Bowen, T.J., Hirotsune, S., Li, Z., Jain, S., Ota, S., Lozach, L.E., Bassett, I.G., Lozach, 
J., Rosenfeld, M.G., et al. (2006). Mnt-Deficient Mammary Glands Exhibit Impaired Involution and 
Tumors with Characteristics of Myc Overexpression. Cancer Res 66, 5565-5573. 
 
Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G.R., and Bishop, J.M. (2001). 
c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-
773. 
 
 142
Tyagi, S., Chabes, A.L., Wysocka, J., and Herr, W. (2007). E2F Activation of S Phase Promoters via 
Association with HCF-1 and the MLL Family of Histone H3K4 Methyltransferases. Molecular Cell 27, 
107. 
 
Vennstrom, B., Sheiness, D., Zabielski, J., and Bishop, J.M. (1982). Isolation and characterization of c-
myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol 42, 
773-779. 
 
Verma, R., Aravind, L., Oania, R., McDonald, W.H., Yates, J.R., 3rd, Koonin, E.V., and Deshaies, R.J. 
(2002). Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. 
Science 298, 611-615. 
 
Vervoorts, J., Luscher-Firzlaff, J., and Luscher, B. (2006). The Ins and Outs of MYC Regulation by 
Posttranslational Mechanisms. J Biol Chem 281, 34725-34729. 
 
Vogel, J.L., and Kristie, T.M. (2000). The novel coactivator C1 (HCF) coordinates multiprotein 
enhancer formation and mediates transcription activation by GABP. EMBO J 19, 683-690. 
 
Voges, D., Zwickl, P., and Baumeister, W. (1999). The 26S proteasome: a molecular machine 
designed for controlled proteolysis. Annu Rev Biochem 68, 1015-1068. 
 
von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., Hydbring, P., 
Weidung, I., Nakayama, K., Nakayama, K.I., et al. (2003). The F-box protein Skp2 participates in c-
Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11, 
1189-1200. 
 
Walker, W., Zhou, Z.Q., Ota, S., Wynshaw-Boris, A., and Hurlin, P.J. (2005). Mnt-Max to Myc-Max 
complex switching regulates cell cycle entry. J Cell Biol 169, 405-413. 
 
Wang, P.F., Tan, M.H., Zhang, C., Morreau, H., and Teh, B.T. (2005). HRPT2, a tumor suppressor 
gene for hyperparathyroidism-jaw tumor syndrome. Horm Metab Res 37, 380-383. 
 
Wanzel, M., Herold, S., and Eilers, M. (2003). Transcriptional repression by Myc. Trends Cell Biol 13, 
146-150. 
 
Weake, V.M., and Workman, J.L. (2008). Histone Ubiquitination: Triggering Gene Activity. Molecular 
Cell 29, 653-663. 
 
Wert, M., Kennedy, S., Palfrey, H.C., and Hay, N. (2001). Myc drives apoptosis in PC12 cells in the 
absence of Max. Oncogene 20, 3746-3750. 
 
Wilson, A.C., LaMarco, K., Peterson, M.G., and Herr, W. (1993). The VP16 accessory protein HCF is 
a family of polypeptides processed from a large precursor protein. Cell 74, 115-125. 
 
Wood, A., Schneider, J., Dover, J., Johnston, M., and Shilatifard, A. (2003). The Paf1 complex is 
essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone 
methylation by COMPASS and Dot1p. J Biol Chem 278, 34739-34742. 
 
Wood, A., Schneider, J., Dover, J., Johnston, M., and Shilatifard, A. (2005). The Bur1/Bur2 complex is 
required for histone H2B monoubiquitination by Rad6/Bre1 and histone methylation by COMPASS. 
Mol Cell 20, 589-599. 
 
Wood, M.A., McMahon, S.B., and Cole, M.D. (2000). An ATPase/helicase complex is an essential 
cofactor for oncogenic transformation by c-Myc. Mol Cell 5, 321-330. 
 
Woodard, G.E., Lin, L., Zhang, J.H., Agarwal, S.K., Marx, S.J., and Simonds, W.F. (2005). 
Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin 
D1/PRAD1 expression. Oncogene 24, 1272-1276. 
 
 143
Wu, S., Cetinkaya, C., Munoz-Alonso, M.J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, 
J., and Larsson, L.-G. (2003). Myc represses differentiation-induced p21CIP1 expression via Miz-1-
dependent interaction with the p21 core promoter. Oncogene 22, 351-360. 
 
Wysocka, J., and Herr, W. (2003). The herpes simplex virus VP16-induced complex: the makings of a 
regulatory switch. Trends in Biochemical Sciences 28, 294. 
 
Wysocka, J., Myers, M.P., Laherty, C.D., Eisenman, R.N., and Herr, W. (2003). Human Sin3 
deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together 
selectively by the cell-proliferation factor HCF-1. Genes Dev 17, 896-911. 
 
Yart, A., Gstaiger, M., Wirbelauer, C., Pecnik, M., Anastasiou, D., Hess, D., and Krek, W. (2005). The 
HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA 
polymerase II. Mol Cell Biol 25, 5052-5060. 
 
Yin, X.Y., Grove, L., and Prochownik, E.V. (1998). Lack of transcriptional repression by max 
homodimers. Oncogene 16, 2629-2637. 
 
Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D.J., Kitabayashi, I., Herr, W., and Cleary, 
M.L. (2004). Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase 
Complex with Menin To Regulate Hox Gene Expression. Mol Cell Biol 24, 5639-5649. 
 
Zeller, K.I., Jegga, A.G., Aronow, B.J., O'Donnell, K.A., and Dang, C.V. (2003). An integrated 
database of genes responsive to the Myc oncogenic transcription factor: identification of direct 
genomic targets. Genome Biol 4, R69. 
 
Zervos, A.S., Gyuris, J., and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to 
bind Myc-Max recognition sites [published erratum appears in Cell 1994 Oct 21;79(2):following 388]. 
Cell 72, 223-232. 
 
Zhang, C., Kong, D., Tan, M.H., Pappas, D.L., Jr., Wang, P.F., Chen, J., Farber, L., Zhang, N., Koo, 
H.M., Weinreich, M., et al. (2006). Parafibromin inhibits cancer cell growth and causes G1 phase 
arrest. Biochem Biophys Res Commun 350, 17-24. 
 
Zhou, Z.Q., and Hurlin, P.J. (2001). The interplay between Mad and Myc in proliferation and 
differentiation. Trends Cell Biol 11, S10-14. 
 
Zhu, B., Mandal, S.S., Pham, A.D., Zheng, Y., Erdjument-Bromage, H., Batra, S.K., Tempst, P., and 
Reinberg, D. (2005). The human PAF complex coordinates transcription with events downstream of 
RNA synthesis. Genes Dev 19, 1668-1673. 
 
Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. 
(1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and 
immortalization. Genes & Development 12, 2424-2433. 
 144
Acknowledgements 
 
First of all I want to thank Peter Gallant for his guidance, advice and support during the completion of 
this work. I would also like to thank the past and present Gallant lab members, who have become 
more than just colleagues, for always being supportive, for their assistance, and an excellent working 
athmosphere: Anja Egli, Toby Hulf, Changqing Li, Sonali Mohanty, Nadine Müller, René Oetterli, 
Regina Pérez, Daniela Schwinkendorf and Dominik Steiger. My very special thanks go to Mirjam Balbi, 
who conducted a large part of the HCF project included in this study for constantly exceeding my 
expectations. 
For specific support I am very grateful to the following people who made everyday work a lot easier: 
Anni Strässle, Raymond Grunder, Matthias Bodmer and Martin Moser for sequencing and qRTPCR. In 
addition, I am indebted to George Hausmann, Christian Mosimann, Reto Städeli and Konrad Basler for 
generously providing me with fly stocks and other reagents used in this work and for their expertise. I 
would like to thank Peder Zipperlen for his help during the setup phase of the screen. For discussions 
and helpful suggestions I acknowledge the members of the Basler, Hafen and Hajnal labs. 
Finally, I am extremely thankful for the support of my friends and family, who have always sustained 
me. 
 145
 Curriculum vitae 
 
 
 
Name 
Vorname 
Geburtsdatum 
Heimatort 
 
 
 
FURRER 
Michael 
27.05.1976 
Unterbäch VS 
Ausbildung 
 
 
Maturität Typus C Kantonschule Oerlikon 
 
01/1996 
Universität Zürich, Biologie 
Grundstudium Biologie 
Fachstudium Zoologie 
Nebenfachstudium 
weiteres Nebenfach 
 
10/1996–04/2002 
10/1996–07/1998 
10/1998–02/2002 
Molekularbiologie 
Physikalische Chemie 
Diplomarbeit Maternal Product from the Gene gomo, an 
Inositol Hexakisphosphate Kinase, is Required 
for the First Mitotic Divisions of Drosophila 
Embryogenesis. 
 
Diplom in Zoologie 
 
04/2002 
Doktorat am Zoologischen Institut seit 01.06.2004 
 
 146
